
<html lang="en"     class="pb-page"  data-request-id="a09db879-6c89-45a4-bac5-1b516ba3fa6d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.6b01058;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2016.59.issue-19"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure–Activity Relationship Study" /></meta><meta name="dc.Creator" content="Stinne W.  Hansen" /></meta><meta name="dc.Creator" content="Mette N.  Erichsen" /></meta><meta name="dc.Creator" content="Bingru  Fu" /></meta><meta name="dc.Creator" content="Walden E.  Bjørn-Yoshimoto" /></meta><meta name="dc.Creator" content="Bjarke  Abrahamsen" /></meta><meta name="dc.Creator" content="Jacob C.  Hansen" /></meta><meta name="dc.Creator" content="Anders A.  Jensen" /></meta><meta name="dc.Creator" content="Lennart  Bunch" /></meta><meta name="dc.Description" content="Screening of a small compound library at the three excitatory amino acid transporter subtypes 1–3 (EAAT1–3) resulted in the identification of compound (Z)-4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,..." /></meta><meta name="Description" content="Screening of a small compound library at the three excitatory amino acid transporter subtypes 1–3 (EAAT1–3) resulted in the identification of compound (Z)-4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 14, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01058" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01058" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01058" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01058" /></link>
        
    
    

<title>Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure–Activity Relationship Study | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01058" /></meta><meta property="og:title" content="Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure–Activity Relationship Study" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0012.jpeg" /></meta><meta property="og:description" content="Screening of a small compound library at the three excitatory amino acid transporter subtypes 1–3 (EAAT1–3) resulted in the identification of compound (Z)-4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid (1a) that exhibited a distinct preference as an inhibitor at EAAT1 (IC50 20 μM) compared to EAAT2 and EAAT3 (IC50 &gt; 300 μM). This prompted us to subject 1a to an elaborate structure–activity relationship study through the purchase and synthesis and subsequent pharmacological characterization of a total of 36 analogues. Although this effort did not result in analogues with substantially improved inhibitory potencies at EAAT1 compared to that displayed by the hit, it provided a detailed insight into structural requirements for EAAT1 activity of this scaffold. The discovery of this new class of EAAT1-selective inhibitors not only supplements the currently available pharmacological tools in the EAAT field but also substantiates the notion that EAAT ligands not derived from α-amino acids hold considerable potential in terms of subtype-selective modulation of the transporters." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01058"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01058">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01058&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01058&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01058&amp;href=/doi/10.1021/acs.jmedchem.6b01058" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 8757-8770</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00472" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01066" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure–Activity Relationship Study</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stinne+W.++Hansen">Stinne W. Hansen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mette+N.++Erichsen">Mette N. Erichsen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bingru++Fu">Bingru Fu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Walden+E.++Bj%C3%B8rn-Yoshimoto">Walden E. Bjørn-Yoshimoto</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bjarke++Abrahamsen">Bjarke Abrahamsen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacob+C.++Hansen">Jacob C. Hansen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anders+A.++Jensen">Anders A. Jensen</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lennart++Bunch">Lennart Bunch</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen Ø 2100, Denmark</span></div><div class="corresp-info"><strong>*</strong>Phone: +45 35 33 62 44. E-mail: <a href="/cdn-cgi/l/email-protection#cfa3aaadba8fbcbaa1abe1a4bae1aba4"><span class="__cf_email__" data-cfemail="14787176615467617a703a7f613a707f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01058&amp;href=/doi/10.1021%2Facs.jmedchem.6b01058" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 8757–8770</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 14, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 July 2016</li><li><span class="item_label"><b>Published</b> online</span>14 September 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 October 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01058" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01058</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8757%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DStinne%2BW.%2BHansen%252C%2BMette%2BN.%2BErichsen%252C%2BBingru%2BFu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D19%26contentID%3Dacs.jmedchem.6b01058%26title%3DIdentification%2Bof%2Ba%2BNew%2BClass%2Bof%2BSelective%2BExcitatory%2BAmino%2BAcid%2BTransporter%2BSubtype%2B1%2B%2528EAAT1%2529%2BInhibitors%2BFollowed%2Bby%2Ba%2BStructure%25E2%2580%2593Activity%2BRelationship%2BStudy%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8770%26publicationDate%3DOctober%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01058"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1396</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01058" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure–Activity Relationship Study&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Stinne&quot;,&quot;last_name&quot;:&quot;W. Hansen&quot;},{&quot;first_name&quot;:&quot;Mette&quot;,&quot;last_name&quot;:&quot;N. Erichsen&quot;},{&quot;first_name&quot;:&quot;Bingru&quot;,&quot;last_name&quot;:&quot;Fu&quot;},{&quot;first_name&quot;:&quot;Walden&quot;,&quot;last_name&quot;:&quot;E. Bjørn-Yoshimoto&quot;},{&quot;first_name&quot;:&quot;Bjarke&quot;,&quot;last_name&quot;:&quot;Abrahamsen&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;C. Hansen&quot;},{&quot;first_name&quot;:&quot;Anders&quot;,&quot;last_name&quot;:&quot;A. Jensen&quot;},{&quot;first_name&quot;:&quot;Lennart&quot;,&quot;last_name&quot;:&quot;Bunch&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;8757-8770&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01058&quot;},&quot;abstract&quot;:&quot;Screening of a small compound library at the three excitatory amino acid transporter subtypes 1–3 (EAAT1–3) resulted in the identification of compound (Z)-4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid (1a) that exhibited a distinct preference as an inhibitor at EAAT1 (IC50 20 μM) compared to EAAT2 and EAAT3 (IC50 &gt; 300 μM). This prompted us to subject 1a to an elaborate structure–activity relationship study through the purchase and synthesis and subsequent pharmacological characterization of a total of 36 analogues. Although this effort did not result in analogues with substantially improved inhibitory potencies at EAAT1 compared to that displayed by the hit, it provided a detailed insight into structural requirements for EAAT1 activity of this scaffold. The discovery of this new class of EAAT1-selective inhibitors not only supplements the currently available pharmacological tools in the EAAT field but also substantiates the notion that EAAT ligands not &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01058&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01058" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01058&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01058" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01058&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01058" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01058&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01058&amp;href=/doi/10.1021/acs.jmedchem.6b01058" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01058" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01058" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01058%26sid%3Dliteratum%253Aachs%26pmid%3D27626828%26genre%3Darticle%26aulast%3DHansen%26date%3D2016%26atitle%3DIdentification%2Bof%2Ba%2BNew%2BClass%2Bof%2BSelective%2BExcitatory%2BAmino%2BAcid%2BTransporter%2BSubtype%2B1%2B%2528EAAT1%2529%2BInhibitors%2BFollowed%2Bby%2Ba%2BStructure%25E2%2580%2593Activity%2BRelationship%2BStudy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D19%26spage%3D8757%26epage%3D8770%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/jmcmar.2016.59.issue-19/20161013/jmcmar.2016.59.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Screening of a small compound library at the three excitatory amino acid transporter subtypes 1–3 (EAAT1–3) resulted in the identification of compound (<i>Z</i>)-4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid (<b>1a</b>) that exhibited a distinct preference as an inhibitor at EAAT1 (IC<sub>50</sub> 20 μM) compared to EAAT2 and EAAT3 (IC<sub>50</sub> > 300 μM). This prompted us to subject <b>1a</b> to an elaborate structure–activity relationship study through the purchase and synthesis and subsequent pharmacological characterization of a total of 36 analogues. Although this effort did not result in analogues with substantially improved inhibitory potencies at EAAT1 compared to that displayed by the hit, it provided a detailed insight into structural requirements for EAAT1 activity of this scaffold. The discovery of this new class of EAAT1-selective inhibitors not only supplements the currently available pharmacological tools in the EAAT field but also substantiates the notion that EAAT ligands not derived from α-amino acids hold considerable potential in terms of subtype-selective modulation of the transporters.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">(<i>S</i>)-Glutamate (<i>S</i>)-(Glu) is the major excitatory neurotransmitter in the CNS being involved in a plethora of physiological and pathophysiological processes. Dysfunctional glutamatergic neurotransmission is known to constitute a core component of a wide range of cognitive, psychiatric, and neurotoxic/neurodegenerative disorders. This fact makes glutamatergic targets highly interesting as drug targets. The synaptic reuptake of (<i>S</i>)-Glu following its release from presynaptic terminals into the synaptic cleft during neurotransmission is mediated by the family of excitatory amino acid transporters (EAATs).<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1-6)</a> The EAAT family consists of five transporters, termed EAAT1–5. The EAAT1,2 subtypes are predominantly expressed in glia cells, and the EAAT3–5 subtypes are predominantly expressed in neurons. The five subtypes are also characterized by distinct expression patterns in the CNS. EAAT2 is the major physiological subtype believed to account for >90% of total Glu uptake in the brain, and EAAT1 and EAAT3 are also widely expressed in the CNS. As for EAAT1, it is the major EAAT subtype in the cerebellum (where the highest density of the transporter is found in Bergmann glia cells), circumventribular organs, inner ear, and the retina, but the transport are also abundantly distributed in other CNS regions.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In contrast, EAAT4 and EAAT5 are expressed almost exclusively in cerebellum and retina, respectively.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a></div><div class="NLM_p">In contrast to the immense efforts made in terms of ligand development in the glutamate receptor field over the last couple of decades, the EAATs have been given considerably less attention as putative drug targets. Because of this, the selection of pharmacological tools for the transporters are rather limited and only a few ligands displaying true subtype-selectivity between the five EAATs have been identified. This has been an obstacle to explorations of the physiological functions and putative therapeutic potential of the respective subtypes.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Most of the ligand development in the EAAT field has been based on the scaffolds of the endogenous substrates for the transporters, (<i>S</i>)-Glu and (<i>S</i>/<i>R</i>)-aspartate (<i>S</i>/<i>R</i>)-(Asp) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). As exemplified in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B, these efforts have yielded a couple of ligands exhibiting distinct selectivity or preference for one EAAT subtype over others. The substrate binding sites in the EAATs are believed to be quite conserved, and this presents a challenge to the development of orthosteric subtype-selective ligands.<a onclick="showRef(event, 'ref3 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref5 ref6">(3, 5, 6)</a> In the light of this, we have previously applied the strategy of identification of novel EAAT inhibitors by screening of compound libraries followed by medicinal chemistry optimization. Compounds comprised in these library screenings are often structurally very different from α-amino acids, which leads to the assumption that hit compounds likely act through allosteric sites in the transporter. A successful outcome of this approach is discovery of the first class of EAAT1-selective inhibitors, represented by the analogues 2-amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-4<i>H</i>-chromene-3-carbonitrile (<b>38</b>, UCPH-101)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and 2-amino-5,6,7,8-tetrahydro-4-(4-methyl)-7-(naphthalen-1-yl)-5-oxo-4<i>H</i>-chromene-3-carbonitrile (<b>39</b>, UCPH-102)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C).<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> This inhibitor class was developed based on a hit compound identified in a screening of a commercial 3040-compound library at EAAT1–3,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and in subsequent studies the structure–activity-relationship (SAR) of this scaffold was explored in great detail.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9-12)</a> In the present study, we report the discovery of a new class of selective EAAT1 inhibitors based on another hit compound from this screening and present an elaborate structure–activity relationship (SAR) study of this inhibitor class.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of the endogenous EAAT substrates (<i>S</i>)-Glu and (<i>S</i>/<i>R</i>)-Asp and reported subtype preferring/selective EAAT inhibitors: WAY213613,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (2<i>S</i>)-3-((3-(trifluoromethyl)phenyl)sulfonamido)aspartic acid (<b>40</b>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> L-β-BA,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> DHK,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> (2<i>S</i>,4<i>R</i>)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid (<b>41</b>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>38</b>,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and <b>39</b>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">From a library screening, compound <b>1a</b> was found to be a putative EAAT1-selective inhibitor.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> When tested at a concentration of ∼100 μM, <b>1a</b> almost completely inhibited the EAAT1-mediated uptake of [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake in EAAT1-HEK293 cells, whereas it exhibited no significant effects on [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake measured in EAAT2- and EAAT3-HEK293 cells in concomitant screenings. This apparent selective EAAT1-selectivity was subsequently verified by detailed characterization of the compound in the [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake assay. <b>1a</b> was found to inhibit EAAT1-mediated uptake in a concentration-dependent manner exhibiting an IC<sub>50</sub> value of 20 μM, whereas it did not inhibit EAAT2- or EAAT3-mediated uptake at concentrations up to 300 μM (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). These pharmacological properties were subsequently confirmed for a batch of <b>1a</b> synthesized by us, which exhibited IC<sub>50</sub> values of 12 μM, >300 μM, and >300 μM at EAAT1, EAAT2, and EAAT3, respectively (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, <a class="ref internalNav" href="#tbl3" aria-label="Tables 3">Tables 3</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The fact that no significant inhibition of EAAT2,3 was observed for <b>1a</b> at 300 μM suggests that the compound is at least 50-fold selective for EAAT1 over EAAT2,3 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Concentration–inhibition curves for (<i>S</i>)-Glu and <b>1a</b> at EAAT1-, EAAT2-, and EAAT3-HEK293 cells in the [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake assay. The figure depicts data from single representative experiments, and data are given as mean ± SD values (in % of specific uptake determined in the absence of test compound).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The interesting selectivity profile exhibited by <b>1a</b> prompted us to perform an elaborate SAR study on this compound scaffold, where a total of 36 analogues were either purchased from commercial sources or synthesized and subsequently tested on EAAT1–3 in a [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake assay. A structural analysis of <b>1a</b> identifies five rotatable bounds, of which the aryl-heteroaryl and the heteroaryl-alkenyl bonds are restrained by strong rotational barriers. Thus, <b>1a</b> is a highly conformationally locked structure with a well-defined low-energy conformation (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). To explore the SAR of this compound class, we disconnected <b>1a</b> into synthetically feasible fragments: an ester moiety (purple), an aryl moiety (blue), a heteroaromatic moiety (red), and heterocycle (green) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Low-energy conformation of <b>1a</b>. (B) Overview of disconnections and chemical modifications of <b>1a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Pharmacological Characterization of <b>2a</b>–<b>2e</b></h3><div class="NLM_p">We first explored the influence of the chloro-carboxy substituted phenyl ring on the EAAT1 activity through the testing of the commercially available analogues <b>2a</b>–<b>2e</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Perhaps not surprisingly, the dramatic structural changes introduced in analogues <b>2b</b>–<b>2e</b> resulted in complete loss of inhibitory activity at EAAT1 (and EAAT2,3). The inactivity of analogue <b>2a</b>, in which the phenyl ring substituent is retained but with a completely different substitution pattern compared to <b>1a</b>, was more informative. This suggested that the presence of a carboxylate group in the 4′-position and/or the presence of a substituent smaller than a bromo atom in the 2′-position was important for EAAT1 activity. The exact importance of these two substituents was investigated further in a subsequent part of the SAR study.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Investigation of the Importance of the 2-Chloro-5-carboxyphenyl Functionality for EAAT1 Activity<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0007.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Compound obtained from commercial supplier.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">None of the Compounds Displayed Inhibitory Activity at EAAT2,3 (IC<sub>50</sub> > 300 μM)</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Pharmacological Characterization of <b>3a</b>–<b>d</b></h3><div class="NLM_p">We next turned to investigate the importance of the ester functionality by characterizing the commercially available analogues <b>3a</b>–<b>3d</b> at EAAT1–3 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The ester functionality was found to be of key importance, and it was therefore decided to retain this functionality throughout the rest of the SAR study.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Investigation of the Importance of the Ester Functionality for EAAT1 Activity (None of the Compounds Displayed Inhibitory Activity at EAAT2,3 (IC<sub>50</sub> > 300 μM))</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Compound obtained from commercial supplier.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Synthesis and Pharmacological Characterization of <b>1b</b>–<b>m</b></h3><div class="NLM_p">We then proceeded with a detailed SAR study of the phenyl ring and its substituents. This work was commenced by resynthesis of <b>1a</b> by coupling of 3-bromo-4-chloro benzoic acid (<b>5</b>) with boronic acid <b>6</b> to give <b>7</b> in good conversion (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Crude <b>7</b> was therefore protected as its benzyl ester under standard conditions, and <b>8</b> was isolated in 65% over two steps. Condensation with <b>9</b>, readily obtained from <b>10</b>, gave the desired target compounds <b>11</b>, and after deprotection, <b>1a</b> in 58% yield.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>1a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub> (aq), DME:EtOH 50 °C; (b) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (c) <b>9</b>, piperidine, EtOH, reflux; (d) FeCl<sub>3</sub>, DCM, rt; (e) ethyl 2-bromoacetate, NaH (60 w/w%), THF, reflux.</p></p></figure><div class="NLM_p">Following the same strategy, (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, step b) Pd-catalyzed coupling of 3-(5-formyl-2-furyl)-4-methoxybenzoic acid with boronic acid <b>6</b> gave the desired target compound <b>1d</b> in 24%. The synthesis of <b>1g</b> was achieved starting from 3-bromo-4-fluoro-benzoic acid which underwent Pd-catalyzed coupling with <b>6</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, step b) to give aldehyde <b>12</b> in 60%. Condensation with <b>9</b> gave target compound <b>1g</b> in 37% yield. To access benzyloxy analogue <b>1e</b>, 4-(benzyloxy)-3-bromobenzoic acid (<b>14</b>) (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) was prepared from <b>13</b> by benzylation of both the phenol and the carboxylic acid functionalities followed by saponification of the benzyl ester.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Coupling of <b>14</b> with <b>6</b> gave the desired product 4-(benzyloxy)-3-(5-formylfuran-2-yl)benzoic acid (<b>15</b>) in low yield as reported by others.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The synthesis of <b>1h</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) commenced by regioselective bromination of 3-amino-2-naphthoic acid (<b>16</b>) to give 3-amino-4-bromo-2-naphthoic acid (<b>17</b>) in 89%. Subsequent deamination by treatment with NaNO<sub>2</sub> in H<sub>2</sub>SO<sub>4</sub> gave 4-bromo-2-naphthoic acid (<b>18</b>) in 91%. Coupling of bromine <b>18</b> with boronic acid <b>6</b> gave the desired aldehyde <b>19</b> in 11% yield. Despite the low yield, the reaction was not optimized further as condensation of <b>19</b> with <b>9</b> gave <b>1h</b> in quantities sufficient for spectral and pharmacological characterization. The synthesis of <b>1c</b> was carried out by condensation of <b>20</b> with <b>6</b> to give <b>1c</b> in 80% yield.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>ortho</i>-Benzyloxy Analogue <b>1e</b> and 1-Naphthyl Analogue <b>1h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) benzyl bromide, anhydrous K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (b) 4 M NaOH (aq), MeOH, rt; (c) (5-formylfuran-2-yl)boronic acid (<b>6</b>), cat. Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, toluene:EtOH (7:3), 90 °C; (d) <b>9</b>, 0.1 equiv piperidine, 0.1 equiv AcOH, EtOH, 90 °C; (e) Br<sub>2</sub>, FeBr<sub>3</sub>, CHCl<sub>3</sub>, 2 h, rt; (g) NaNO<sub>2</sub>, H<sub>2</sub>SO<sub>4</sub>, AcOH, then Cu<sub>2</sub>O, reflux; (g) <b>6</b>, cat. Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, toluene:EtOH (7:3), 90 °C. (h) <b>9</b>, 0.1 equiv piperidine, 0.1 equiv AcOH, EtOH, 90 °C.</p></p></figure><div class="NLM_p">Pharmacological evaluation of <b>1a</b>–<b>1m</b> at EAAT1–3 (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) revealed a number of interesting observations: Repositioning of the 2′-chlorine atom to the 4′-position (compound <b>1b</b>) led to complete loss of EAAT1 inhibitory activity. The same was observed when the carboxylate group was relocated from the 5′-position to the 4′-position (compound <b>1c</b>). Substitution of the chlorine for a methoxy group (compound <b>1d</b>) was well accepted, whereas the benzyloxy group introduced in this position in analogue <b>1e</b> evidently was too bulky (IC<sub>50</sub> > 300 μM). Analogues with a methyl group (compound <b>1f</b>) or a fluorine atom (compound <b>1g</b>) in this position both exhibited ∼5-fold drop in inhibitory activity. Interestingly, a 1-naphthyl group (compound <b>1h</b>) was well accepted, which opens up for introduction of additional substitutions. Analogues <b>1i</b>–<b>1m</b> were all inactive, which further underlines the necessity of a substituent in the 2′-position and a carboxylate group in the 5′-position. Importantly, the size of the 2′-substituent is clearly essential for the EAAT1 inhibitory activity, as evidenced by the equipotent EAAT1 activity of the Cl- and MeO-analogues <b>1a</b> and <b>1d</b> compared to the inactivity of analogues with smaller (Me, F) or bigger (benzyloxy) substituents. It was decided to retain the 2′-chloro functionality throughout the rest of the SAR study.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Detailed SAR Study of the Phenyl Ring and Its Substitution Pattern for EAAT1 Activity (None of the Compounds Displayed Inhibitory Activity at EAAT2,3 (IC<sub>50</sub> > 300 μM))</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0009.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Compound obtained from commercial supplier.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">The concentration–inhibition curve for the compound was not complete within the tested concentration range, thus the IC<sub>50</sub> value was estimated from the fitted curve.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthesis and Pharmacological Characterization of <b>1n</b>–<b>q</b></h3><div class="NLM_p">The next step was a SAR study of the importance of the furan ring and the alkene functionality for EAAT1 activity. In these analogues, the furan ring of <b>1a</b> was substituted with a phenyl (<b>1n</b> and <b>1o</b>) or a 2,5-thienyl (<b>1p</b>) ring systems and the alkene for an alkyl bond (<b>1q</b>). Synthesis of the meta-substituted phenyl analogue <b>1n</b> was accomplished by coupling of commercially available 3-bromo-4-chlorobenzoic acid with <b>6</b> to give <b>21</b>, which was then condensed with <b>9</b> to give the target compound <b>1n</b> in 55% yield. Analogously, the para-substituted analogue <b>1o</b> was prepared in 49% yield, while the 2,5-thienyl analogue <b>1p</b> was obtained in 50% yield from respective aldehydes. Synthesis of <b>1q</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) was achieved by first reducing aldehyde <b>8</b> to the alcohol <b>22</b>, which was then converted to chloride <b>23</b>. <i>N</i>-Alkylation of heterocycle <b>25</b> under standard conditions provided <b>24</b>, which after deprotection gave <b>1q</b> in 52%.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Conformationally Relieved Analogue <b>1q</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) NaBH<sub>4</sub>, THF, rt; (b) SOCl<sub>2</sub>, pyridine, DCM; (c) NaH, DMF; (d) H<sub>2</sub> (g), Pd/C; (e) NaH, THF, 50 °C.</p></p></figure><div class="NLM_p">Interestingly, the meta-substituted phenyl analogue <b>1n</b> exhibited EAAT1 activity although it displayed slightly lower inhibitory potency compared to <b>1a</b>. On the other hand, the <i>para</i>-substituted phenyl analogue <b>1o</b> was completely inactive. The 2,5-thienyl analogue <b>1p</b> was also inactive, which is surprising given the similarity in substitution geometry compared to <b>1n</b> and <b>1a</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). The heterocyclic analogue <b>1q</b> displayed no inhibitory activity at EAAT1, which underlines the importance of the linear geometry of the molecule for transporter activity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR Study of the Influence of the Furan Ring and the Alkene Functionalities on EAAT1 Inhibitory Activity (None of the Compounds Displayed Inhibitory Activity at EAAT2,3 (IC<sub>50</sub> > 300 μM))</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0010.gif" alt="" id="fx4" /></img><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis and Pharmacological Characterization of <b>4b</b>–<b>4e</b></h3><div class="NLM_p">The limited success enhancing the potency of <b>1a</b> led us to explore more fundamental changes to the core skeleton. Having learned that the carboxylate and the alkene functionalities were important, we decided to synthesize truncated as well as conformationally relieved analogues of <b>1a</b> wherein only the ethyl 2-(2,4-dioxothiazolidin-3-yl)acetate (<b>9</b>) heterocycle was conserved. In total, 11 analogues <b>4b</b>–<b>4f</b> and <b>4g</b>–<b>4e</b>, respectively, were prepared by condensation of the corresponding aldehyde (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) with <b>9</b> in accordance with previously applied conditions (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The pharmacological properties exhibited by these 11 analogues (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) were however disappointing, as they were all very inactive at EAAT1–3.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR Study of Conformationally Relieved Analogues <b>4a</b>–<b>g</b> Wherein the Ethyl 2-(2,4-Dioxothiazolidin-3-yl)acetate (<b>9</b>) Heterocycle Is Conserved from Lead Structure <b>1a</b><a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0011.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>Table a</sup><p class="last">None of the compounds <b>4a</b>–<b>g</b> displayed inhibitory activity at EAAT2,3 (IC<sub>50</sub> > 300 μM).</p></div></div><div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have identified a new class of EAAT1-selective inhibitors by screening of a commercially available compound library. While the SAR study presented herein of <b>1a</b> largely failed to to improve its EAAT1 inhibitory potency, it did disclose substantial insight into the pharmacophore elements which will be useful in future work within the field. More importantly, the EAAT1-selectivity exhibited by this inhibitor class substantiates the notion gained from the <b>38</b>/<b>39</b> inhibitor class, that subtype-selective EAAT modulators can emerge from scaffolds with no structural similarity to the α-amino acids. Considering the distinct chemical structure of <b>1a</b> compared to the EAAT substrates, it seems plausible that the compound analogously to <b>38</b>/<b>39</b> could mediate its EAAT1 inhibition through an allosteric site in the transporter.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, it should be stressed that a definite conclusion as to whether <b>1a</b> and the other inhibitors in this class are indeed allosteric inhibitors or actually target the substrate-binding pocket in EAAT1 will have to await further experimental data. Finally, it is noteworthy that even though <b>1a</b> clearly is not nearly as potent and selective an EAAT1 inhibitor as <b>38</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> or <b>39</b>,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> the inhibitory potency and degree of selectivity exhibited by <b>1a</b> at EAAT1 are nevertheless roughly comparable to the properties displayed by DHK at EAAT2.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In view of the extensive use of this prototypic EAAT2 inhibitor as a pharmacological tool in studies of EAAT2 function in native tissues over the years, we propose that <b>1a</b> analogously could be a valuable tool in future explorations of the physiological roles mediated by and the therapeutic potential in EAAT1, be it as a supplement or alternative to <b>38</b>/<b>39</b>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70866" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70866" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p">All reactions involving anhydrous solvents or sensitive agents were performed under a nitrogen atmosphere, and glassware was dried prior to use. Solvents were dried according to standard procedures, and reactions were monitored by analytical thin-layer chromatography (TLC, Merck silica gel 60 F<sub>254</sub> aluminum sheets). Flash chromatography was carried out using Merck silica gel 60A (35–70 μm), and dry column chromatography was carried out using Merck silica gel 60 (15–40 μm). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance 400 MHz in CDCl<sub>3</sub> using CHCl<sub>3</sub> as internal standard unless otherwise noted. MS spectra were recorded using LC-MS performed using an Agilent 1200 solvent delivery system equipped with an autoinjector coupled to an Agilent 6400 triple quadrupole mass spectrometer equipped with an electrospray ionization source. Gradients of 5% aqueous acetonitrile containing 0.05% formic acid (eluent A) and 95% aqueous acetonitrile containing 0.05% formic acid (eluent B) were employed. Analytical HPLC was performed using a Dionex UltiMate 3000 pump and photodiode array detector (200 and 210 nm, respectively) installed with an XTerra MS C<sub>18</sub> 3.5 μm, 4.6 mm × 150 mm column, using a 5 → 95% MeCN gradient in H<sub>2</sub>O containing 0.1% TFA. Melting points were measured using a MPA 100 Optimelt automatic melting point system. Optical rotation was measured using a PerkinElmer 241 polarimeter with Na lamp (589 nm). All commercial chemicals were used without further purification. The purity of all tested compounds was determined by HPLC to be >95%.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (<i>Z</i>)-4-Chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic Acid (<b>1a</b>)</h4><div class="NLM_p last">Under a nitrogen atmosphere, (<i>Z</i>)-benzyl 4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoate (<b>11</b>) (0.100 g, 0.190 mmol, 1 equiv) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (3.8 mL). FeCl<sub>3</sub> (0.124 g, 0.761 mmol, 4 equiv) was added during ice-cooling, and after 10 min of stirring at that temperature the mixture was left to come to rt for 2.5 h. The reaction was quenched by addition of H<sub>2</sub>O (30 mL) and then extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 50 mL). The combined organic phases were dried using anhydrous MgSO<sub>4</sub>, filtered, and evaporated to give a brown solid (0.093 g). The crude product was purified by dry column vacuum chromatography (eluent: 100:1 CH<sub>2</sub>Cl<sub>2</sub>/AcOH) to give the title compound (0.048 g, 58%) as yellow solid. <i>R</i><sub>f</sub> (100:1 CH<sub>2</sub>Cl<sub>2</sub>/AcOH) 0.14. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.53 (d, 1H, <i>J</i> = 2.0 Hz), 7.94 (dd, 1H, <i>J</i> = 2.0 Hz, <i>J</i> = 8.3 Hz), 7.92 (s, 1H), 7.75 (d, 1H, <i>J</i> = 8.3 Hz), 7.52 (d, 1H, <i>J</i> = 3.8 Hz), 7.38 (d, 1H, <i>J</i> = 3.8 Hz), 4.50 (s, 2H), 4.18 (q, 2H, <i>J</i> = 7.3 Hz), 1.22 (t, 3H, <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.4, 166.7, 166.0, 164.6, 152.6, 149.0, 133.8, 131.6, 130.9, 130.4, 128.8, 127.1, 121.7, 119.7, 118.2, 115.0, 61.6, 42.2, 13.9. LC-MS [M + H<sup>+</sup>] calcd for C<sub>19</sub>H<sub>15</sub>ClNO<sub>7</sub>S, 436.03; found, 436.1. Elem. Anal. Calcd for C<sub>19</sub>H<sub>14</sub>ClNO<sub>7</sub>S: C, 52.36; H, 3.24; N, 3.21; S, 7.36. Found: C, 52.28; H, 3.31; N, 3.20; S, 7.01. Melting point: 227.0–230.5 °C (1 °C/min) (decomposes).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 3-Chloro-4-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)2-furyl)benzoic Acid (<b>1c</b>)</h4><div class="NLM_p last">3-Chloro-4-(5-formyl-2-furyl)benzoic acid (<b>20</b>) (101 mg, 0.403 mmol) was suspended in abs EtOH (15 mL), and a solution of 3-(2-ethoxy-2-oxoethanyl)2,4-dioxothiazolidine (81 mg, 0.399 mmol) in abs EtOH (3 mL) was added. After gentle heating and stirring for 10 min, piperidine (75 μL, 0.758 mmol) was added and the reaction mixture was heated to reflux and stirred at that temperature for 1 h. Thereafter, the reaction mixture was cooled to rt and quenched with satd aq NH<sub>4</sub>Cl (50 mL) and the resulting precipitate was filtered off, washed with H<sub>2</sub>O (10 mL), and dried giving the title compound as a light-brown solid (140 mg, 0.321 mmol, 80%). <i>R</i><sub>f</sub> = 0 (<i>n</i>-heptane/EtOAc 1:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.05–7.93 (m, 3H), 7.91 (s, 1H), 7.52 (d, <i>J</i> = 3.9 Hz, 1H), 7.39 (d, <i>J</i> = 3.9 Hz, 1H), 4.50 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 167.5, 166.7, 166.5, 164.6, 153.3, 149.1, 131.4, 129.3, 128.5, 128.4, 127.8, 121.8, 119.6, 118.1, 115.2, 61.6, 42.2, 14.0 (one signal missing or coinciding with others). LC-MS (Bruker): [M + H]<sup>+</sup><sub>calcd</sub> 436.02, [M + H]<sup>+</sup><sub>found</sub> 436.0. HPLC: >98%, retention time 2.39 min, reverse phase, H<sub>2</sub>O/MeCN/TFA gradient run, 4 mL min<sup>–1</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 3-(5-{[3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene]methyl}-2-furyl)-4-methoxybenzoic Acid (<b>1d</b>)</h4><div class="NLM_p last">3-(5-Formyl-2-furyl)-4-methoxybenzoic acid (150 mg, 0.609 mmol) and 3-(2-ethoxy-2-oxoethanyl)2,4-dioxothiazolidine (140 mg, 0.690 mmol) were suspended in abs EtOH (40 mL), and the reaction mixture was stirred for 5 min at rt under N<sub>2</sub> before piperidine (114 μL, 1.157 mmol) was added. The reaction mixture was then heated to reflux and stirred at that temperature for 5 h. Thereafter, the reaction mixture was cooled to rt and quenched with satd aq NH<sub>4</sub>Cl (15 mL) and H<sub>2</sub>O (20 mL). The resulting dark-brown precipitate was filtered off, washed with H<sub>2</sub>O (2 × 5 mL), and dried before being purified by column chromatography (2 cm Ø, 100 mL SiO<sub>2</sub>, eluent CH<sub>2</sub>Cl<sub>2</sub>:EtOAc:AcOH, 100:10:1). The yellow band <i>R</i><sub>f</sub> = 0.31 was isolated, giving the title compound as an orange solid (64 mg, 0.148 mmol, 24%). <i>R</i><sub>f</sub> = 0.31 (CH<sub>2</sub>Cl<sub>2</sub>:EtOAc:AcOH, 100:10:1). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.48 (d, <i>J</i> = 2.1 Hz, 1H), 7.95 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H), 7.88 (s, 1H), 7.34 (d, <i>J</i> = 3.7 Hz, 1H), 7.23 (d, <i>J</i> = 3.7 Hz, 1H), 7.21 (d, <i>J</i> = 8.6 Hz, 1H), 4.49 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 4.01 (s, 3H), 1.22 (t, <i>J</i> = 7.1 Hz, 5H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) (rotamers) δ: 167.6, 167.0, 166.7, 166.7, 166.5, 164.7, 162.6, 159.1, 153.3, 151.6, 148.7, 148.0, 131.6, 131.4, 129.6, 127.2, 124.5, 122.4, 121.2, 119.8, 117.4, 117.1, 116.8, 114.4, 114.3, 112.1, 112.0, 61.6, 56.3, 42.1, 13.9. LC-MS (Bruker): [M + H]<sup>+</sup><sub>calcd</sub> 432.07, [M + H]<sup>+</sup><sub>found</sub> 432.1. HPLC: >96%, retention time 2.45 min, reverse phase, H<sub>2</sub>O/MeCN/TFA gradient run, 4 mL min<sup>–1</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>Z</i>)-4-(Benzyloxy)-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic Acid (<b>1e</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with aldehyde <b>15</b> (36 mg, 0.11 mmol, 1.0 equiv), <b>9</b> (67 mg, 0.33 mmol, 3.0 equiv), piperidine (1 μL, 0.01 mmol, 0.1 equiv), AcOH (1 μL, 0.01 mmol, 0.1 equiv), and EtOH (5 mL) and reflux for 2 days. The precipitate was taken into acetone and filtered. The filtrate was concentrated under reduced pressure, and the obtained solid was recrystallized from EtOH which yielded the product as a yellow solid (4 mg, 7%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ: 8.71 (d, <i>J</i> = 2.1 Hz, 1H), 8.09 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.70 (s, 1H), 7.49–7.38 (m, 5H), 7.14 (d, <i>J</i> = 8.7 Hz, 1H), 7.08 (d, <i>J</i> = 3.6 Hz, 1H), 6.87 (d, <i>J</i> = 3.7 Hz, 1H), 5.30 (s, 2H), 4.48 (s, 2H), 4.24 (q, <i>J</i> = 7.1 Hz, 2H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (600 MHz, CDCl<sub>3</sub>) δ: 168.4, 168.0, 166.5, 165.6, 159.2, 153.9, 148.5, 135.6, 132.3, 129.3, 129.1, 128.8, 128.0, 122.3, 121.0, 119.9, 118.7, 118.3, 114.5, 112.3, 71.3, 62.2, 42.2, 29.9, 14.3. LC-MS: [M + H]<sup>+</sup><sub>calcd</sub> 508.10, [M + H]<sup>+</sup><sub>found</sub> 508.1.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-Fluoro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)2-furyl)benzoic Acid (<b>1g</b>)</h4><div class="NLM_p last">4-Fluoro-3-(5-formyl-2-furyl)benzoic acid (<b>12</b>) (18 mg, 0.077 mmol) was suspended in abs EtOH (6 mL), and a solution of 3-(2-ethoxy-2-oxoethanyl)2,4-dioxothiazolidine (16 mg, 0.0787 mmol) in abs EtOH (3 mL) was added followed by piperidine (15 μL, 0.151 mmol). The reaction mixture was heated to reflux under N<sub>2</sub> and stirred at that temperature for 2 h. Thereafter, the reaction mixture was cooled to rt and quenched with satd aq NH<sub>4</sub>Cl (20 mL). The resulting precipitate was filtered off, washed with H<sub>2</sub>O (10 mL), and dried, giving the title compound as a brown solid (12 mg, 0.029 mmol, 37%). <i>R</i><sub>f</sub> = 0 (<i>n</i>-heptane/EtOAc 1:1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 13.32 (s, 1H), 8.49 (dd, <i>J</i> = 7.4, 2.2 Hz, 1H), 8.03 (ddd, <i>J</i> = 8.6, 4.9, 2.2 Hz, 1H), 7.94 (s, 1H), 7.54 (dd, <i>J</i> = 11.1, 8.7 Hz, 1H), 7.39 (d, <i>J</i> = 3.8 Hz, 1H), 7.25 (t, <i>J</i> = 3.6 Hz, 1H), 4.50 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ: 167.4, 166.7, 165.8, 164.6, 161.6, 159.9, 150.5, 149.1, 131.8, 131.8, 128.1, 127.6, 127.6, 122.1, 119.7, 117.9, 117.2, 117.1, 117.0, 117.0, 114.4, 114.3, 61.6, 42.2, 13.9. LC-MS: [M + H]<sup>+</sup><sub>calcd</sub> 420.06 [M + H]<sup>+</sup><sub>found</sub> 420.0. HPLC: >95%, retention time 1.96 min, reverse phase, H<sub>2</sub>O/MeCN/TFA gradient run, 4 mL min<sup>–1</sup>. Melting point: decomposition.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>Z</i>)-4-(5-((3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)-2-naphthoic Acid (<b>1h</b>)</h4><div class="NLM_p last">Piperidine (2 μL, 0.02 mmol, 0.1 equiv) and AcOH (1 μL, 0.02 mmol, 0.1 equiv) were added to a solution of <b>19</b> (45 mg, 0.17 mmol, 1.0 equiv) and <b>9</b> (35 mg, 0.17 mmol, 1.0 equiv) in EtOH (8 mL). The mixture was allowed to stir at reflux for 3 days, and the solvent was removed under reduced pressure. The crude product was purified by gradient flash chromatography (heptane:EtOAc, 1:0–2:1, with 0.5% of AcOH) on silica gel, which yielded the product as a yellow solid (33 mg, 43%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 13.32 (s, 1H), 8.72 (s, 1H), 8.44 (d, <i>J</i> = 8.6 Hz, 1H), 8.40 (d, <i>J</i> = 1.6 Hz, 1H), 8.28 (d, <i>J</i> = 8.1 Hz, 1H), 7.97 (s, 1H), 7.82 (ddd, <i>J</i> = 8.4, 6.8, 1.3 Hz, 1H), 7.74 (ddd, <i>J</i> = 8.1, 7.0, 1.1 Hz, 1H), 7.47 (d, <i>J</i> = 3.7 Hz, 1H), 7.43 (d, <i>J</i> = 3.7 Hz, 1H), 4.49 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.5, 166.8, 166.7, 164.6, 156.3, 149.3, 133.1, 132.1, 130.7, 130.5, 129.7, 127.8, 127.4, 126.6, 125.6, 124.9, 122.1, 120.0, 117.2, 114.0, 61.6, 42.1, 13.9. Melting point: 158.9–161.5 °C.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 6-Chloro-3′-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)-[1,1′-biphenyl]-3-carboxylic Acid (<b>1n</b>)</h4><div class="NLM_p last">6-Chloro-3′-formyl-[1,1′-biphenyl]-3-carboxylic acid (<b>21</b>) (30 mg, 0.115 mmol) was suspended in abs EtOH (3 mL) and a solution of 3-(2-ethoxy-2-oxoethanyl)2,4-dioxothiazolidine (23 mg, 0.115 mmol) in abs EtOH (3 mL) was added and the reaction mixture was stirred for 5 min at rt under N<sub>2</sub> before piperidine (21.6 μL, 0.219 mmol) was added. The reaction mixture was then heated to reflux and stirred at that temperature for 2 h. Thereafter, the reaction mixture was cooled to rt and quenched with satd aq NH<sub>4</sub>Cl (20 mL). The resulting yellow precipitate was filtered off, washed with H<sub>2</sub>O (10 mL), and dried, giving the title compound as a yellow solid (28 mg, 0.063 mmol, 55%). <i>R</i><sub>f</sub> = 0 (<i>n</i>-heptane/EtOAc 1:1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.10 (s, 1H), 7.92–7.85 (m, 2H), 7.76–7.64 (m, 3H), 7.62–7.53 (m, 2H), 4.50 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ: 166.8, 166.7, 166.6, 164.8, 139.8, 137.7, 133.9, 132.8, 132.0, 131.7, 131.0, 130.1, 129.5, 129.3, 129.2, 121.2, 61.7, 42.3, 14.0. LC-MS (Bruker): [M + H]<sup>+</sup><sub>calcd</sub> 446.05 [M + H]<sup>+</sup><sub>found</sub> 446.0. HPLC: >95%, retention time 2.67 min, reverse phase, H<sub>2</sub>O/MeCN/TFA gradient run, 4 mL min<sup>–1</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 6-Chloro-4′-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)-[1,1′-biphenyl]-3-carboxylic Acid (<b>1o</b>)</h4><div class="NLM_p last">6-Chloro-4′-formyl-[1,1′-biphenyl]-3-carboxylic acid (30 mg, 0.115 mmol) was suspended in abs EtOH (3 mL) and a solution of 3-(2-ethoxy-2-oxoethanyl)2,4-dioxothiazolidine (23 mg, 0.115 mmol) in abs EtOH (3 mL) was added and the reaction mixture was stirred for 5 min at rt under N<sub>2</sub> before piperidine (21.6 μL, 0.219 mmol) was added. The reaction mixture was then heated to reflux and stirred at that temperature for 4 h. Thereafter, the reaction mixture was cooled to rt and quenched with satd aq NH<sub>4</sub>Cl (20 mL). The resulting yellow precipitate was filtered off, washed with H<sub>2</sub>O (10 mL), and dried, giving the title compound as a yellow solid (28 mg, 0.063 mmol, 55%). <i>R</i><sub>f</sub> = 0 (<i>n</i>-heptane/EtOAc 1:1), 0.3 (CH<sub>2</sub>Cl<sub>2</sub>:EtOAc:AcOH, 100:10:1). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.08 (s, 1H), 7.98–7.90 (m, 2H), 7.82–7.76 (m, 2H), 7.72–7.64 (m, 3H), 4.52 (s, 2H), 4.19 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H), signal from COOH is missing. <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ: 166.8, 166.7, 166.3, 164.9, 140.4, 138.6, 133.5, 132.4, 131.9, 130.3, 130.2, 121.1, 61.7, 42.3, 14.0, six Ar-C signals are missing or coinciding with others. LC-MS (Bruker): [M + H]<sup>+</sup><sub>calcd</sub> 446.05 [M + H]<sup>+</sup><sub>found</sub> 446.0. HPLC: >96%, retention time 2.70 min, reverse phase, H<sub>2</sub>O/MeCN/TFA gradient run, 4 mL min<sup>–1</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-Chloro-3-(5-{[3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene]methyl}thiophen-2-yl)benzoic Acid (<b>1p</b>)</h4><div class="NLM_p last">4-Chloro-3-(5-formylthiophen-2-yl)benzoic acid (17.6 mg, 0.065 mmol) was suspended in abs EtOH (2 mL) and a solution of 3-(2-ethoxy-2-oxoethanyl)2,4-dioxothiazolidine (15 mg, 0.072 mmol) in abs EtOH (1 mL) was added and the reaction mixture was stirred for 5 min at rt under N<sub>2</sub> before piperidine (12 μL, 0.125 mmol) was added. The reaction mixture was then heated to reflux and stirred at that temperature for 2.5 h. Thereafter, the reaction mixture was cooled to rt and quenched with satd aq NH<sub>4</sub>Cl (20 mL). The resulting orange precipitate was filtered off, washed with H<sub>2</sub>O (10 mL), and dried. The solid was subsequently redissolved in abs EtOH (2 mL), a solution of 3-(2-ethoxy-2-oxoethanyl)2,4-dioxothiazolidine (9 mg, 0.044 mmol) in abs EtOH (1 mL) was added, and the reaction mixture was stirred for 5 min at rt under N<sub>2</sub> before piperidine (20 μL, 0.202 mmol) was added. The reaction mixture was then heated to reflux and stirred at that temperature for 5 h. Thereafter, the reaction mixture was cooled to rt and quenched with satd aq NH<sub>4</sub>Cl (5 mL) and H<sub>2</sub>O (5 mL). The resulting orange precipitate was filtered off, washed with H<sub>2</sub>O (5 mL), and dried, giving the title compound as an orange solid (15 mg, 0.033 mmol, 50%). <i>R</i><sub>f</sub> = 0.31 (CH<sub>2</sub>Cl<sub>2</sub>:EtOAc:AcOH, 100:10:1). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 13.44 (s, 1H), 8.32 (s, 1H), 8.17 (d, <i>J</i> = 2.1 Hz, 1H), 7.96 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.83 (d, <i>J</i> = 4.0 Hz, 1H), 7.78 (d, <i>J</i> = 8.4 Hz, 1H), 7.73 (d, <i>J</i> = 3.9 Hz, 1H), 4.50 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ: 167.1, 166.5, 166.4, 165.0, 145.4, 138.5, 136.1, 135.9, 132.2, 131.9, 131.7, 131.2, 130.9, 130.1, 127.4, 119.0, 62.1, 42.9, 14.4. LC-MS: [M + H]<sup>+</sup><sub>calcd</sub> 452.00 [M + H]<sup>+</sup><sub>found</sub> 451.9. HPLC: >96%, retention time 2.08 min, reverse phase, H<sub>2</sub>O/MeCN/TFA gradient run, 4 mL min<sup>–1</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-Chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxoimidazolidin-1-yl)methyl)furan-2-yl)benzoic Acid (<b>1q</b>)</h4><div class="NLM_p last">Under a nitrogen atmosphere, 10% Pd/C (0.136 g) was added to anhydrous THF (20 mL). H<sub>2</sub> was bobbled through the mixture, and it was allowed to stir under a H<sub>2</sub> atmosphere at rt for 20 min. Then a solution of benzyl 4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxoimidazolidin-1-yl)methyl)furan-2-yl)benzoate (0.340 g, 0.665 mmol) in anhydrous THF (20 mL) was added, and the mixture was stirred at rt for 2 h. Then the H<sub>2</sub> atmosphere was exchanged with nitrogen, and the mixture was filtered through a plug of Celite, which was then washed with THF. The filtrate was evaporated to give slightly yellow oil (0.327 g). The crude product was purified by dry column vacuum chromatography (eluent: 2:8:0.1 EtOAc/CH<sub>2</sub>Cl<sub>2</sub>/AcOH) and coevaporation with toluene to give the title compound (0.145 g, 52%) as white solid. <i>R</i><sub>f</sub> (25:75:1 EtOAc/CH<sub>2</sub>Cl<sub>2</sub>/AcOH) 0.32. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.43 (d, 1H, <i>J</i> = 2.0 Hz), 7.85 (dd, 1H, <i>J</i> = 2.0 Hz, <i>J</i> = 8.3 Hz), 7.48 (d, 1H, <i>J</i> = 8.3 Hz), 7.05 (d, 1H, <i>J</i> = 3.5 Hz), 6.41 (d, 1H, <i>J</i> = 3.5 Hz), 4.63 (s, 2H), 4.22 (s, 2H), 4.15 (q, 2H, <i>J</i> = 7.3 Hz), 3.99 (s, 2H), 1.21 (t, 3H, <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 170.2, 169.2, 167.0, 155.7, 149.7, 149.3, 135.7, 131.2, 129.7, 129.5, 129.1, 128.3, 112.7, 111.2, 62.0, 49.8, 39.9, 39.6, 14.1. LC-MS [M + H<sup>+</sup>] calcd for C<sub>19</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>7</sub>, 421.08; found, 421.1. Elem. Anal. Calcd for C<sub>19</sub>H<sub>17</sub>ClN<sub>2</sub>O<sub>7</sub>·0.05C<sub>7</sub>H<sub>8</sub>: C, 54.63; H, 4.12; N, 6.58. Found: C, 54.72; H, 4.22; N, 6.65. Melting point: 120.1–123.8 °C (1 °C/min).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>Z</i>)-4-((3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)benzoic Acid (<b>4a</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with commercially available 4-formylbenzoic acid (100 mg, 0.67 mmol, 1 equiv), <b>9</b> (136 mg, 0.67 mmol, 1 equiv), piperidine (7 μL, 0.07 mmol, 0.1 equiv), AcOH (4 μL, 0.07 mmol, 0.1 equiv), and EtOH (5 mL) and reflux for 4 days. The precipitate was washed with EtOH and dried, which yielded the product as an off-white solid (98 mg, 44%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 13.24 (s, 1H), 8.06 (s, 1H), 8.10–7.75 (m, 4H), 4.51 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.1, 167.0, 166.9, 165.2, 137.1, 133.3, 132.7, 130.7, 130.5, 123.3, 62.2, 42.8, 14.4; Melting point: 200.9–205.1 °C.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>Z</i>)-4-((3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)-3-hydroxybenzoic Acid (<b>4b</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with commercially available 4-formyl-3-hydroxybenzoic acid (200 mg, 1.20 mmol, 1.0 equiv), <b>9</b> (244 mg, 1.20 mmol, 1.0 equiv), piperidine (12 μL, 0.12 mmol, 0.1 equiv), AcOH (7 μL, 0.12 mmol, 0.1 equiv), and EtOH (7 mL) and reflux for 4 days. Purified by gradient flash chromatography (heptane:EtOAc, 1:1–1:1.5, with 0.5% of AcOH) on silica gel, which yielded the product as a yellow solid (130 mg, 31%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.99 (s, 1H), 8.14 (s, 1H), 7.55–7.50 (m, 3H), 4.49 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 166.9, 166.7, 166.5, 165.0, 157.1, 134.0, 129.0, 128.3, 123.6, 121.5, 120.4, 116.5, 61.7, 42.2, 13.9. Melting point: 225.3–229.1 °C.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>Z</i>)-3-((3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)benzoic Acid (<b>4c</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with commercially available 3-formylbenzoic acid (28) (330 mg, 2.20 mmol, 1.0 equiv), <b>9</b> (447 mg, 2.20 mmol, 1.0 equiv), piperidine (22 μL, 0.22 mmol, 0.1 equiv), AcOH (13 μL, 0.22 mmol, 0.1 equiv), and EtOH (8 mL) and reflux for 16 h. The reaction mixture was allowed to cool to rt, and the precipitate was filtered out and recrystallized from EtOH, which yielded the product as a white solid (334 mg, 45%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 13.31 (s, 1H), 8.20 (t, <i>J</i> = 1.2 Hz, 1H), 8.10 (s, 1H), 8.05 (dt, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.91 (dt, <i>J</i> = 7.9, 1.2 Hz, 1H), 7.69 (t, <i>J</i> = 7.8 Hz, 1H), 4.51 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 166.6, 166.5, 166.4, 164.7, 134.3, 133.2, 133.1, 131.8, 131.2, 130.4, 129.8, 121.7, 61.7, 42.3, 13.9. Melting point: 198.3–202.1 °C.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>Z</i>)-5-((3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)-2-hydroxybenzoic Acid (<b>4d</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with commercially available 5-formyl-2-hydroxybenzoic acid (100 mg, 0.60 mmol, 1.0 equiv), <b>1</b> (122 mg, 0.60 mmol, 1.0 equiv), piperidine (6 μL, 0.06 mmol, 0.1 equiv), AcOH (4 μL, 0.06 mmol, 0.1 equiv), and EtOH (5 mL) and reflux for 11 days. Purified by flash chromatography (heptane:EtOAc, 1:5, with 0.5% of AcOH) on silica gel, which yielded the product as a yellow solid (75 mg, 36%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.08 (d, <i>J</i> = 2.4 Hz, 1H), 7.97 (s, 1H), 7.77 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 7.09 (d, <i>J</i> = 8.7 Hz, 1H), 4.48 (s, 2H), 4.17 (q, <i>J</i> = 7.1 Hz, 2H), 1.21 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 170.9, 166.7, 166.6, 165.0, 163.4, 137.0, 133.6, 132.9, 123.5, 118.5, 117.5, 114.9, 61.6, 42.2, 13.9. Melting point: 199.1–202.8 °C.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>Z</i>)-3-((3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)-4-hydroxybenzoic Acid (<b>4e</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with commercially available 3-formyl-4-hydroxybenzoic acid (250 mg, 1.50 mmol, 1.0 equiv), <b>9</b> (305 mg, 1.50 mmol, 1.0 equiv), piperidine (15 μL, 0.15 mmol, 0.1 equiv), AcOH (9 μL, 0.15 mmol, 0.1 equiv), and EtOH (8 mL) and reflux for 2 days. Purified by gradient flash chromatography (heptanes:EtOAc, 2:1–1:1, with 0.5% of AcOH) on silica gel, which yielded the product as a yellow solid (180 mg, 34%), <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.85 (s, 1H), 11.52 (s, 1H), 8.14 (s, 1H), 8.01 (d, <i>J</i> = 2.0 Hz, 1H), 7.91 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H), 7.06 (d, <i>J</i> = 8.6 Hz, 1H), 4.50 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H), <sup>13</sup>C NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 166.7, 166.6, 166.4, 165.0, 161.1, 133.8, 130.3, 128.4, 122.1, 120.3, 119.6, 116.2, 61.6, 42.2, 13.9;, Melting point: 200.9–204.0 °C.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>Z</i>)-Ethyl 2-(5-(3-(1<i>H</i>-Tetrazol-5-yl)benzylidene)-2,4-dioxothiazolidin-3-yl)acetate (<b>4f</b>)</h4><div class="NLM_p last">Piperidine (10 μL, 0.10 mmol, 0.1 equiv) was added to a solution of 3-(1<i>H</i>-tetrazol-5-yl)benzaldehyde (<b>31</b>) (170 mg, 0.98 mmol, 1.0 equiv) and <b>9</b> (199 mg, 0.98 mmol, 1.0 equiv) in EtOH (4 mL). The mixture was allowed to stir at reflux for 18 h then cooled to 0 °C. Then 1 M HCl (5 mL) was added and the resulting precipitate was filtered off, washed with water (8 mL) and hepetanes (8 mL), and dried, which yielded the product as a white solid (162 mg, 45%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.28 (s, 1H), 8.14 (d, <i>J</i> = 7.7 Hz, 1H), 8.08 (s, 1H), 7.85 (d, <i>J</i> = 8.0 Hz, 1H), 7.78 (t, <i>J</i> = 7.8 Hz, 1H), 4.52 (s, 2H), 4.19 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 166.6, 166.5, 164.7, 155.4, 133.8, 132.9, 132.4, 130.5, 128.9, 128.1, 125.6, 122.2, 61.7, 42.3, 13.9. Melting point: 220.5–223.8 °C.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>Z</i>)-2-(3-((3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)phenyl)acetic Acid (<b>4g</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with <b>32</b> (175 mg, 1.07 mmol, 1.0 equiv), <b>9</b> (217 mg, 1.07 mmol, 1.0 equiv), piperidine (10 μL, 0.11 mmol, 0.1 equiv), AcOH (6 μL, 0.11 mmol, 0.1 equiv), and EtOH (5 mL) and reflux for 5 days. Purified by flash chromatography (heptane:EtOAc, 1:1, with 0.5% of AcOH) on silica gel and recrystallized from MeOH, which yielded the product as a white solid (60 mg, 16%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.44 (s, 1H), 7.98 (s, 1H), 7.57–7.40 (m, 4H), 4.50 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 3.68 (s, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 172.8, 167.4, 167.1, 165.4, 136.9, 134.4, 133.2, 132.6, 131.5, 129.8, 129.1, 121.1, 62.1, 42.7, 40.7, 14.4. Melting point: 154.9–158.5 °C.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>Z</i>)-2-(3-((3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)-4-hydroxyphenyl)acetic Acid (<b>4h</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with <b>33</b> (320 mg, 1.78 mmol, 1.0 equiv), <b>9</b> (362 mg, 1.78 mmol, 1.0 equiv), piperidine (18 μL, 0.18 mmol, 0.1 equiv), AcOH (10 μL, 0.18 mmol, 0.1 equiv), and EtOH (8 mL) and reflux for 5 days. Purified by flash chromatography (MeOH:EtOAc, 1:5, with 0.5% of AcOH) on silica gel and recrystallized from MeOH, which yielded the product as a yellow solid (149 mg, 23%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.32 (s, 1H), 10.58 (s, 1H), 8.14 (s, 1H), 7.29 (d, <i>J</i> = 2.0 Hz, 1H), 7.23 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 6.93 (d, <i>J</i> = 8.4 Hz, 1H), 4.48 (s, 2H), 4.17 (q, <i>J</i> = 7.1 Hz, 2H), 3.54 (s, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 173.2, 167.7, 167.2, 165.6, 156.7, 134.5, 129.8, 129.7, 126.8, 119.8, 119.5, 116.6, 62.1, 42.6, 40.5, 14.4. Melting point: 204.3–208.6 °C.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>Z</i>)-4-((3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)-3-hydroxybenzoic Acid (<b>4i</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with aldehyde <b>34</b> (140 mg, 0.79 mmol, 1.0 equiv), <b>9</b> (161 mg, 0.79 mmol, 1.0 equiv), piperidine (8 μL, 0.08 mmol, 0.1 equiv), AcOH (5 μL, 0.08 mmol, 0.1 equiv), and EtOH (5 mL) and reflux for 3 days. Purified by gradient flash chromatography (heptane:EtOAc, 4:1–2.5:1, with 0.5% of AcOH) on silica gel, which yielded the product as an off-white solid (115 mg, 40%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.16 (s, 1H), 7.96 (s, 1H), 7.54–7.36 (m, 4H), 4.50 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 2.89 (t, <i>J</i> = 7.5 Hz, 2H), 2.59 (t, <i>J</i> = 7.5 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 173.6, 166.9, 166.7, 164.9, 142.2, 134.2, 132.8, 131.1, 130.1, 129.4, 128.0, 120.5, 61.7, 42.2, 34.8, 30.0, 13.9. Melting point: 148.2–152.1 °C.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>Z</i>)-3-(3-((3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)-4-hydroxyphenyl)propanoic Acid (<b>4j</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with aldehyde <b>35</b> (100 mg, 0.51 mmol, 1.0 equiv), <b>9</b> (103 mg, 0.51 mmol, 1.0 equiv), piperidine (5 μL, 0.05 mmol, 0.1 equiv), AcOH (3 μL, 0.05 mmol, 0.1 equiv), and EtOH (5 mL) and reflux for 2 days. Purified by flash chromatography (heptane:EtOAc, 1:1, with 0.5% of AcOH) on silica gel and recrystallized from a mixture (1:1:0.01) of MeCN, H<sub>2</sub>O and DMSO, which yielded the product as a yellow solid (84 mg, 43%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.14 (s, 1H), 10.47 (s, 1H), 8.13 (s, 1H), 7.23–6.89 (m, 3H), 4.48 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 2.78 (t, <i>J</i> = 7.4 Hz, 2H), 2.52 (t, <i>J</i> = 7.3 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 173.7, 167.3, 166.7, 165.1, 155.8, 133.0, 132.1, 129.5, 128.1, 119.4, 118.9, 116.2, 61.6, 42.1, 35.3, 29.3, 13.9. Melting point: 185.1–188.3 °C.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>E</i>)-3-(3-((<i>Z</i>)-(3-(2-Ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)phenyl)acrylic Acid (<b>4k</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>1h</b>, with <b>36</b> (100 mg, 0.57 mmol, 1.0 equiv), <b>9</b> (115 mg, 0.57 mmol, 1.0 equiv), piperidine (6 μL, 0.06 mmol, 0.1 equiv), AcOH (4 μL, 0.06 mmol, 0.1 equiv), and EtOH (5 mL) and reflux for 3 days. Purified by flash chromatography (heptane:EtOAc, 1:1.25, with 0.5% of AcOH) on silica gel, which yielded the product as a white solid (101 mg, 49%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.51 (s, 1H), 8.03 (s, 1H), 7.96 (s, 1H), 7.84 (d, <i>J</i> = 7.6 Hz, 1H), 7.67 (d, <i>J</i> = 7.7 Hz, 1H), 7.64 (d, <i>J</i> = 15.6 Hz, 1H), 7.60 (t, <i>J</i> = 7.7 Hz, 1H), 6.63 (d, <i>J</i> = 16.1 Hz, 1H), 4.51 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.4, 166.8, 166.6, 164.8, 142.5, 135.4, 133.5, 133.4, 130.7, 130.4, 130.1, 130.0, 121.4, 121.0, 61.7, 42.3, 13.9. Melting point: 172.6–175.1 °C.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 4-Chloro-3-(5-formylfuran-2-yl)benzoic Acid (<b>7</b>)</h4><div class="NLM_p last">A flask was charged with (5-formylfuran-2-yl)boronic acid (5.95 g, 42.5 mmol, 2 equiv), 3-bromo-4-chlorobenzoic acid (4.96 g, 21.2 mmol, 1 equiv), and (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub> (0.75 g, 1.06 mmol, 0.05 equiv) and then evacuated and refilled with N<sub>2</sub> three times. DME (70 mL, degassed), EtOH (70 mL, degassed), and 2 M Na<sub>2</sub>CO<sub>3</sub> (64 mL, 128 mmol, 6 equiv, degassed) were added, and the mixture was heated to 50 °C and stirred at that temperature for 20 h. The mixture was allowed to cool to rt and was then evaporated in vacuo. The residue was suspended in H<sub>2</sub>O (700 mL) and filtered through a plug of Celite, which was then washed with H<sub>2</sub>O (700 mL). The combined aqueous filtrates were acidified (pH 1–2) using 1 M HCl. The solids were filtered off, washed with H<sub>2</sub>O, and freeze-dried to give off-white solid (5.4 g). The crude product was used in the next step without further purification.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Benzyl 4-Choro-3-(5-formylfuran-2-yl)benzoate (<b>8</b>)</h4><div class="NLM_p last">Crude 4-chloro-3-(5-formylfuran-2-yl)benzoic acid (<b>7</b>) (5.44 g, 21.2 mmol, 1 equiv) was dissolved in DMF (125 mL). K<sub>2</sub>CO<sub>3</sub> (4.41 g, 31.8 mmol, 1.5 equiv) was added, followed by benzyl bromide (2.8 mL, 23.4 mmol, 1.1 equiv). The mixture was stirred at rt for 2.5 h, and then the DMF was reduced in vacuo. The residue was suspended in Et<sub>2</sub>O (750 mL) and H<sub>2</sub>O (750 mL). The phases were separated, and the aqueous phase was washed with H<sub>2</sub>O (750 mL). Precipitation occurred in the organic phase, therefore additional Et<sub>2</sub>O (250 mL) was added followed by EtOAc (750 mL). The organic phase was washed with H<sub>2</sub>O (250 mL). The combined aqueous phases were then extracted with EtOAc (3 × 250 mL). The combined organic phases were dried using anhydrous MgSO<sub>4</sub>, filtered, and evaporated to give orange solid (7.29 g). The crude product was purified by dry column vacuum chromatography (EtOAc/heptane) to give the title compound (4.70 g, 65%) as orange solid. <i>R</i><sub>f</sub> (10:48 EtOAc/petroleum ether (40–65 °C)) 0.54. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.73 (s, 1H), 8.64 (d, 1H, <i>J</i> = 2.0 Hz), 7.98 (dd, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.5 Hz), 7.55 (d, 1H, <i>J</i> = 8.5 Hz), 7.49–7.36 (m, 5H), 7.36 (d, 1H, <i>J</i> = 3.9 Hz), 7.31 (d, 1H, <i>J</i> = 3.6 Hz), 5.41 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 177.9, 165.1, 154.3, 152.1, 136.3, 135.7, 131.3, 130.9, 130.5, 129.5, 128.8, 128.6, 128.5, 128.1, 122.1, 113.9, 67.5. LC-MS [M + H<sup>+</sup>] calcd for C<sub>19</sub>H<sub>14</sub>ClO<sub>4</sub>, 341.06; found, 341.1. Melting point: 120.0–121.8 °C (1 °C/min).</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Ethyl 2-(2,4-Dioxothiazolidin-3-yl)acetate (<b>9</b>)</h4><div class="NLM_p last">In an ice bath, NaH (60 w/w%, 2.22 g, 55.5 mmol, 1.3 equiv) was slowly added to a stirred solution of thiazolidine-2,4-dione (5.00 g, 42.7 mmol, 1.0 equiv) in anhydrous THF (25 mL). The stirring was continued at rt until the evolution of gas ceased. In an ice bath, ethyl 2-bromoacetate (7.00 mL, 64.0 mmol, 1.5 equiv) was added to the obtained solution. The reaction mixture was heated to reflux and stirred at that temperature for 5 h before the solvent was removed under reduced pressure. The residue was diluted with cold water (50 mL) and extracted with EtOAc (3 × 50 mL). The combined organic phases were dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude was purified by flash chromatography (DCM) on silica gel, which yielded the product as a colorless oil (6.75 g, 84%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 4.34 (s, 2H), 4.23 (q, <i>J</i> = 7.1 Hz, 2H), 4.03 (s, 2H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (400 MHz, CDCl<sub>3</sub>) δ: 171.2, 170.8, 166.3, 62.3, 42.3, 34.0, 14.2.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>Z</i>)-Benzyl 4-Chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoate (<b>11</b>)</h4><div class="NLM_p last">2,4-Dioxothiazolidine <b>9</b> (0.244 g, 1.2 mmol, 1 equiv) was dissolved in absolute EtOH (15 mL). Benzyl 4-chloro-3-(5-formylfuran-2-yl)benzoate (<b>8</b>) (0.41 g, 1.2 mmol, 1 equiv) and piperidine (119 μL, 1.2 mmol, 1 equiv) were added. The mixture was heated to reflux and stirred that temperature for 1.5 h and then allowed to cool to rt. The solids was filtered off and washed with cold EtOH. Drying in vacuum oven gave the title compound (0.55 g, 88%) as a yellow solid. <i>R</i><sub>f</sub> (1:5 EtOAc:heptanes) 0.30. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.64 (d, 1H, <i>J</i> = 2.2 Hz), 7.96 (dd, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.5 Hz), 7.70 (s, 1H), 7.55 (d, 1H, <i>J</i> = 8.5 Hz), 7.53–7.47 (m, 2H), 7.43–7.35 (m, 3H), 7.34 (d, 1H, <i>J</i> = 3.9 Hz), 6.95 (d, 1H, <i>J</i> = 3.9 Hz), 5.42 (s, 2H), 4.49 (s, 2H), 4.26 (q, 2H, <i>J</i> = 7.2 Hz), 1.32 (t, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 168.0, 166.3, 165.4, 165.1, 153.4, 149.2, 135.7, 135.5, 131.4, 130.3, 129.63, 129.60, 128.9, 128.8, 128.7, 128.0, 120.3, 119.6, 114.9, 67.6, 62.4, 42.4, 14.5. LC-MS [M + H<sup>+</sup>] calcd for C<sub>26</sub>H<sub>21</sub>ClNO<sub>7</sub>S, 526.07; found, 526.1. Melting point: 177.8–178.4 °C (1 °C/min).</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-Fluoro-3-(5-formyl-2-furyl)benzoic Acid (<b>12</b>)</h4><div class="NLM_p last">3-Bromo-4-fluorobenzoic acid (55 mg, 0.251 mmol), (5-formyl-2-furyl)boronic acid (71 mg, 0.508 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (9 mg, 0.013 mmol) were mixed in a vial, which was subsequently evacuated and backfilled with N<sub>2</sub> several times. DME (1 mL, degassed), aq Na<sub>2</sub>CO<sub>2</sub> (2M, 1 mL, degassed), and EtOH (1 mL, degassed) were added and the two-phase reaction mixture was heated to 50 °C and stirred at that temperature for 17 h, after which it was cooled to rt and the solvent was removed in vacuo. The resulting black solid was resuspended in H<sub>2</sub>O (50 mL) and filtered through a plug of Celite (3 cm Ø, 1.5 cm), and the Celite was washed through with additional H<sub>2</sub>O (2 × 10 mL). The combined aq solution was extracted with EtOAc (3 × 20 mL) and CH<sub>2</sub>Cl<sub>2</sub> (20 mL) before it was acidified with aq HCl (2M, app 10 mL) until pH ≈ 1. The resulting orange precipitate was filtered off, washed with H<sub>2</sub>O (3 × 5 mL), and dried, giving the title compound as a yellow solid (35 mg, 0.149 mmol, 60%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 13.37 (s, 1H), 9.70 (s, 1H), 8.45 (dd, <i>J</i> = 7.3, 2.3 Hz, 1H), 8.05 (ddd, <i>J</i> = 8.6, 5.0, 2.3 Hz, 1H), 7.70 (d, <i>J</i> = 3.8 Hz, 1H), 7.55 (dd, <i>J</i> = 11.0, 8.6 Hz, 1H), 7.21 (t, <i>J</i> = 3.8 Hz, 1H). <sup>13</sup>C NMR (100 MHz, MeOD) δ: 179.5, 168.0, 164.8, 162.2, 153.6, 153.6, 153.5, 133.8, 133.7, 130.0, 130.0, 129.3, 125.1, 118.8, 118.7, 117.8, 117.6, 114.2, 114.1. LC-MS: [M + H]<sup>+</sup><sub>calcd</sub> 235.03 [M + H]<sup>+</sup><sub>found</sub> 235.0. HPLC: >98%, retention time 1.62 min, reverse phase, H<sub>2</sub>O/MeCN/TFA gradient run, 4 mL min<sup>–1</sup>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 4-(Benzyloxy)-3-bromobenzoic Acid (<b>14</b>)</h4><div class="NLM_p last">Benzyl bromide (157 mg, 0.92 mmol, 2.0 equiv) and anhydrous K<sub>2</sub>CO<sub>3</sub> (159 mg, 1.15 mmol, 2.5 equiv) were added to a solution of 3-bromo-4-hydroxybenzoic acid (100 mg, 0.46 mmol, 1.0 equiv) in anhydrous acetone (10 mL). The mixture was allowed to stir at reflux for 16 h and filtered hot. The filtrate was concentrated under reduced pressure. Then 4 M aq NaOH (345 μL, 1.38 mmol, 3.0 equiv) was added to a solution of the obtained crude product in MeOH (8 mL), and the mixture was allowed to stir at rt for 16 h. The solvent was removed under reduced pressure, and the residue was acidified with 4 M HCl and extracted with EtOAc (3 × 15 mL). The combined organic phases were dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure, which yielded the product as a white solid (95 mg, 67% for two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.08 (d, <i>J</i> = 2.1 Hz, 1H), 7.92 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H), 7.51–7.33 (m, 5H), 7.31 (d, <i>J</i> = 8.7 Hz, 1H), 5.30 (s, 2H). Spectral data in agreement with reported by Kulkarni et al.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-(Benzyloxy)-3-(5-formylfuran-2-yl)benzoic Acid (<b>15</b>)</h4><div class="NLM_p last">Synthesis was carried out as described for <b>19</b>, with bromine <b>14</b> (280 mg, 0.91 mmol, 1.0 equiv), <b>6</b> (140 mg, 1.00 mmol, 1.1 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub> (58 mg, 0.05 mmol, 0.05 equiv), 2 M aqueous K<sub>2</sub>CO<sub>3</sub> solution (1.4 mL, 2.73 mmol, 3 equiv), and a mixture (7:3) of toluene and EtOH (10 mL) and reflux for 5 days. Purified by gradient flash chromatography (heptane:EtOAc, 1:0–2.5:1, with 0.5% of AcOH) on silica gel, which yielded the product as a yellow solid (45 mg, 15%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ: 9.63 (s, 1H), 8.70 (d, <i>J</i> = 2.2 Hz, 1H), 8.09 (dd, <i>J</i> = 8.7, 2.2 Hz, 1H), 7.58–7.40 (m, 5H), 7.47 (d, <i>J</i> = 3.8 Hz, 1H), 7.35 (d, <i>J</i> = 8.8 Hz, 1H), 7.14 (d, <i>J</i> = 3.7 Hz, 1H), 5.38 (s, 2H). Spectral data in agreement with earlier reported.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-Amino-4-bromo-2-naphthoic Acid (<b>17</b>)</h4><div class="NLM_p last">In a flask wrapped up with foil, FeBr<sub>3</sub> (1.36 g, 4.60 mmol, 0.1 equiv) was added to a well-stirred solution of 3-amino-2-naphthoic acid (<b>16</b>) (8.57 g, 45.8 mmol, 1.0 equiv) in CHCl<sub>3</sub> (220 mL). A solution of bromine (2.58 mL, 50.4 mmol, 1.1 equiv) in CHCl<sub>3</sub> (120 mL) was added dropwise. The reaction mixture was allowed to stir for 16 h at rt. The precipitate was collected and washed with CHCl<sub>3</sub> (200 mL). The crude was dissolved in 1 M aqueous NaOH (250 mL) and then acidified with AcOH. The precipitate was filtered out and dried, which yielded the product as a yellow solid (10.85 g, 89%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.57 (s, 1H), 7.91 (d, <i>J</i> = 8.2 Hz, 1H), 7.86 (d, <i>J</i> = 8.6 Hz, 1H), 7.61 (t, <i>J</i> = 7.9 Hz, 1H), 7.28 (t, <i>J</i> = 7.7 Hz, 1H). <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.2, 144.5, 135.2, 133.8, 130.9, 130.5, 125.9, 124.2, 123.0, 116.1, 103.7.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4-Bromo-2-naphthoic Acid (<b>18</b>)</h4><div class="NLM_p last">3-Amino-4-bromo-2-naphthoic acid (<b>17</b>) (4.20 g, 15.8 mmol, 1.0 equiv) was added to AcOH (100 mL). The mixture was heated to boil then rapidly cooled to 15 °C. In an ice bath, the obtained suspension and NaNO<sub>2</sub> (1.33 g, 18.9 mmol, 1.2 equiv) was added to a mixture (1:1) of concentrated H<sub>2</sub>SO<sub>4</sub> and AcOH (20 mL). The resulting mixture was allowed to stir for 2.5 h before it was poured into a well-stirred suspension of Cu<sub>2</sub>O (6.33 g, 44.2 mmol, 2.8 equiv) in MeOH (90 mL) and allowed to stir at 60 °C for 1 h before it was cooled to rt. The obtained mixture was filtered, and the filtrate was concentrated under reduced pressure. The residue was diluted with Et<sub>2</sub>O (100 mL) and extracted with saturated aqueous NaHCO<sub>3</sub> (3 × 250 mL). The combined aqueous phases were acidified with 4 M HCl. The precipitate was filtered off and dried, which yielded the product as a brown solid (3.62 g, 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 13.37 (s, 1H), 8.67 (s, 1H), 8.25 (d, <i>J</i> = 1.5 Hz, 1H), 8.23 (d, <i>J</i> = 8.1 Hz, 1H), 8.20 (t, <i>J</i> = 8.4 Hz, 1H), 7.85 (ddd, <i>J</i> = 8.4, 6.9, 1.3 Hz, 1H), 7.73 (ddd, <i>J</i> = 8.1, 7.0, 1.1 Hz, 1H).</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-(5-Formylfuran-2-yl)-2-naphthoic Acid (<b>19</b>)</h4><div class="NLM_p last">4-Bromo-2-naphthoic acid (<b>18</b>) (100 mg, 0.40 mmol, 1.0 equiv) was dissolved in a mixture (7:3) of toluene and EtOH (10 mL) and degassed with argon. Pd(PPh<sub>3</sub>)<sub>4</sub> (23 mg, 0.02 mmol, 0.1 equiv) and (5-formylfuran-2-yl)boronic acid (<b>6</b>) (62 mg, 0.44 mmol, 1.1 equiv) were added to the obtained solution and degassed with argon for. Degassed 2 M aqueous K<sub>2</sub>CO<sub>3</sub> solution (0.60 mL, 1.20 mmol, 3 equiv) was then added, and the mixture was allowed to stir at reflux for 4 days. The reaction mixture was allowed to cool to rt, then filtered through Celite, and the filtrate was concentrated under reduced pressure. The residue was acidified with 4 M HCl, then extracted with EtOAc (3 × 10 mL) and washed with water (2 × 20 mL) and brine (20 mL). The organic phase was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by gradient flash chromatography (heptanes:EtOAc, 1:0–2:1, with 0.5% of AcOH) on silica gel, yielding the product as a yellow solid (12 mg, 11%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.79 (s, 1H), 8.76 (s, 1H), 8.49 (d, <i>J</i> = 8.6 Hz, 1H), 8.46 (d, <i>J</i> = 1.6 Hz, 1H), 8.07 (d, <i>J</i> = 8.1 Hz, 1H), 7.75 (ddd, <i>J</i> = 8.3, 6.8, 1.3 Hz, 1H), 7.66 (ddd, <i>J</i> = 8.1, 7.0, 1.1 Hz, 1H), 7.46 (d, <i>J</i> = 3.6 Hz, 1H), 7.02 (d, <i>J</i> = 3.6 Hz, 1H).</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-Chloro-4-(5-formyl-2-furyl)benzoic Acid (<b>20</b>)</h4><div class="NLM_p last">4-Bromo-3-chlorobenzoic acid (600 mg, 2.55 mmol), (5-formyl-2-furyl)boronic acid (713 mg, 5.10 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (90 mg, 0.128 mmol) were mixed in a round-bottom flask which was subsequently evacuated and backfilled with N<sub>2</sub> four times. DME (11 mL, degassed), aq Na<sub>2</sub>CO<sub>2</sub> (2M, 11 mL, degassed), and EtOH (11 mL, degassed) were added, and the reaction mixture was heated to 50 °C and stirred at that temperature for 19 h, after which it was cooled to rt and the solvent was removed in vacuo. The resulting black solid was resuspended in H<sub>2</sub>O (100 mL) and filtered through a plug of Celite (4 cm Ø, 2 cm), and the Celite was washed through with H<sub>2</sub>O (2 × 20 mL). The combined aq solution was extracted with EtOAc (3 × 50 mL) before it was acidified with aq HCl (1M, app 20 mL) until pH ≈ 1. The voluminous yellow precipitate was filtered off, washed with H<sub>2</sub>O (3 × 10 mL), and dried, giving the title compound as a yellow solid (497 mg, 1.983 mmol, 78%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 13.49 (s, 1H), 9.70 (s, 1H), 8.09–7.97 (m, 3H), 7.70 (d, <i>J</i> = 3.8 Hz, 1H), 7.51 (d, <i>J</i> = 3.8 Hz, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 178.6, 165.5, 153.1, 151.9, 132.5, 131.4, 130.5, 130.4, 129.2, 128.4, 124.1, 114.8. LC-MS: [M + H]<sup>+</sup><sub>calcd</sub> 251.01 [M + H]<sup>+</sup><sub>found</sub> 251.0. HPLC: >96%, retention time 1.66 min, reverse phase, H<sub>2</sub>O/MeCN/TFA gradient run, 4 mL min<sup>–1</sup>.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 6-Chloro-3′-formyl-[1,1′-biphenyl]-3-carboxylic Acid (<b>21</b>)</h4><div class="NLM_p last">3-Bromo-4-chlorobenzoic acid (99 mg, 0.420 mmol, (3-formylphenyl)boronic acid (126 mg, 0.840 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (15 mg, 0.021 mmol) were mixed in a vial which was subsequently evacuated and backfilled with argon several times. DME (1.2 mL, degassed), aq Na<sub>2</sub>CO<sub>2</sub> (2M, 1.3 mL, degassed), and abs EtOH (1.2 mL, degassed) was added, and the two-phase reaction mixture was heated to 50 °C and stirred at that temperature for 17 h. Thereafter, it was cooled to rt and the solvent was removed in vacuo. The resulting black solid was resuspended in H<sub>2</sub>O (50 mL) and filtered through a plug of Celite (3 cm Ø, 2 cm), and the Celite was washed through with additional H<sub>2</sub>O (2 × 10 mL). The combined aq solution was acidified with aq HCl (2M, app 10 mL) until pH ≈ 1. The resulting white precipitate was filtered off, washed with H<sub>2</sub>O (3 × 10 mL), and dried, giving the title compound as a yellow solid (100 mg, 0.384 mmol, 91%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 13.32 (s, 1H), 10.09 (s, 1H), 8.02–7.94 (m, 4H), 7.86–7.81 (m, 1H), 7.78–7.71 (m, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 193.0, 192.9, 166.2, 138.8, 138.7, 136.3, 136.3, 135.9, 135.2, 132.0, 130.4, 130.4, 130.3, 130.2, 129.3, 128.9. Rotamers of this compound gives double signals for some of the protons. LC-MS: [M + H]<sup>+</sup><sub>calcd</sub> 261.03 [M + H]<sup>+</sup><sub>found</sub> 261.0. HPLC: >94%, retention time 2.17 min, reverse phase, H<sub>2</sub>O/MeCN/TFA gradient run, 4 mL min<sup>–1</sup>.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Benzyl 4-Chloro-3-(5-(hydroxymethyl)furan-2-yl)benzoate (<b>22</b>)</h4><div class="NLM_p last">Under a nitrogen atmosphere, benzyl 4-chloro-3-(5-formylfuran-2-yl)benzoate (<b>8</b>) (0.638 g, 1.87 mmol, 1 equiv) was suspended in anhydrous MeOH (40 mL). NaBH<sub>4</sub> (0.215 g, 5.62 mmol, 3 equiv) was added, and the mixture was stirred at rt for 45 min. The reaction was quenched by addition of saturated NaHCO<sub>3</sub> (80 mL). MeOH was removed by evaporation in vacuo. The residue was partitioned between H<sub>2</sub>O (200 mL) and EtOAc (200 mL), and the aqueous phase was extracted with EtOAc (2 × 200 mL). The combined organic phases were dried using anhydrous MgSO<sub>4</sub>, filtered, and evaporated to give yellow oil (0.58 g). The crude product was purified by dry column vacuum chromatography (EtOAc/heptane) to give the title compound (0.46 g, 71%) as slightly yellow solid. <i>R</i><sub>f</sub> (3:7 EtOAc/heptane) 0.18. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.54 (d, 1H, <i>J</i> = 2.2 Hz), 7.85 (dd, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.3 Hz), 7.48 (d, 1H, <i>J</i> = 8.5 Hz), 7.48–7.32 (m, 5H), 7.11 (d, 1H, <i>J</i> = 3.6 Hz), 6.45 (d, 1H, <i>J</i> = 3.4 Hz), 5.40 (s, 2H), 4.70 (d, 2H, <i>J</i> = 6.3 Hz), 1.90 (t, 1H, <i>J</i> = 6.3 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 165.2, 156.9, 147.8, 136.5, 134.1, 132.1, 129.5, 129.4, 129.3, 129.2, 128.9, 128.7, 128.4, 113.5, 110.1, 67.3, 56.3. LC-MS [M + (−OH)] calcd for C<sub>19</sub>H<sub>14</sub>ClO<sub>3</sub>, 325.06; found, 325.1. Melting point: 72.2–74.2 °C (1 °C/min).</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Benzyl 4-Chloro-3-(5-(chloromethyl)furan-2-yl)benzoate (<b>23</b>)</h4><div class="NLM_p last">Under a nitrogen atmosphere, benzyl 4-chloro-3-(5-(hydroxymethyl)furan-2-yl)benzoate (<b>22</b>) (1.00 g, 2.92 mmol, 1 equiv) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (20 mL). The solution was cooled to approximately 0 °C. Pyridine (0.26 mL, 3.21 mmol, 1.1 equiv) was added, followed by thionyl chloride (1.3 mL, 17.2 mmol, 5.9 equiv). The mixture was stirred at rt for 2 h and was then diluted with CH<sub>2</sub>Cl<sub>2</sub> (80 mL) and quenched by addition of H<sub>2</sub>O (80 mL). The phases were separated, and the organic phase was washed with H<sub>2</sub>O (3 × 80 mL), dried using anhydrous MgSO<sub>4</sub>, filtered, and evaporated to give the title compound (1.05 g, quant) as slightly red solid. <i>R</i><sub>f</sub> (3:7 EtOAc/heptane) 0.60. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.56 (d, 1H, <i>J</i> = 2.2 Hz), 7.88 (dd, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.5 Hz), 7.49 (d, 1H, <i>J</i> = 8.3 Hz), 7.49–7.32 (m, 5H), 7.12 (d, 1H, <i>J</i> = 3.4 Hz), 6.52 (d, 1H, <i>J</i> = 3.4 Hz), 5.40 (s, 2H), 4.47 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 165.5, 150.3, 150.0, 135.9, 135.0, 131.1, 129.5, 129.2, 129.1, 128.8, 128.5, 128.4, 112.9, 112.1, 67.3, 37.7. LC-MS [M + H<sup>+</sup>] calcd for C<sub>19</sub>H<sub>14</sub>ClO<sub>3</sub>, 325.06; found, 325.1. Melting point: 87.5–89.2 °C (1 °C/min).</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Benzyl 4 Chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-1-yl)methyl)furan (<b>24</b>)</h4><div class="NLM_p last">Under a nitrogen atmosphere, NaH (60% dispersion in mineral oil) (0.062 g, 1.523 mmol, 1.1 equiv) was suspended in anhydrous DMF (5 mL) and stirred at rt for 30 min. A solution of ethyl 2-(2,5-dioxoimidazolidin-1-yl)acetate (<b>25</b>) (0.260 g, 1.384 mmol, 1 equiv) in anhydrous DMF (5 mL) was added, and the mixture was stirred at rt for 30 min. A solution of benzyl 4-chloro-3-(5-(chloromethyl)furan-2-yl)benzoate (<b>23</b>) (0.500 g, 1.384 mmol, 1 equiv) in anhydrous DMF (5 mL) was added, and the mixture was stirred at rt for 19 h. The mixture was quenched by addition of H<sub>2</sub>O (100 mL). The phases were separated, and the aqueous phase was extracted with EtOAc (3 × 150 mL), diluted with H<sub>2</sub>O (50 mL), and extracted with EtOAc (3 × 150 mL). The combined organic phases were dried using anhydrous MgSO<sub>4</sub>, filtered, and evaporated to give yellow oil (0.734 g). The crude product was purified by dry column vacuum chromatography (EtOAc/heptane (0–30%)) to give the title compound (0.503 g, 71%) as yellow oil. <i>R</i><sub>f</sub> (1:1 EtOAc/heptane) 0.37. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.48 (d, 1H, <i>J</i> = 2.0 Hz), 7.91 (dd, 1H, <i>J</i> = 2.0 Hz, <i>J</i> = 8.3 Hz), 7.53 (d, 1H, <i>J</i> = 8.3 Hz), 7.51–7.35 (m, 5H), 7.11 (d, 1H, <i>J</i> = 3.5 Hz), 6.49 (d, 1H, 3.5 Hz), 5.42 (s, 2H), 4.70 (s, 2H), 4.28 (s, 2H), 4.24 (q, 2H, <i>J</i> = 7.3 Hz), 4.04 (s, 2H), 1.30 (t, 3H, <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 169.1, 167.0, 165.4, 155.6, 149.8, 149.2, 135.8, 135.0, 131.1, 129.3, 129.1, 129.0, 128.7, 128.4, 128.3, 112.5, 111.1, 67.1, 62.0, 49.8, 39.8, 39.6, 14.1. LC-MS [M + H<sup>+</sup>] calcd for C<sub>26</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>7</sub>, 511.13; found, 511.2.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Ethyl 2-(2,5-Dioxoimidazolidin-1-yl)acetate (<b>25</b>)</h4><div class="NLM_p last">Under a nitrogen atmosphere, NaH (60% in mineral oil) (0.882 g, 22.0 mmol, 1.1 equiv) was suspended in anhydrous THF (90 mL). Hydantoin (2.00 g, 20.0 mmol, 1 equiv) was added, and the mixture was stirred at rt for 1 h. Ethyl 2-bromoacetate (2.25 mL, 20.0 mmol, 1 equiv) dissolved in anhydrous THF (8 mL) was added, and the mixture was heated to 50 °C and stirred at that temperature for 17.5 h. The mixture was allowed to cool to rt and was then quenched by addition of aqueous Na<sub>2</sub>CO<sub>3</sub> (10%, 100 mL). The two phases were separated, and the aqueous phase was neutralized (pH 7) using concentrated aqueous HCl and then extracted with EtOAc (100 mL). The combined organic phases were dried using anhydrous MgSO<sub>4</sub>, filtered, and evaporated to give off-white solid (2.45 g). The crude product was purified by dry column vacuum chromatography (EtOAc/heptane) to give the title compound (0.68 g, 18%) as white solid. <i>R</i><sub>f</sub> (1:1 EtOAc/heptane) 0.09. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 5.67 (br s, 1H), 4.26 (s, 2H), 4.23 (q, 2H, <i>J</i> = 7.2 Hz), 4.08 (d, 2H, 1.1 Hz), 1.30 (t, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ: 170.8, 167.1, 157.6, 62.2, 46.9, 39.6, 14.4. LC-MS [M + H<sup>+</sup>] calcd for C<sub>7</sub>H<sub>11</sub>N<sub>2</sub>O<sub>4</sub>, 187.07; found, 187.0. Melting point: 118.6–119.8 °C (1 °C/min).</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 3-(1<i>H</i>-Tetrazol-5-yl)benzaldehyde (<b>31</b>)</h4><div class="NLM_p last">Commercially available 3-formylbenzonitrile (50 mg, 0.38 mmol, 1.0 equiv) and TBAF·3H<sub>2</sub>O (180 mg, 0.57 mmol, 1.5 equiv) were added to TMSN<sub>3</sub> (227 μL, 1.71 mmol, 4.5 equiv). The mixture was allowed to stir at 90 °C for 15 h. The reaction mixture was diluted with EtOAc (10 mL) and washed with 1 M HCl (3 × 5 mL). The organic phase was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure, which yielded the product as a white solid (55 mg, 83%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.13 (s, 1H), 8.58 (t, <i>J</i> = 1.5 Hz, 1H), 8.37 (dt, <i>J</i> = 7.7, 1.3 Hz, 1H), 8.13 (dt, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.86 (t, <i>J</i> = 7.7 Hz, 1H).</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-(3-Formylphenyl)acetic Acid (<b>32</b>)</h4><div class="NLM_p last">Benzoyl peroxide (7 mg, 0.03 mmol, 0.01 equiv) was added to a solution of commercially available 2-(3-methylphenyl)acetic acid (0.50 g, 3.33 mmol, 1.0 equiv) and <i>N</i>-bromosuccinimide (0.89 g, 5.00 mmol, 1.5 equiv) in CHCl<sub>3</sub> (20 mL). The mixture was heated to reflux and stirred at that temperature for 24 h before the solvent was removed under reduced pressure. The residue was dissolved in a mixture (1:1) of EtOH and H<sub>2</sub>O (20 mL) and hexamethylenetetramine (1.26 g, 8.99 mmol, 2.7 equiv) was added, and the mixture was refluxed for for 4 h. Concentrated HCl (1.6 mL, 20.0 mmol, 6 equiv) was slowly added to the mixture at reflux. The mixture was allowed to stir at reflux for 30 min and then cooled to rt. DCM (10 mL) and H<sub>2</sub>O (10 mL) were added, and the phases were separated. The organic phase was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was taken into saturated aqueous NaHCO<sub>3</sub> (10 mL) and washed with DCM (2 × 10 mL). The aqueous phase was acidified with 4 M HCl (8 mL) and extracted with DCM (3 × 20 mL). The organic phases were dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure, which yielded the product as an off-white solid (275 mg, 51%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 10.02 (s, 1H), 7.84–7.50 (m, 4H), 3.76 (s, 2H).</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-(3-Formyl-4-hydroxyphenyl)acetic Acid (<b>33</b>)</h4><div class="NLM_p last">First, 1 M aqueous LiOH (30 mL, 30 mmol, 9.0 equiv) was added to a solution of <b>37</b> (660 mg, 3.40 mmol, 1 equiv) in THF (6 mL). The mixture was then allowed to stir at reflux for 15 h. The reaction mixture was acidified with 4 M HCl and extracted with EtOAc (3 × 40 mL). The combined organic phases were dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography (heptane:EtOAc, 1:1), which yielded the product as a white solid (254 mg, 42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.24 (s, 1H), 7.53 (d, <i>J</i> = 2.3 Hz, 1H), 7.40 (dd, <i>J</i> = 8.5, 2.4 Hz, 1H), 6.94 (d, <i>J</i> = 8.5 Hz, 1H), 3.53 (s, 2H). <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 191.4, 172.7, 159.5, 137.6, 129.5, 126.1, 121.9, 117.2, 39.5.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 3-(3-Formylphenyl)propanoic Acid (<b>34</b>)</h4><div class="NLM_p last">NaBH<sub>4</sub> (168 mg, 4.44 mmol, 3.0 equiv) was added portionwise over 5 min to a well-stirred solution of <b>36</b> (260 mg, 1.48 mmol, 1.0 equiv) and NiCl<sub>2</sub>·6H<sub>2</sub>O (352 mg, 1.48 mmol, 1.0 equiv) in MeOH (20 mL) at rt. The reaction mixture was allowed to stir at rt for 1 h and quenched with saturated aqueous NH<sub>3</sub>·HCl (10 mL). The mixture was filtered through a plug of Celite, and the filtrate was extracted with EtOAc (3 × 20 mL). The combined organic phases were dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography (heptane:EtOAc, 1:1, with 0.5% of AcOH) on silica gel, which yielded the product as a white solid (140 mg, 53%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.98 (s, 1H), 7.77 (t, <i>J</i> = 1.5 Hz, 1H), 7.73 (dt, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.59 (dt, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.51 (t, <i>J</i> = 7.5 Hz, 1H), 2.80 (t, <i>J</i> = 7.6 Hz, 2H), 2.51 (t, <i>J</i> = 7.6 Hz, 2H).</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 3-(3-Formyl-4-hydroxyphenyl)propanoic Acid (<b>35</b>)</h4><div class="NLM_p last">First 4 M NaOH (7.5 mL, 30 mmol, 10 equiv) was added to a solution of 3-(4-hydroxyphenyl)propanoic acid (500 mg, 3.01 mmol, 1.0 equiv) in CHCl<sub>3</sub> (10 mL). The mixture was then heated to reflux and stirred at that temperature for 6 h before it was acidified with 4 M HCl. The solvent was removed under reduced pressure, and the residue was extracted with EtOAc (3 × 20 mL). The combined organic phases were dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude was purified by flash chromatography (heptane:EtOAc, 1:1, with 0.5% of AcOH), which yielded a mixture (1:2) of the product and starting material (363 mg). The mixture was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 10.22 (s, 1H), 9.12 (s, 1H), 7.49 (d, <i>J</i> = 2.3 Hz, 1H), 7.39 (dd, <i>J</i> = 8.5, 2.4 Hz, 1H), 6.92 (d, <i>J</i> = 8.4 Hz, 1H), 2.77 (t, <i>J</i> = 7.5 Hz, 2H), 2.51 (t, <i>J</i> = 7.5 Hz, 2H).</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>E</i>)-3-(3-Formylphenyl)acrylic Acid (<b>36</b>)</h4><div class="NLM_p last">Commercially available isophthalaldehyde (1.0 g, 7.46 mmol, 1.0 equiv) and malonic acid (0.80 g, 7.46 mmol, 1.0 equiv) were added to a mixture of pyridine and EtOH (1:1, 20 mL). The mixture was heated to reflux and stirred at that temperature for 16 h. The reaction mixture was allowed to cool to rt and acidified with 6 M HCl (20 mL). The precipitate was filtered off and purified by flash chromatography (heptane:EtOAc, 1:1.25, with 0.5% of AcOH) on silica gel, which yielded the product as a white solid (0.75 g, 58%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.52 (s, 1H), 10.04 (s, 1H), 8.22 (s, 1H), 8.03 (d, <i>J</i> = 7.7 Hz, 1H), 7.93 (d, <i>J</i> = 7.6 Hz, 1H), 7.68 (d, <i>J</i> = 15.9 Hz, 1H), 7.64 (t, <i>J</i> = 7.7 Hz, 1H), 6.66 (d, <i>J</i> = 16.1 Hz, 1H).</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Methyl 2-(3-Formyl-4-hydroxyphenyl)acetate (<b>37</b>)</h4><div class="NLM_p last">Paraformaldehyde (1.90 g, 63.2 mmol, 7 equiv), MgCl<sub>2</sub> (1.72 g, 18.1 mmol, 2.0 equiv), and triethylamine (2.74 g, 27.1 mmol, 3.0 equiv) were added to a solution of methyl 2-(4-hydroxyphenyl)acetate (1.50 g, 9.03 mmol, 1.0 equiv) in MeCN (25 mL). The obtained yellow mixture was heated to reflux and stirred at that temperature for 2 h. The reaction mixture was acidified with 6 M HCl and concentrated under reduced pressure. The residue was extracted with diethyl ether (3 × 30 mL), and the combined organic phases were dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by flash chromatography (heptanes:EtOAc, 6:1), which yielded the product as a white solid (1.07 g, 61%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 10.94 (s, 1H), 9.88 (s, 1H), 7.48 (d, <i>J</i> = 2.2 Hz, 1H), 7.44 (dd, <i>J</i> = 8.5, 2.3 Hz, 1H), 6.96 (d, <i>J</i> = 8.5 Hz, 1H), 3.71 (s, 3H), 3.62 (s, 2H). <sup>13</sup>C NMR (400 MHz, CDCl<sub>3</sub>) δ: 196.5, 171.9, 160.9, 138.2, 134.2, 125.6, 120.6, 118.1, 52.3, 40.0.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp Uptake Assay</h3><div class="NLM_p last">The screening of a commercial compound library consisting of 3040 compounds (Chembridge Corporation, San Diego, CA) at stable HEK293 cell lines expressing human EAAT1, EAAT2, and EAAT3 in a conventional [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake assay has been described previously.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The pharmacological properties of the identified hit <b>1a</b>, and its analogues were subsequently characterized at the three cell lines in the assay essentially as described previously.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Briefly, the cell lines were maintained in culture medium [Dulbecco’s Modified Eagle Medium (DMEM) supplemented with penicillin (100 U/mL), streptomycin (100 μg/mL), and 5% dialyzed fetal bovine serum] supplemented with 1 mg/mL G-418 at 37 °C in a humidified 5% CO<sub>2</sub> incubator. The day before the assay, cells were split into poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated white 96-well plates (PerkinElmer, Boston, MA). Then 16–24 h later, the culture medium was aspirated and cells were washed twice with 100 μL of assay buffer (Hank’s Buffered Saline Solution supplemented with 20 mM HEPES, 1 mM CaCl<sub>2</sub> and 1 mM MgCl<sub>2</sub>, pH 7.4). Then 50 μL of assay buffer supplemented with 30 nM [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-aspartate (PerkinElmer, Boston, MA) and various concentrations of test compounds were added to the wells, and the plate was incubated at 37 °C for 5 min. Nonspecific [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake in the cells was determined in the presence of 3 mM (<i>S</i>)-Glu. The assay mixtures was quickly removed from the wells, which were then washed with 3 × 75 μL of ice-cold assay buffer, and 150 μL of Microscint20 scintillation fluid (PerkinElmer, Boston, MA) was added to each well. The plate was shaken for at least 1 h and counted in a TopCounter (PerkinElmer, Boston, MA). The experiments were performed in duplicate 3–4 times for each compound.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d46e3952-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01058">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01058" class="ext-link">10.1021/acs.jmedchem.6b01058</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01058/suppl_file/jm6b01058_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01058/suppl_file/jm6b01058_si_001.csv">jm6b01058_si_001.csv (3.68 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01058" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lennart Bunch</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7f131a1d0a3f0c0a111b51140a511b14"><span class="__cf_email__" data-cfemail="1d71787f685d6e687379337668337976">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stinne W. Hansen</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mette N. Erichsen</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bingru Fu</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walden E. Bjørn-Yoshimoto</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bjarke Abrahamsen</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob C. Hansen</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anders A. Jensen</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d46e4004-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Lundbeck Foundation, the Novo Nordisk Foundation and the Danish Medical Research Council are thanked for financial support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i66" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i66"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i67" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i67"> Abbreviations Used</h2><tr><td class="NLM_term">DHK</td><td class="NLM_def"><p class="first last">dihydrokainic acid</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nercous system</p></td></tr><tr><td class="NLM_term">EAAT</td><td class="NLM_def"><p class="first last">excitatory amino acid transporter</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity-relationship</p></td></tr><tr><td class="NLM_term">TBOA</td><td class="NLM_def"><p class="first last">threo-benzyloxy aspartate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 21 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Danbolt, N. C.</span><span> </span><span class="NLM_article-title">Glutamate Uptake</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/S0301-0082(00)00067-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1016%2FS0301-0082%2800%2900067-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=11369436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFWns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2001&pages=1-105&author=N.+C.+Danbolt&title=Glutamate+Uptake&doi=10.1016%2FS0301-0082%2800%2900067-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate uptake</span></div><div class="casAuthors">Danbolt, N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-105</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with >1200 refs.  Brain tissue has a remarkable ability to accumulate glutamate.  This ability is due to glutamate transporter proteins present in the plasma membranes of both glial cells and neurons.  The transporter proteins represent the only (significant) mechanism for removal of glutamate from the extracellular fluid and their importance for the long-term maintenance of low and non-toxic concns. of glutamate is now well documented.  In addn. to this simple, but essential glutamate removal role, the glutamate transporters appear to have more sophisticated functions in the modulation of neurotransmission.  They may modify the time course of synaptic events, the extent and pattern of activation and desensitization of receptors outside the synaptic cleft and at neighboring synapses (intersynaptic cross-talk).  Further, the glutamate transporters provide glutamate for synthesis of e.g.  GABA, glutathione, and protein, and for energy prodn.  They also play roles in peripheral organs and tissues (e.g. bone, heart, intestine, kidneys, pancreas, and placenta).  Glutamate uptake appears to be modulated on virtually all possible levels, i.e. DNA transcription, mRNA splicing and degrdn., protein synthesis and targeting, and actual amino acid transport activity and assocd. ion channel activities.  A variety of sol. compds. (e.g. glutamate, cytokines, and growth factors) influence glutamate transporter expression and activities.  Neither the normal functioning of glutamatergic synapses nor the pathogenesis of major neurol. diseases (e.g. cerebral ischemia, hypoglycemia, amyotrophic lateral sclerosis, Alzheimer's disease, traumatic brain injury, epilepsy, and schizophrenia) as well as non-neurol. diseases (e.g. osteoporosis) can be properly understood unless more is learned about these transporter proteins.  Like glutamate itself, glutamate transporters are somehow involved in almost all aspects of normal and abnormal brain activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrbDph2PBuBbVg90H21EOLACvtfcHk0lhSokNZx7lcfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFWns74%253D&md5=a7118c1df858a0994af6207f852f82b6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2800%2900067-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252800%252900067-8%26sid%3Dliteratum%253Aachs%26aulast%3DDanbolt%26aufirst%3DN.%2BC.%26atitle%3DGlutamate%2520Uptake%26jtitle%3DProg.%2520Neurobiol.%26date%3D2001%26volume%3D65%26spage%3D1%26epage%3D105%26doi%3D10.1016%2FS0301-0082%2800%2900067-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Excitatory Amino Acid Transporters as Potential Drug Targets</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span><span class="refDoi"> DOI: 10.1517/14728220902926127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1517%2F14728220902926127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=19456273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFCitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=719-731&author=L.+Bunchauthor=M.+N.+Erichsenauthor=A.+A.+Jensen&title=Excitatory+Amino+Acid+Transporters+as+Potential+Drug+Targets&doi=10.1517%2F14728220902926127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acid transporters as potential drug targets</span></div><div class="casAuthors">Bunch, Lennart; Erichsen, Mette N.; Jensen, Anders A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-731</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Excitatory amino acid transporters (EAATs) are transmembrane proteins responsible for the uptake of (S)-glutamate (Glu) from the synaptic cleft, thereby terminating the glutamatergic neurotransmitter signal.  Today five subtypes have been identified.  Except for EAAT2, their individual roles or functions in the CNS are yet to be fully understood due to the shortage of subtype-selective ligands.  Objective/methods: We examine the latest developments in this field by addressing EAAT expression pattern, localization and pharmacol.  We present highlights of published work on inhibitors as well as enhancers which display subtype preference or selectivity and discuss which pathol. conditions in the CNS such ligands may be beneficial to.  Results/conclusions: Not until subtype-selective enhancers, inhibitors and substrates for all five EAAT subtypes have been discovered can a full and detailed understanding of EAATs be obtained.  Thus we encourage collaboration between org. chemists and mol. pharmacologists, who, together, may pave the way for new EAAT ligands of importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlwp3CUxYad7Vg90H21EOLACvtfcHk0lhSokNZx7lcfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFCitrw%253D&md5=a7af1f649527b26e6e8052caf6598446</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14728220902926127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220902926127%26sid%3Dliteratum%253Aachs%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DExcitatory%2520Amino%2520Acid%2520Transporters%2520as%2520Potential%2520Drug%2520Targets%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D719%26epage%3D731%26doi%3D10.1517%2F14728220902926127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Vandenberg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, R. M.</span><span> </span><span class="NLM_article-title">Mechanisms of Glutamate Transport</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1621</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span><span class="refDoi"> DOI: 10.1152/physrev.00007.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1152%2Fphysrev.00007.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=24137018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2013&pages=1621-1657&author=R.+J.+Vandenbergauthor=R.+M.+Ryan&title=Mechanisms+of+Glutamate+Transport&doi=10.1152%2Fphysrev.00007.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of glutamate transport</span></div><div class="casAuthors">Vandenberg, Robert J.; Ryan, Renae M.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1621-1657</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  L-Glutamate is the predominant excitatory neurotransmitter in the mammalian central nervous system and plays important roles in a wide variety of brain functions, but it is also a key player in the pathogenesis of many neurol. disorders.  The control of glutamate concns. is crit. to the normal functioning of the central nervous system, and in this review we discuss how glutamate transporters regulate glutamate concns. to maintain dynamic signaling mechanisms between neurons.  In 2004, the crystal structure of a prokaryotic homolog of the mammalian glutamate transporter family of proteins was crystd. and its structure detd.  This has paved the way for a better understanding of the structural basis for glutamate transporter function.  In this review we provide a broad perspective of this field of research, but focus primarily on the more recent studies with a particular emphasis on how our understanding of the structure of glutamate transporters has generated new insights.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzAmcjroPMPLVg90H21EOLACvtfcHk0ljbzXElf0UqSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShtrrP&md5=b573b96bbaf6f03c835c471cf2aaf7b8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00007.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00007.2013%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberg%26aufirst%3DR.%2BJ.%26aulast%3DRyan%26aufirst%3DR.%2BM.%26atitle%3DMechanisms%2520of%2520Glutamate%2520Transport%26jtitle%3DPhysiol.%2520Rev.%26date%3D2013%26volume%3D93%26spage%3D1621%26epage%3D1657%26doi%3D10.1152%2Fphysrev.00007.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahlke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørn-Yoshimoto, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Excitatory Amino Acid Transporters: Recent Insights into Molecular Mechanisms, Novel Modes of Modulation and New Therapeutic Possibilities</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1016/j.coph.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1016%2Fj.coph.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=25466154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCktbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=116-123&author=A.+A.+Jensenauthor=C.+Fahlkeauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=L.+Bunch&title=Excitatory+Amino+Acid+Transporters%3A+Recent+Insights+into+Molecular+Mechanisms%2C+Novel+Modes+of+Modulation+and+New+Therapeutic+Possibilities&doi=10.1016%2Fj.coph.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities</span></div><div class="casAuthors">Jensen, Anders A.; Fahlke, Christoph; Bjoern-Yoshimoto, Walden E.; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116-123</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The five excitatory amino acid transporters (EAAT1-5) mediating the synaptic uptake of the major excitatory neurotransmitter glutamate are differently expressed throughout the CNS and at the synaptic level.  Although EAATs are crucial for normal excitatory neurotransmission, explorations into the physiol. functions mediated by the different transporter subtypes and their resp. therapeutic potential have so far been sparse, in no small part due to the limited selection of pharmacol. tools available.  In the present update, we outline important new insights into the mol. compns. of EAATs and their intricate transport process, the novel approaches to pharmacol. modulation of the transporters that have emerged, and interesting new perspectives in EAAT as drug targets proposed in recent years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHCPIMplW6KLVg90H21EOLACvtfcHk0ljbzXElf0UqSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCktbvF&md5=4619d6aebdc64cfd77a44bae4379eb53</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DFahlke%26aufirst%3DC.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DExcitatory%2520Amino%2520Acid%2520Transporters%253A%2520Recent%2520Insights%2520into%2520Molecular%2520Mechanisms%252C%2520Novel%2520Modes%2520of%2520Modulation%2520and%2520New%2520Therapeutic%2520Possibilities%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2015%26volume%3D20%26spage%3D116%26epage%3D123%26doi%3D10.1016%2Fj.coph.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S. G.</span><span> </span><span class="NLM_article-title">New Views of Glutamate Transporter Structure and Function: Advances and Challenges</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1016%2Fj.neuropharm.2010.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=20708631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=172-181&author=J.+Jiangauthor=S.+G.+Amara&title=New+Views+of+Glutamate+Transporter+Structure+and+Function%3A+Advances+and+Challenges&doi=10.1016%2Fj.neuropharm.2010.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New views of glutamate transporter structure and function: Advances and challenges</span></div><div class="casAuthors">Jiang, Jie; Amara, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-181</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neuronal and glial glutamate transporters limit the action of excitatory amino acids after their release during synaptic transmission.  Recent structural and functional investigations have revealed much about the transport and conducting mechanisms of members of the sodium-coupled symporter family responsible for glutamate clearance in the nervous system.  In this review we summarize emerging views on the general structure, binding sites for substrates and coupled ions, and transport mechanisms of mammalian glutamate transporters, integrating results from a large body of work on carrier structure-function relationships with several crystal structures obtained for the archaeal ortholog, GltPh.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAUxmtx--OBLVg90H21EOLACvtfcHk0ljbzXElf0UqSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FF&md5=4df5a1e8ea9f5be507e3a403aadb2f67</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DAmara%26aufirst%3DS.%2BG.%26atitle%3DNew%2520Views%2520of%2520Glutamate%2520Transporter%2520Structure%2520and%2520Function%253A%2520Advances%2520and%2520Challenges%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D172%26epage%3D181%26doi%3D10.1016%2Fj.neuropharm.2010.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Grewer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gameiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauen, T.</span><span> </span><span class="NLM_article-title">SLC1 Glutamate Transporters</span> <span class="citation_source-journal">Pfluegers Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1007/s00424-013-1397-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1007%2Fs00424-013-1397-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=24240778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyls7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2014&pages=3-24&author=C.+Grewerauthor=A.+Gameiroauthor=T.+Rauen&title=SLC1+Glutamate+Transporters&doi=10.1007%2Fs00424-013-1397-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">SLC1 glutamate transporters</span></div><div class="casAuthors">Grewer, Christof; Gameiro, Armanda; Rauen, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The plasma membrane transporters for the neurotransmitter glutamate belong to the solute carrier 1 family.  They are secondary active transporters, taking up glutamate into the cell against a substantial concn. gradient.  The driving force for concentrative uptake is provided by the cotransport of Na+ ions and the countertransport of one K+ in a step independent of the glutamate translocation step.  Due to eletrogenicity of transport, the transmembrane potential can also act as a driving force.  Glutamate transporters are expressed in many tissues, but are of particular importance in the brain, where they contribute to the termination of excitatory neurotransmission.  Glutamate transporters can also run in reverse, resulting in glutamate release from cells.  Due to these important physiol. functions, glutamate transporter expression and, therefore, the transport rate, are tightly regulated.  This review summarizes recent literature on the functional and biophys. properties, structure-function relationships, regulation, physiol. significance, and pharmacol. of glutamate transporters.  Particular emphasis is on the insight from rapid kinetic and electrophysiol. studies, transcriptional regulation of transporter expression, and reverse transport and its importance for pathophysiol. glutamate release under ischemic conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7CB_CXRaoDrVg90H21EOLACvtfcHk0li_zTQIb2qK8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyls7%252FK&md5=a15133383ebbc3dbe813b7f34bd02821</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00424-013-1397-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-013-1397-7%26sid%3Dliteratum%253Aachs%26aulast%3DGrewer%26aufirst%3DC.%26aulast%3DGameiro%26aufirst%3DA.%26aulast%3DRauen%26aufirst%3DT.%26atitle%3DSLC1%2520Glutamate%2520Transporters%26jtitle%3DPfluegers%2520Arch.%26date%3D2014%26volume%3D466%26spage%3D3%26epage%3D24%26doi%3D10.1007%2Fs00424-013-1397-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hansen, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haym, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørn-Yoshimoto, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storgaard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">New Insight into the Structure-Activity Relationships of the Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors UCPH-101 and UCPH-102</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1002/cmdc.201500525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1002%2Fcmdc.201500525" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=382-402&author=S.+W.+Hansenauthor=M.+N.+Erichsenauthor=T.+H.+V+Huynhauthor=J.+A.+Ruizauthor=I.+Haymauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=B.+Abrahamsenauthor=J.+Hansenauthor=M.+Storgaardauthor=A.+L.+Eriksenauthor=A.+A.+Jensenauthor=L.+Bunch&title=New+Insight+into+the+Structure-Activity+Relationships+of+the+Selective+Excitatory+Amino+Acid+Transporter+Subtype+1+%28EAAT1%29+Inhibitors+UCPH-101+and+UCPH-102&doi=10.1002%2Fcmdc.201500525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500525%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DS.%2BW.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV%26aulast%3DRuiz%26aufirst%3DJ.%2BA.%26aulast%3DHaym%26aufirst%3DI.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DHansen%26aufirst%3DJ.%26aulast%3DStorgaard%26aufirst%3DM.%26aulast%3DEriksen%26aufirst%3DA.%2BL.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DNew%2520Insight%2520into%2520the%2520Structure-Activity%2520Relationships%2520of%2520the%2520Selective%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520%2528EAAT1%2529%2520Inhibitors%2520UCPH-101%2520and%2520UCPH-102%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D382%26epage%3D402%26doi%3D10.1002%2Fcmdc.201500525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Haym, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, M. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørn-Yoshimoto, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Bioavailability Studies and in Vitro Profiling of the Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitor UCPH-102</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1002/cmdc.201500527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1002%2Fcmdc.201500527" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=403-419&author=I.+Haymauthor=T.+H.+V+Huynhauthor=S.+W.+Hansenauthor=M.+H.+F.+Pedersenauthor=J.+A.+Ruizauthor=M.+N.+Erichsenauthor=M.+Gyntherauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=B.+Abrahamsenauthor=J.+F.+Bastlundauthor=C.+Bundgaardauthor=A.+L.+Eriksenauthor=A.+A.+Jensenauthor=L.+Bunch&title=Bioavailability+Studies+and+in+Vitro+Profiling+of+the+Selective+Excitatory+Amino+Acid+Transporter+Subtype+1+%28EAAT1%29+Inhibitor+UCPH-102&doi=10.1002%2Fcmdc.201500527"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500527%26sid%3Dliteratum%253Aachs%26aulast%3DHaym%26aufirst%3DI.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV%26aulast%3DHansen%26aufirst%3DS.%2BW.%26aulast%3DPedersen%26aufirst%3DM.%2BH.%2BF.%26aulast%3DRuiz%26aufirst%3DJ.%2BA.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DGynther%26aufirst%3DM.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DEriksen%26aufirst%3DA.%2BL.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DBioavailability%2520Studies%2520and%2520in%2520Vitro%2520Profiling%2520of%2520the%2520Selective%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520%2528EAAT1%2529%2520Inhibitor%2520UCPH-102%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D403%26epage%3D419%26doi%3D10.1002%2Fcmdc.201500527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span><span class="refDoi"> DOI: 10.1021/jm8013458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8013458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=912-915&author=A.+A.+Jensenauthor=M.+N.+Erichsenauthor=C.+W.+Nielsenauthor=T.+B.+Stensb%C3%B8lauthor=J.+Kehlerauthor=L.+Bunch&title=Discovery+of+the+First+Selective+Inhibitor+of+Excitatory+Amino+Acid+Transporter+Subtype+1&doi=10.1021%2Fjm8013458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1</span></div><div class="casAuthors">Jensen, Anders A.; Erichsen, Mette N.; Nielsen, Christina W.; Stensboel, Tine B.; Kehler, Jan; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">912-915</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of the first class of subtype-selective inhibitors of the human excitatory amino acid transporter subtype 1 (EAAT1) and its rat orthologue GLAST is reported.  An opening structure-activity relationship of 25 analogs is presented that addresses the influence of substitutions at the 4- and 7-positions of the parental skeleton 2-amino-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile.  The most potent analog 10 displays high nanomolar inhibitory activity at EAAT1 and a >400-fold selectivity over EAAT2 and EAAT3, making it a highly valuable pharmacol. tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVu7PAOshxerVg90H21EOLACvtfcHk0li_zTQIb2qK8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs78%253D&md5=7036a6fe617a9908a36fda6a87400e2c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm8013458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8013458%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DNielsen%26aufirst%3DC.%2BW.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520the%2520First%2520Selective%2520Inhibitor%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D912%26epage%3D915%26doi%3D10.1021%2Fjm8013458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monrad, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekker-Jensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationship Study of First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1:2-Amino-4-(4-Methoxyphenyl)-7-(Naphthalen-1-Yl)-5-Oxo-5,6,7,8-Tetrahydro-4 H -Chromene-3-Carbonitrile (UCPH-101)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7180</span><span class="NLM_x">–</span> <span class="NLM_lpage">7191</span><span class="refDoi"> DOI: 10.1021/jm1009154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1009154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7180-7191&author=M.+N.+Erichsenauthor=T.+H.+V.+Huynhauthor=B.+Abrahamsenauthor=J.+F.+Bastlundauthor=C.+Bundgaardauthor=O.+Monradauthor=A.+Bekker-Jensenauthor=C.+W.+Nielsenauthor=K.+Frydenvangauthor=A.+A.+Jensenauthor=L.+Bunch&title=Structure%E2%80%93Activity+Relationship+Study+of+First+Selective+Inhibitor+of+Excitatory+Amino+Acid+Transporter+Subtype+1%3A2-Amino-4-%284-Methoxyphenyl%29-7-%28Naphthalen-1-Yl%29-5-Oxo-5%2C6%2C7%2C8-Tetrahydro-4+H+-Chromene-3-Carbonitrile+%28UCPH-101%29&doi=10.1021%2Fjm1009154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm1009154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009154%26sid%3Dliteratum%253Aachs%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DMonrad%26aufirst%3DO.%26aulast%3DBekker-Jensen%26aufirst%3DA.%26aulast%3DNielsen%26aufirst%3DC.%2BW.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationship%2520Study%2520of%2520First%2520Selective%2520Inhibitor%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%253A2-Amino-4-%25284-Methoxyphenyl%2529-7-%2528Naphthalen-1-Yl%2529-5-Oxo-5%252C6%252C7%252C8-Tetrahydro-4%2520H%2520-Chromene-3-Carbonitrile%2520%2528UCPH-101%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7180%26epage%3D7191%26doi%3D10.1021%2Fjm1009154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Huynh, T. H. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship Study of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitor 2-Amino-4-(4-Methoxyphenyl)-7-(Naphthalen-1-Yl)-5-Oxo-5,6,7,8-Tetrahydro-4H-Chromene-3-Carbonitrile (UCPH-101) and Absolute Configurational as</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5403</span><span class="NLM_x">–</span> <span class="NLM_lpage">5412</span><span class="refDoi"> DOI: 10.1021/jm300345z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300345z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5403-5412&author=T.+H.+V+Huynhauthor=I.+Shimauthor=H.+Bohrauthor=B.+Abrahamsenauthor=B.+Nielsenauthor=A.+A.+Jensenauthor=L.+Bunch&title=Structure-Activity+Relationship+Study+of+Selective+Excitatory+Amino+Acid+Transporter+Subtype+1+%28EAAT1%29+Inhibitor+2-Amino-4-%284-Methoxyphenyl%29-7-%28Naphthalen-1-Yl%29-5-Oxo-5%2C6%2C7%2C8-Tetrahydro-4H-Chromene-3-Carbonitrile+%28UCPH-101%29+and+Absolute+Configurational+as&doi=10.1021%2Fjm300345z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm300345z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300345z%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV%26aulast%3DShim%26aufirst%3DI.%26aulast%3DBohr%26aufirst%3DH.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DStructure-Activity%2520Relationship%2520Study%2520of%2520Selective%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520%2528EAAT1%2529%2520Inhibitor%25202-Amino-4-%25284-Methoxyphenyl%2529-7-%2528Naphthalen-1-Yl%2529-5-Oxo-5%252C6%252C7%252C8-Tetrahydro-4H-Chromene-3-Carbonitrile%2520%2528UCPH-101%2529%2520and%2520Absolute%2520Configurational%2520as%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5403%26epage%3D5412%26doi%3D10.1021%2Fjm300345z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demmer, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Probing for Improved Potency and in Vivo Bioavailability of Excitatory Amino Acid Transporter Subtype 1 Inhibitors UCPH-101 and UCPH-102: Design, Synthesis and Pharmacological Evaluation of Substituted 7-Biphenyl Analogs</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1964</span><span class="NLM_x">–</span> <span class="NLM_lpage">1979</span><span class="refDoi"> DOI: 10.1007/s11064-014-1264-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1007%2Fs11064-014-1264-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=24682739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlWjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=1964-1979&author=M.+N.+Erichsenauthor=J.+Hansenauthor=J.+A.+Ruizauthor=C.+S.+Demmerauthor=B.+Abrahamsenauthor=J.+F.+Bastlundauthor=C.+Bundgaardauthor=A.+A.+Jensenauthor=L.+Bunch&title=Probing+for+Improved+Potency+and+in+Vivo+Bioavailability+of+Excitatory+Amino+Acid+Transporter+Subtype+1+Inhibitors+UCPH-101+and+UCPH-102%3A+Design%2C+Synthesis+and+Pharmacological+Evaluation+of+Substituted+7-Biphenyl+Analogs&doi=10.1007%2Fs11064-014-1264-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Probing for Improved Potency and In Vivo Bioavailability of Excitatory Amino Acid Transporter Subtype 1 Inhibitors UCPH-101 and UCPH-102: Design, Synthesis and Pharmacological Evaluation of Substituted 7-Biphenyl Analogs</span></div><div class="casAuthors">Erichsen, Mette N.; Hansen, Jeanette; Ruiz, Josep A.; Demmer, Charles S.; Abrahamsen, Bjarke; Bastlund, Jesper F.; Bundgaard, Christoffer; Jensen, Anders A.; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1964-1979</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The soly. properties of these EAAT1 inhibitors with the objective to develop analogs more suited as pharmacol. tools for in vivo studies of EAAT1 in terms of their bioavailability was discussed.  A total of 23 novel UCPH-101/102 analogs I [R1 = Me, Ph; R2 = o-Br, o-Ph, o-(m-ClC6H4), etc.] were designed, synthesized and characterized pharmacol. at EAAT1-3 in a [3H]-D-aspartate uptake assay.  Most notably, the potent EAAT1 inhibition displayed of UCPH-101 and UCPH-102 was retained in analog in which the napht-1-yl group in the 7-position of UCPH-102 has been replaced by an o-biphenyl moiety.  In contrast, EAAT1 activity was dramatically compromised in analogs comprising m- and p-biphenyl groups as 7-substituents, resp.  O-biphenyl analog displayed low bioavailability after oral administration in rats, and this problem was addressed by the synthesis of a series of analogs with different chloro, fluoro, methoxy, triflouromethyl and carboxy substitution patterns at the o-biphenyl group and m- and p-pyridine analogs.  Unfortunately, all of the modifications resulted in substantial decreased EAAT1 inhibitory activity, which supported the notion of a very lipophilic binding pocket in EAAT1 for the arom. 7-substituent in these ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDAz_LSWRbT7Vg90H21EOLACvtfcHk0liqImvnsfgRWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlWjurw%253D&md5=e31d6f9bcbdd690a2716d1fa31105adf</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs11064-014-1264-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-014-1264-8%26sid%3Dliteratum%253Aachs%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHansen%26aufirst%3DJ.%26aulast%3DRuiz%26aufirst%3DJ.%2BA.%26aulast%3DDemmer%26aufirst%3DC.%2BS.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DProbing%2520for%2520Improved%2520Potency%2520and%2520in%2520Vivo%2520Bioavailability%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520Inhibitors%2520UCPH-101%2520and%2520UCPH-102%253A%2520Design%252C%2520Synthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Substituted%25207-Biphenyl%2520Analogs%26jtitle%3DNeurochem.%2520Res.%26date%3D2014%26volume%3D39%26spage%3D1964%26epage%3D1979%26doi%3D10.1007%2Fs11064-014-1264-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIlvain, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrick, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosanu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J.</span><span> </span><span class="NLM_article-title">Characterization of Novel Aryl-Ether, Biaryl, and Fluorene Aspartic Acid and Diaminopropionic Acid Analogs as Potent Inhibitors of the High-Affinity Glutamate Transporter EAAT2</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">974</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span><span class="refDoi"> DOI: 10.1124/mol.105.012005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1124%2Fmol.105.012005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=16014807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyhu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=974-982&author=J.+Dunlopauthor=H.+B.+McIlvainauthor=T.+A.+Carrickauthor=B.+Jowauthor=Q.+Luauthor=D.+Kowalauthor=S.+Linauthor=A.+Greenfieldauthor=C.+Grosanuauthor=K.+Fanauthor=R.+Petroskiauthor=J.+Williamsauthor=A.+Fosterauthor=J.+Butera&title=Characterization+of+Novel+Aryl-Ether%2C+Biaryl%2C+and+Fluorene+Aspartic+Acid+and+Diaminopropionic+Acid+Analogs+as+Potent+Inhibitors+of+the+High-Affinity+Glutamate+Transporter+EAAT2&doi=10.1124%2Fmol.105.012005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2</span></div><div class="casAuthors">Dunlop, John; McIlvain, H. Beal; Carrick, Tikva A.; Jow, Brian; Lu, Qiang; Kowal, Dianne; Lin, Steven; Greenfield, Alexander; Grosanu, Cristina; Fan, Kristi; Petroski, Robert; Williams, John; Foster, Alan; Butera, John</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">974-982</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In this study, we describe the pharmacol. characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of EAAT2, the predominant glutamate transporter in forebrain regions.  The rank order of potency detd. for the inhibition of human EAAT2 was N4-[4-(2-bromo-4,5-difluorophenoxy)phenyl]-L-asparagine (WAY-213613) (IC50 = 85 ± 5 nM) > N4-(2'-methyl-1,1'-biphenyl-4-yl)-L-asparagine (WAY-213394) (IC50 = 145 ± 22 nM) = N4-[7-(trifluoromethyl)-9H-fluoren-2-yl]-L-asparagine (WAY-212922) (IC50 = 157 ± 11 nM) = 3-{[(4'-chloro-2-methyl-1,1'-biphenyl-4-yl)carbonyl]amino}- L-alanine (WAY-211686) (IC50 = 190 ± 10 nM).  WAY-213613 was the most selective of the compds. examd., with IC50 values for inhibition of EAAT1 and EAAT3 of 5 and 3.8 μM, resp., corresponding to a 59- and 45-fold selectivity toward EAAT2.  An identical rank order to potency [WAY-213613 (35 ± 7 nM) > WAY-213394 (92 ± 13 nM) = WAY-212922 (95 ± 8 nM) = WAY-211686 (101 ± 20 nM)] was obsd. for the inhibition of glutamate uptake in rat cortical synaptosomes, consistent with the predominant contribution of EAAT2 to this activity.  Kinetic studies with each of the compds. in synaptosomes revealed a competitive mechanism of inhibition.  All compds. were detd. to be nonsubstrates by evaluating both the stimulation of currents in EAAT2-injected oocytes and the heteroexchange of D-[3H]aspartate from cortical synaptosomes.  WAY-213613 represents the most potent and selective inhibitor of EAAT2 identified to date.  Taken in combination with its selectivity over ionotropic and metabotropic glutamate receptors, this compd. represents a potential tool for the further elucidation of EAAT2 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVqqndi70Gr7Vg90H21EOLACvtfcHk0ljTWG0uaSmjeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyhu7nK&md5=933a42c1c37af6a8bf8390f8a93e5f82</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.012005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.012005%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DMcIlvain%26aufirst%3DH.%2BB.%26aulast%3DCarrick%26aufirst%3DT.%2BA.%26aulast%3DJow%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DGreenfield%26aufirst%3DA.%26aulast%3DGrosanu%26aufirst%3DC.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DA.%26aulast%3DButera%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520Novel%2520Aryl-Ether%252C%2520Biaryl%252C%2520and%2520Fluorene%2520Aspartic%2520Acid%2520and%2520Diaminopropionic%2520Acid%2520Analogs%2520as%2520Potent%2520Inhibitors%2520of%2520the%2520High-Affinity%2520Glutamate%2520Transporter%2520EAAT2%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D974%26epage%3D982%26doi%3D10.1124%2Fmol.105.012005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hansen, J. C.; Bjørn-Yoshimoto, W. E.; Bisballe, N.; Nielsen, B.; Jensen, A. A.; Bunch, L.</span><span> </span><span class="NLM_article-title">β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01066</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01066" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&author=J.+C.+Hansen&author=W.+E.+Bj%C3%B8rn-Yoshimoto&author=N.+Bisballe&author=B.+Nielsen&author=A.+A.+Jensen&author=L.+Bunch&title=%CE%B2-Sulfonamido+Functionalized+Aspartate+Analogues+as+Excitatory+Amino+Acid+Transporter+Inhibitors%3A+Distinct+Subtype+Selectivity+Profiles+Arising+from+Subtle+Structural+Differences&doi=10.1021%2Facs.jmedchem.6b01066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01066%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DJ.%2BC.%26atitle%3D%25CE%25B2-Sulfonamido%2520Functionalized%2520Aspartate%2520Analogues%2520as%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Inhibitors%253A%2520Distinct%2520Subtype%2520Selectivity%2520Profiles%2520Arising%2520from%2520Subtle%2520Structural%2520Differences%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26doi%3D10.1021%2Facs.jmedchem.6b01066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Esslinger, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerdes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awes, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mavencamp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhoderick, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlin, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, R. J.</span><span> </span><span class="NLM_article-title">The Substituted Aspartate Analogue L-Beta-Threo-Benzyl-Aspartate Preferentially Inhibits the Neuronal Excitatory Amino Acid Transporter EAAT3</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1016%2Fj.neuropharm.2005.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=16183084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFehsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=850-861&author=C.+S.+Esslingerauthor=S.+Agarwalauthor=J.+Gerdesauthor=P.+A.+Wilsonauthor=E.+S.+Davisauthor=A.+N.+Awesauthor=E.+O%E2%80%99Brienauthor=T.+Mavencampauthor=H.+P.+Kochauthor=D.+J.+Poulsenauthor=J.+F.+Rhoderickauthor=A.+R.+Chamberlinauthor=M.+P.+Kavanaughauthor=R.+J.+Bridges&title=The+Substituted+Aspartate+Analogue+L-Beta-Threo-Benzyl-Aspartate+Preferentially+Inhibits+the+Neuronal+Excitatory+Amino+Acid+Transporter+EAAT3&doi=10.1016%2Fj.neuropharm.2005.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The substituted aspartate analogue L-β-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3</span></div><div class="casAuthors">Esslinger, C. Sean; Agarwal, Shailesh; Gerdes, John; Wilson, Paul A.; Davis, Erin S.; Awes, Alicia N.; O'Brien, Erin; Mavencamp, Teri; Koch, Hans P.; Poulsen, David J.; Rhoderick, Joseph F.; Chamberlin, A. Richard; Kavanaugh, Michael P.; Bridges, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">850-861</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The excitatory amino acid transporters (EAATs) play key roles in the regulation of CNS L-glutamate, esp. related to synthesis, signal termination, synaptic spillover, and excitotoxic protection.  Inhibitors available to delineate EAAT pharmacol. and function are essentially limited to those that non-selectively block all EAATs or those that exhibit a substantial preference for EAAT2.  Thus, it is difficult to selectively study the other subtypes, particularly EAAT1 and EAAT3.  Structure activity studies on a series of β-substituted aspartate analogs identify L-β-benzyl-aspartate (L-β-BA) as among the first blockers that potently and preferentially inhibits the neuronal EAAT3 subtype.  Kinetic anal. of D-[3H]aspartate uptake into C17.2 cells expressing the hEAATs demonstrate that L-β-threo-BA is the more potent diastereomer, acts competitively, and exhibits a 10-fold preference for EAAT3 compared to EAAT1 and EAAT2.  Electrophysiol. recordings of EAAT-mediated currents in Xenopus oocytes identify L-β-BA as a non-substrate inhibitor.  Analyzing L-β-threo-BA within the context of a novel EAAT2 pharmacophore model suggests: a highly conserved positioning of the electrostatic carboxyl and amino groups; nearby regions that accommodate select structural modifications (cyclopropyl rings, Me groups, oxygen atoms); and a unique region L-β-threo-BA occupied by the benzyl moieties of L-TBOA, L-β-threo-BA and related analogs.  It is plausible that the preference of L-β-threo-BA and L-TBOA for EAAT3 and EAAT2, resp., could reside in the latter two pharmacophore regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4vqhxyJbFa7Vg90H21EOLACvtfcHk0ljTWG0uaSmjeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFehsL7I&md5=5bf2793da482cf7bbf27e6a3b0d1bce8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DEsslinger%26aufirst%3DC.%2BS.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DGerdes%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DP.%2BA.%26aulast%3DDavis%26aufirst%3DE.%2BS.%26aulast%3DAwes%26aufirst%3DA.%2BN.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%26aulast%3DMavencamp%26aufirst%3DT.%26aulast%3DKoch%26aufirst%3DH.%2BP.%26aulast%3DPoulsen%26aufirst%3DD.%2BJ.%26aulast%3DRhoderick%26aufirst%3DJ.%2BF.%26aulast%3DChamberlin%26aufirst%3DA.%2BR.%26aulast%3DKavanaugh%26aufirst%3DM.%2BP.%26aulast%3DBridges%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520Substituted%2520Aspartate%2520Analogue%2520L-Beta-Threo-Benzyl-Aspartate%2520Preferentially%2520Inhibits%2520the%2520Neuronal%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520EAAT3%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D850%26epage%3D861%26doi%3D10.1016%2Fj.neuropharm.2005.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span> </span><span class="NLM_article-title">Pharmacological Characterization of Human Excitatory Amino Acid Transporters EAAT1, EAAT2 and EAAT3 in a Fluorescence-Based Membrane Potential Assay</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2115</span><span class="NLM_x">–</span> <span class="NLM_lpage">2127</span><span class="refDoi"> DOI: 10.1016/j.bcp.2004.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1016%2Fj.bcp.2004.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=15135308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVCis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=2115-2127&author=A.+A.+Jensenauthor=H.+Br%C3%A4uner-Osborne&title=Pharmacological+Characterization+of+Human+Excitatory+Amino+Acid+Transporters+EAAT1%2C+EAAT2+and+EAAT3+in+a+Fluorescence-Based+Membrane+Potential+Assay&doi=10.1016%2Fj.bcp.2004.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay</span></div><div class="casAuthors">Jensen, Anders A.; Brauner-Osborne, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2115-2127</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We have expressed the human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 stably in HEK293 cells and characterized the transporters pharmacol. in a conventional [3H]-d-aspartate uptake assay and in a fluorescence-based membrane potential assay, the FLIPR Membrane Potential (FMP) assay.  The Km and Ki values obtained for 12 std. EAAT ligands at EAAT1, EAAT2 and EAAT3 in the FMP assay correlated well with the Ki values obtained in the [3H]-d-aspartate assay (r2 values of 0.92, 0.92, and 0.95, resp.).  Furthermore, the pharmacol. characteristics of the cell lines in the FMP assay were in good agreement with previous findings in electrophysiol. studies of the transporters.  The FMP assay was capable of distinguishing between substrates and non-substrate inhibitors and to discriminate between "full" and "partial" substrates at the transporters.  Taking advantage of the prolific nature of the FMP assay, interactions of the EAATs with substrates and inhibitors were studied in some detail.  This is the first report of a high throughput screening assay for EAATs.  We propose that the assay will be of great use in future studies of the transporters.  Although conventional electrophysiol. set-ups might be superior in terms of studying sophisticated kinetic aspects of the uptake process, the FMP assay enables the collection of considerable amts. of highly reproducible data with relatively little labor.  Furthermore, considering that the no. of EAAT ligands presently available is limited, and that almost all of these are characterized by low potency and a low degree of subtype selectivity, future screening of compd. libraries at the EAAT-cell lines in the FMP assay could help identify structurally and pharmacol. novel ligands for the transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS6Um79wVYz7Vg90H21EOLACvtfcHk0lgieaBPF2yveA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVCis78%253D&md5=06e3c536844acca52fdba733175a93c6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26atitle%3DPharmacological%2520Characterization%2520of%2520Human%2520Excitatory%2520Amino%2520Acid%2520Transporters%2520EAAT1%252C%2520EAAT2%2520and%2520EAAT3%2520in%2520a%2520Fluorescence-Based%2520Membrane%2520Potential%2520Assay%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26spage%3D2115%26epage%3D2127%26doi%3D10.1016%2Fj.bcp.2004.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Arriza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadiche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdoch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S.</span><span> </span><span class="NLM_article-title">Functional Comparisons of Three Glutamate Transporter Subtypes Cloned from Human Motor Cortex</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5559</span><span class="NLM_x">–</span> <span class="NLM_lpage">5569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1523%2FJNEUROSCI.14-09-05559.1994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=7521911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=5559-5569&author=J.+Arrizaauthor=W.+Fairmanauthor=J.+Wadicheauthor=G.+Murdochauthor=M.+Kavanaughauthor=S.+Amara&title=Functional+Comparisons+of+Three+Glutamate+Transporter+Subtypes+Cloned+from+Human+Motor+Cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex</span></div><div class="casAuthors">Arriza, Jeffrey L.; Fairman, Wendy A.; Wadiche, Jacques I.; Murdoch, Geoffrey H.; Kavanaugh, Michael P.; Amara, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5559-69</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Reuptake plays an important role in regulating synaptic and extracellular concns. of glutamate.  Three glutamate transporters expressed in human motor cortex, termed EAAT1, EAAT2, and EAAT3 (for excitatory amino acid transporter), have been characterized by their mol. cloning and functional expression.  Each EAAT subtype mRNA was found in all human brain regions analyzed.  The most prominent regional variation in message content was in cerebellum where EAAT1 expression predominated.  EAAT1 and EAAT3 mRNAs were also expressed in various non-nervous tissues, whereas expression of EAAT2 was largely restricted to brain.  The kinetic parameters and pharmacol. characteristics of transport mediated by each EAAT subtype were detd. in transfected mammalian cells by radiolabel uptake and in microinjected oocytes by voltage-clamp measurements.  The affinities of the EAAT subtypes for L-glutamate were similar, with Km detns. varying from 48 to 97 μm in the mammalian cell assay and from 18 to 28 μM in oocytes.  Glutamate uptake inhibitors were used to compare the pharmacologies of the EAAT subtypes.  The EAAT2 subtype was distinguishable from the EAAT1/EAAT3 subtypes by the potency of several inhibitors, but most notably by sensitivity to kainic acid (KA) and dihydrokainic acid (DHK).  KA and DHK potently inhibited EAAT2 transport, but did not significantly affect transport by EAAT1/EAAT3.  Using voltage-clamp measurements, most inhibitors were found to be substrates that elicited transport currents.  In contrast, KA and DHK did not evoke currents and they were found to block EAAT2-mediated transport competitively.  This selective interaction with the EAAT2 subtype could be a significant factor in KA neurotoxicity.  These studies provide a foundation for understanding the role of glutamate transporters in human excitatory neurotransmission and in neuropathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdLh7iGWaRnbVg90H21EOLACvtfcHk0lgieaBPF2yveA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVyrsQ%253D%253D&md5=27b0072f8a4cd584e3b3bcb5582e697f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.14-09-05559.1994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.14-09-05559.1994%26sid%3Dliteratum%253Aachs%26aulast%3DArriza%26aufirst%3DJ.%26aulast%3DFairman%26aufirst%3DW.%26aulast%3DWadiche%26aufirst%3DJ.%26aulast%3DMurdoch%26aufirst%3DG.%26aulast%3DKavanaugh%26aufirst%3DM.%26aulast%3DAmara%26aufirst%3DS.%26atitle%3DFunctional%2520Comparisons%2520of%2520Three%2520Glutamate%2520Transporter%2520Subtypes%2520Cloned%2520from%2520Human%2520Motor%2520Cortex%26jtitle%3DJ.%2520Neurosci.%26date%3D1994%26volume%3D14%26spage%3D5559%26epage%3D5569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Alaux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gefflaut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Chemoenzymatic Synthesis of a Series of 4-Substituted Glutamate Analogues and Pharmacological Characterization at Human Glutamate Transporters Subtypes 1–3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7980</span><span class="NLM_x">–</span> <span class="NLM_lpage">7992</span><span class="refDoi"> DOI: 10.1021/jm050597z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050597z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2htrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7980-7992&author=S.+Alauxauthor=M.+Kuskauthor=E.+Sagotauthor=J.+Bolteauthor=A.+A.+Jensenauthor=H.+Br%C3%A4uner-Osborneauthor=T.+Gefflautauthor=L.+Bunch&title=Chemoenzymatic+Synthesis+of+a+Series+of+4-Substituted+Glutamate+Analogues+and+Pharmacological+Characterization+at+Human+Glutamate+Transporters+Subtypes+1%E2%80%933&doi=10.1021%2Fjm050597z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoenzymatic Synthesis of a Series of 4-Substituted Glutamate Analogues and Pharmacological Characterization at Human Glutamate Transporters Subtypes 1-3</span></div><div class="casAuthors">Alaux, Sebastien; Kusk, Mie; Sagot, Emanuelle; Bolte, Jean; Jensen, Anders A.; Braeuner-Osborne, Hans; Gefflaut, Thierry; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7980-7992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of L-2,4-syn-4-alkylglutamic acid analogs I (R = Me, Et, Pr, Bu, i-Pr, i-Bu, pentyl, iso-pentyl, CH2Ph) were synthesized in high yields and high enantiomeric excess (> 99%) from their corresponding 4-substituted ketoglutaric acids dilithium salts II via enzymic transamination using aspartate aminotransferase (AAT) from pig heart or E. coli.  I were evaluated as potential ligands for the glutamate transporters EAAT1, EAAT2, and EAAT3 (excitatory amino acid transporter, subtypes 1-3) in the FLIPR membrane potential (FMP) assay.  The results showed a distinct change in the pharmacol. profile when the 4-Me group (an EAAT1 substrate and EAAT2,3 inhibitor) was extended to a 4-Et group, as this analog is an inhibitor at all three subtypes, EAAT1-3.  In addn., both large and bulky hydrophobic substituents in the 4-position of L-2,4-syn-glutamic acid are allowed by all three glutamate transporter subtypes EAAT1-3 while maintaining inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSrh51A-3q1rVg90H21EOLACvtfcHk0lgieaBPF2yveA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2htrfP&md5=5bad1a4908b9df5f7d5e8a6da9b35af7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm050597z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050597z%26sid%3Dliteratum%253Aachs%26aulast%3DAlaux%26aufirst%3DS.%26aulast%3DKusk%26aufirst%3DM.%26aulast%3DSagot%26aufirst%3DE.%26aulast%3DBolte%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DGefflaut%26aufirst%3DT.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DChemoenzymatic%2520Synthesis%2520of%2520a%2520Series%2520of%25204-Substituted%2520Glutamate%2520Analogues%2520and%2520Pharmacological%2520Characterization%2520at%2520Human%2520Glutamate%2520Transporters%2520Subtypes%25201%25E2%2580%25933%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7980%26epage%3D7992%26doi%3D10.1021%2Fjm050597z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kulkarni, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationships Comparing N-(6-Methylpyridin-Yl)-Substituted Aryl Amides to 2-Methyl-6-(Substituted-Arylethynyl)pyridines or 2-Methyl-4-(Substituted-Arylethynyl)thiazoles as Novel Metabotropic Glutamate Receptor Subtype 5 Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3563</span><span class="NLM_x">–</span> <span class="NLM_lpage">3575</span><span class="refDoi"> DOI: 10.1021/jm900172f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900172f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFWns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3563-3575&author=S.+S.+Kulkarniauthor=M.-F.+Zouauthor=J.+Caoauthor=J.+R.+Deschampsauthor=A.+L.+Rodriguezauthor=P.+J.+Connauthor=A.+H.+Newman&title=Structure-Activity+Relationships+Comparing+N-%286-Methylpyridin-Yl%29-Substituted+Aryl+Amides+to+2-Methyl-6-%28Substituted-Arylethynyl%29pyridines+or+2-Methyl-4-%28Substituted-Arylethynyl%29thiazoles+as+Novel+Metabotropic+Glutamate+Receptor+Subtype+5+Antagonists&doi=10.1021%2Fjm900172f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships Comparing N-(6-Methylpyridin-yl)-Substituted Aryl Amides to 2-Methyl-6-(substituted-arylethynyl)pyridines or 2-Methyl-4-(substituted-arylethynyl)thiazoles as Novel Metabotropic Glutamate Receptor Subtype 5 Antagonists</span></div><div class="casAuthors">Kulkarni, Santosh S.; Zou, Mu-Fa; Cao, Jianjing; Deschamps, Jeffrey R.; Rodriguez, Alice L.; Conn, P. Jeffrey; Hauck Newman, Amy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3563-3575</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metabotropic glutamate receptor subtype 5 (mGluR5) has been implicated in anxiety, depression, pain, mental retardation, and addiction.  The potent and selective noncompetitive mGluR5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP, 1) has been a critically important tool used to further elucidate the role of mGluR5 in these CNS disorders.  In an effort to provide novel and structurally diverse selective mGluR5 antagonists, we previously described a set of analogs with moderate activity wherein the alkyne bond was replaced with an amide group.  In the present report, extended series of both amide and alkyne-based ligands were synthesized.  MGluR5 binding and functional data were obtained that identified (1) several novel alkynes with comparable affinities to 1 at mGluR5 (e.g., 10 and 20-23), but (2) most structural variations to the amide template were not well tolerated, although a few potent amides were discovered (e.g., 55 and 56).  Several of these novel analogs show drug-like phys. properties (e.g., cLogP range = 2-5) that support their use for in vivo investigation into the role of mGluR5 in CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvM-VWtFX94LVg90H21EOLACvtfcHk0ljYVkY40lgsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFWns7g%253D&md5=4396120f547f4ecd5ef92a02b50ed77f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm900172f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900172f%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BS.%26aulast%3DZou%26aufirst%3DM.-F.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DStructure-Activity%2520Relationships%2520Comparing%2520N-%25286-Methylpyridin-Yl%2529-Substituted%2520Aryl%2520Amides%2520to%25202-Methyl-6-%2528Substituted-Arylethynyl%2529pyridines%2520or%25202-Methyl-4-%2528Substituted-Arylethynyl%2529thiazoles%2520as%2520Novel%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3563%26epage%3D3575%26doi%3D10.1021%2Fjm900172f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pomel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgat-Charvillon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valognes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillieron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Françon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rückle, T.</span><span> </span><span class="NLM_article-title">Furan-2-Ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase Gamma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3857</span><span class="NLM_x">–</span> <span class="NLM_lpage">3871</span><span class="refDoi"> DOI: 10.1021/jm0601598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0601598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3857-3871&author=V.+Pomelauthor=J.+Klicicauthor=D.+Coviniauthor=D.+D.+Churchauthor=J.+P.+Shawauthor=K.+Roulinauthor=F.+Burgat-Charvillonauthor=D.+Valognesauthor=M.+Campsauthor=C.+Chabertauthor=C.+Gillieronauthor=B.+Fran%C3%A7onauthor=D.+Perrinauthor=D.+Leroyauthor=D.+Gretenerauthor=A.+Nicholsauthor=P.+A.+Vitteauthor=S.+Carboniauthor=C.+Rommelauthor=M.+K.+Schwarzauthor=T.+R%C3%BCckle&title=Furan-2-Ylmethylene+Thiazolidinediones+as+Novel%2C+Potent%2C+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+Gamma&doi=10.1021%2Fjm0601598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0601598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601598%26sid%3Dliteratum%253Aachs%26aulast%3DPomel%26aufirst%3DV.%26aulast%3DKlicic%26aufirst%3DJ.%26aulast%3DCovini%26aufirst%3DD.%26aulast%3DChurch%26aufirst%3DD.%2BD.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DRoulin%26aufirst%3DK.%26aulast%3DBurgat-Charvillon%26aufirst%3DF.%26aulast%3DValognes%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DGillieron%26aufirst%3DC.%26aulast%3DFran%25C3%25A7on%26aufirst%3DB.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DGretener%26aufirst%3DD.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DVitte%26aufirst%3DP.%2BA.%26aulast%3DCarboni%26aufirst%3DS.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26atitle%3DFuran-2-Ylmethylene%2520Thiazolidinediones%2520as%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520Gamma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3857%26epage%3D3871%26doi%3D10.1021%2Fjm0601598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahlke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Allosteric Modulation of an Excitatory Amino Acid Transporter: The Subtype-Selective Inhibitor UCPH-101 Exerts Sustained Inhibition of EAAT1 through an Intramonomeric Site in the Trimerization Domain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3396-12.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1523%2FJNEUROSCI.3396-12.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=23325245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVemsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1068-1087&author=B.+Abrahamsenauthor=N.+Schneiderauthor=M.+N.+Erichsenauthor=T.+H.+Huynhauthor=C.+Fahlkeauthor=L.+Bunchauthor=A.+A.+Jensen&title=Allosteric+Modulation+of+an+Excitatory+Amino+Acid+Transporter%3A+The+Subtype-Selective+Inhibitor+UCPH-101+Exerts+Sustained+Inhibition+of+EAAT1+through+an+Intramonomeric+Site+in+the+Trimerization+Domain&doi=10.1523%2FJNEUROSCI.3396-12.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of an excitatory amino acid transporter:the subtype-selective inhibitor UCPH-101 exerts sustained inhibition of EAAT1 through an intramonomeric site in the trimerization domain</span></div><div class="casAuthors">Abrahamsen, Bjarke; Schneider, Nicole; Erichsen, Mette N.; Huynh, Tri H. V.; Fahlke, Christoph; Bunch, Lennart; Jensen, Anders A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1068-1087</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In the present study, the mechanism of action and mol. basis for the activity of the first class of selective inhibitors of the human excitatory amino acid transporter subtype 1 (EAAT1) and its rodent ortholog GLAST are elucidated.  The previously reported specificity of UCPH-101 and UCPH-102 for EAAT1 over EAAT2 and EAAT3 is demonstrated to extend to the EAAT4 and EAAT5 subtypes as well.  Interestingly, brief exposure to UCPH-101 induces a long-lasting inactive state of EAAT1, whereas the inhibition exerted by closely related analogs is substantially more reversible in nature.  In agreement with this, the kinetic properties of UCPH-101 unblocking of the transporter are considerably slower than those of UCPH-102.  UCPH-101 exhibits noncompetitive inhibition of EAAT1, and its binding site in GLAST has been delineated in an elaborate mutagenesis study.  Substitutions of several residues in TM3, TM4c, and TM7a of GLAST have detrimental effects on the inhibitory potency and/or efficacy of UCPH-101 while not affecting the pharmacol. properties of (S)-glutamate or the competitive EAAT inhibitor TBOA significantly.  Hence, UCPH-101 is proposed to target a predominantly hydrophobic crevice in the "trimerization domain" of the GLAST monomer, and the inhibitor is demonstrated to inhibit the uptake through the monomer that it binds to exclusively and not to affect substrate translocation through the other monomers in the GLAST trimer.  The allosteric mode of UCPH-101 inhibition underlines the functional importance of the trimerization domain of the EAAT and demonstrates the feasibility of modulating transporter function through ligand binding to regions distant from its "transport domain.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARUXvJR5bE7Vg90H21EOLACvtfcHk0ljYVkY40lgsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVemsLg%253D&md5=5e2b79367256a04008e6180cb9856d6f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3396-12.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3396-12.2013%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DSchneider%26aufirst%3DN.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%26aulast%3DFahlke%26aufirst%3DC.%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DAllosteric%2520Modulation%2520of%2520an%2520Excitatory%2520Amino%2520Acid%2520Transporter%253A%2520The%2520Subtype-Selective%2520Inhibitor%2520UCPH-101%2520Exerts%2520Sustained%2520Inhibition%2520of%2520EAAT1%2520through%2520an%2520Intramonomeric%2520Site%2520in%2520the%2520Trimerization%2520Domain%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D1068%26epage%3D1087%26doi%3D10.1523%2FJNEUROSCI.3396-12.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Valentina Arkhipova, Haigen Fu, Mark W. H. Hoorens, Gianluca Trinco, Lucien N. Lameijer, Egor Marin, Ben L. Feringa, Gerrit J. Poelarends, Wiktor Szymanski, Dirk J. Slotboom, <span class="NLM_string-name hlFld-ContribAuthor">Albert Guskov</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Aspects of Photopharmacology: Insight into the Binding of Photoswitchable and Photocaged Inhibitors to the Glutamate Transporter Homologue. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (3)
                                     , 1513-1520. <a href="https://doi.org/10.1021/jacs.0c11336" title="DOI URL">https://doi.org/10.1021/jacs.0c11336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c11336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c11336%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DStructural%252BAspects%252Bof%252BPhotopharmacology%25253A%252BInsight%252Binto%252Bthe%252BBinding%252Bof%252BPhotoswitchable%252Band%252BPhotocaged%252BInhibitors%252Bto%252Bthe%252BGlutamate%252BTransporter%252BHomologue%26aulast%3DArkhipova%26aufirst%3DValentina%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29102020%26date%3D15012021%26volume%3D143%26issue%3D3%26spage%3D1513%26epage%3D1520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Na Liu, Anders A. Jensen, <span class="NLM_string-name hlFld-ContribAuthor">Lennart Bunch</span>. </span><span class="cited-content_cbyCitation_article-title">β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2212-2220. <a href="https://doi.org/10.1021/acsmedchemlett.0c00342" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00342%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%2525CE%2525B2-Indolyloxy%252BFunctionalized%252BAspartate%252BAnalogs%252Bas%252BInhibitors%252Bof%252Bthe%252BExcitatory%252BAmino%252BAcid%252BTransporters%252B%252528EAATs%252529%26aulast%3DLiu%26aufirst%3DNa%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22062020%26date%3D26082020%26date%3D01092020%26volume%3D11%26issue%3D11%26spage%3D2212%26epage%3D2220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peng Wu, Walden E. Bjørn-Yoshimoto, Markus Staudt, Anders A. Jensen, <span class="NLM_string-name hlFld-ContribAuthor">Lennart Bunch</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Structure–Activity Relationship Study of Imidazo[1,2-a]pyridine-3-amines as First Selective Inhibitors of Excitatory Amino Acid Transporter Subtype 3 (EAAT3). </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (10)
                                     , 4414-4429. <a href="https://doi.org/10.1021/acschemneuro.9b00447" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00447</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00447%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentification%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudy%252Bof%252BImidazo%25255B1%25252C2-a%25255Dpyridine-3-amines%252Bas%252BFirst%252BSelective%252BInhibitors%252Bof%252BExcitatory%252BAmino%252BAcid%252BTransporter%252BSubtype%252B3%252B%252528EAAT3%252529%26aulast%3DWu%26aufirst%3DPeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13082019%26date%3D17092019%26date%3D01102019%26volume%3D10%26issue%3D10%26spage%3D4414%26epage%3D4429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bichu  Cheng</span>, <span class="hlFld-ContribAuthor ">Denis  Shchepakin</span>, <span class="hlFld-ContribAuthor ">Michael P.  Kavanaugh</span>, and <span class="hlFld-ContribAuthor ">Dirk  Trauner</span>  . </span><span class="cited-content_cbyCitation_article-title">Photoswitchable Inhibitor of a Glutamate Transporter. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 1668-1672. <a href="https://doi.org/10.1021/acschemneuro.7b00072" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00072%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DPhotoswitchable%252BInhibitor%252Bof%252Ba%252BGlutamate%252BTransporter%26aulast%3DCheng%26aufirst%3DBichu%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D21022017%26date%3D17042017%26date%3D16052017%26date%3D16082017%26date%3D17042017%26volume%3D8%26issue%3D8%26spage%3D1668%26epage%3D1672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Khuri</span>, <span class="hlFld-ContribAuthor ">Arik A.  Zur</span>, <span class="hlFld-ContribAuthor ">Matthias B.  Wittwer</span>, <span class="hlFld-ContribAuthor ">Lawrence  Lin</span>, <span class="hlFld-ContribAuthor ">Sook Wah  Yee</span>, <span class="hlFld-ContribAuthor ">Andrej  Sali</span>, and <span class="hlFld-ContribAuthor ">Kathleen M.  Giacomini</span>  . </span><span class="cited-content_cbyCitation_article-title">Computational Discovery and Experimental Validation of Inhibitors of the Human Intestinal Transporter OATP2B1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (6)
                                     , 1402-1413. <a href="https://doi.org/10.1021/acs.jcim.6b00720" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00720%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComputational%252BDiscovery%252Band%252BExperimental%252BValidation%252Bof%252BInhibitors%252Bof%252Bthe%252BHuman%252BIntestinal%252BTransporter%252BOATP2B1%26aulast%3DKhuri%26aufirst%3DNatalia%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D28112016%26date%3D15062017%26date%3D26062017%26date%3D31052017%26volume%3D57%26issue%3D6%26spage%3D1402%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob C.  Hansen</span>, <span class="hlFld-ContribAuthor ">Walden E.  Bjørn-Yoshimoto</span>, <span class="hlFld-ContribAuthor ">Niels  Bisballe</span>, <span class="hlFld-ContribAuthor ">Birgitte  Nielsen</span>, <span class="hlFld-ContribAuthor ">Anders A.  Jensen</span>, and <span class="hlFld-ContribAuthor ">Lennart  Bunch</span>  . </span><span class="cited-content_cbyCitation_article-title">β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8771-8786. <a href="https://doi.org/10.1021/acs.jmedchem.6b01066" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01066%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Sulfonamido%252BFunctionalized%252BAspartate%252BAnalogues%252Bas%252BExcitatory%252BAmino%252BAcid%252BTransporter%252BInhibitors%25253A%252BDistinct%252BSubtype%252BSelectivity%252BProfiles%252BArising%252Bfrom%252BSubtle%252BStructural%252BDifferences%26aulast%3DHansen%26aufirst%3DJacob%2BC.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18072016%26date%3D16092016%26date%3D13102016%26volume%3D59%26issue%3D19%26spage%3D8771%26epage%3D8786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuang  Zheng</span>, <span class="hlFld-ContribAuthor ">Wen  Xie</span>, <span class="hlFld-ContribAuthor ">Longcai  Fei</span>, <span class="hlFld-ContribAuthor ">Nannan  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Research on the Relationship Between Schizophrenia and Excitatory Amino Acid Transporter 1 Gene Based on Nanogold Amplification Technology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nanoscience and Nanotechnology</span><span> <strong>2021,</strong> <em>21 </em>
                                    (2)
                                     , 1278-1285. <a href="https://doi.org/10.1166/jnn.2021.18659" title="DOI URL">https://doi.org/10.1166/jnn.2021.18659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1166/jnn.2021.18659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1166%2Fjnn.2021.18659%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nanoscience%2520and%2520Nanotechnology%26atitle%3DResearch%252Bon%252Bthe%252BRelationship%252BBetween%252BSchizophrenia%252Band%252BExcitatory%252BAmino%252BAcid%252BTransporter%252B1%252BGene%252BBased%252Bon%252BNanogold%252BAmplification%252BTechnology%26aulast%3DZheng%26aufirst%3DShuang%26date%3D2021%26volume%3D21%26issue%3D2%26spage%3D1278%26epage%3D1285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianbing  Huang</span>, <span class="hlFld-ContribAuthor ">Herong  Qin</span>, <span class="hlFld-ContribAuthor ">Hui  Liang</span>, <span class="hlFld-ContribAuthor ">Jiang  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">An AIE polymer prepared via aldehyde-hydrazine step polymerization and the application in Cu2+ and S2− detection. </span><span class="cited-content_cbyCitation_journal-name">Polymer</span><span> <strong>2020,</strong> <em>202 </em>, 122663. <a href="https://doi.org/10.1016/j.polymer.2020.122663" title="DOI URL">https://doi.org/10.1016/j.polymer.2020.122663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.polymer.2020.122663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.polymer.2020.122663%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymer%26atitle%3DAn%252BAIE%252Bpolymer%252Bprepared%252Bvia%252Baldehyde-hydrazine%252Bstep%252Bpolymerization%252Band%252Bthe%252Bapplication%252Bin%252BCu2%25252B%252Band%252BS2%2525E2%252588%252592%252Bdetection%26aulast%3DHuang%26aufirst%3DJianbing%26date%3D2020%26volume%3D202%26spage%3D122663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Basant  Mohamed</span>, <span class="hlFld-ContribAuthor ">Zakaria K.  Abdel‐Samii</span>, <span class="hlFld-ContribAuthor ">Eatedal H.  Abdel‐Aal</span>, <span class="hlFld-ContribAuthor ">Hisham A.  Abbas</span>, <span class="hlFld-ContribAuthor ">Moataz A.  Shaldam</span>, <span class="hlFld-ContribAuthor ">Amany M.  Ghanim</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of imidazolidine‐2,4‐dione and 2‐thioxoimidazolidin‐4‐one derivatives as inhibitors of virulence factors production in
              Pseudomonas aeruginosa. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (5)
                                     <a href="https://doi.org/10.1002/ardp.201900352" title="DOI URL">https://doi.org/10.1002/ardp.201900352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900352%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Bof%252Bimidazolidine%2525E2%252580%2525902%25252C4%2525E2%252580%252590dione%252Band%252B2%2525E2%252580%252590thioxoimidazolidin%2525E2%252580%2525904%2525E2%252580%252590one%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bvirulence%252Bfactors%252Bproduction%252Bin%252BPseudomonas%252Baeruginosa%26aulast%3DMohamed%26aufirst%3DBasant%26date%3D2020%26date%3D2020%26volume%3D353%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Volodymyr  Dibrivnyi</span>, <span class="hlFld-ContribAuthor ">Andriy  Marshalek</span>, <span class="hlFld-ContribAuthor ">Iryna  Sobechko</span>, <span class="hlFld-ContribAuthor ">Yuriy  Horak</span>, <span class="hlFld-ContribAuthor ">Mykola  Obushak</span>, <span class="hlFld-ContribAuthor ">Nadiia  Velychkivska</span>, <span class="hlFld-ContribAuthor ">Lubomyr  Goshko</span>. </span><span class="cited-content_cbyCitation_article-title">Thermodynamic properties of some isomeric 5-(nitrophenyl)-furyl-2 derivatives. </span><span class="cited-content_cbyCitation_journal-name">BMC Chemistry</span><span> <strong>2019,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13065-019-0619-2" title="DOI URL">https://doi.org/10.1186/s13065-019-0619-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13065-019-0619-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13065-019-0619-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Chemistry%26atitle%3DThermodynamic%252Bproperties%252Bof%252Bsome%252Bisomeric%252B5-%252528nitrophenyl%252529-furyl-2%252Bderivatives%26aulast%3DDibrivnyi%26aufirst%3DVolodymyr%26date%3D2019%26date%3D2019%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andriy R.  Vakhula</span>, <span class="hlFld-ContribAuthor ">Yuriy I.  Horak</span>, <span class="hlFld-ContribAuthor ">Roman Z.  Lytvyn</span>, <span class="hlFld-ContribAuthor ">Alexandra I.  Lesyuk</span>, <span class="hlFld-ContribAuthor ">Vasyl  Kinzhybalo</span>, <span class="hlFld-ContribAuthor ">Fedor I.  Zubkov</span>, <span class="hlFld-ContribAuthor ">Mykola D.  Obushak</span>. </span><span class="cited-content_cbyCitation_article-title">5-Aryl-2-furaldehydes in the synthesis of tetrahydropyrimidinones by Biginelli reaction. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2018,</strong> <em>54 </em>
                                    (5)
                                     , 545-549. <a href="https://doi.org/10.1007/s10593-018-2301-3" title="DOI URL">https://doi.org/10.1007/s10593-018-2301-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-018-2301-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-018-2301-3%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3D5-Aryl-2-furaldehydes%252Bin%252Bthe%252Bsynthesis%252Bof%252Btetrahydropyrimidinones%252Bby%252BBiginelli%252Breaction%26aulast%3DVakhula%26aufirst%3DAndriy%2BR.%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D5%26spage%3D545%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander A.  Fadeev</span>, <span class="hlFld-ContribAuthor ">Maxim G.  Uchuskin</span>, <span class="hlFld-ContribAuthor ">Igor V.  Trushkov</span>, <span class="hlFld-ContribAuthor ">Anton S.  Makarov</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(II) bromide-catalyzed conjugate addition of furans to α,β-unsaturated carbonyl compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2017,</strong> <em>53 </em>
                                    (12)
                                     , 1286-1293. <a href="https://doi.org/10.1007/s10593-018-2206-1" title="DOI URL">https://doi.org/10.1007/s10593-018-2206-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-018-2206-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-018-2206-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DCopper%252528II%252529%252Bbromide-catalyzed%252Bconjugate%252Baddition%252Bof%252Bfurans%252Bto%252B%2525CE%2525B1%25252C%2525CE%2525B2-unsaturated%252Bcarbonyl%252Bcompounds%26aulast%3DFadeev%26aufirst%3DAlexander%2BA.%26date%3D2017%26date%3D2018%26volume%3D53%26issue%3D12%26spage%3D1286%26epage%3D1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of the endogenous EAAT substrates (<i>S</i>)-Glu and (<i>S</i>/<i>R</i>)-Asp and reported subtype preferring/selective EAAT inhibitors: WAY213613,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (2<i>S</i>)-3-((3-(trifluoromethyl)phenyl)sulfonamido)aspartic acid (<b>40</b>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> L-β-BA,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> DHK,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> (2<i>S</i>,4<i>R</i>)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid (<b>41</b>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>38</b>,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and <b>39</b>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Concentration–inhibition curves for (<i>S</i>)-Glu and <b>1a</b> at EAAT1-, EAAT2-, and EAAT3-HEK293 cells in the [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake assay. The figure depicts data from single representative experiments, and data are given as mean ± SD values (in % of specific uptake determined in the absence of test compound).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Low-energy conformation of <b>1a</b>. (B) Overview of disconnections and chemical modifications of <b>1a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>1a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub> (aq), DME:EtOH 50 °C; (b) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (c) <b>9</b>, piperidine, EtOH, reflux; (d) FeCl<sub>3</sub>, DCM, rt; (e) ethyl 2-bromoacetate, NaH (60 w/w%), THF, reflux.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>ortho</i>-Benzyloxy Analogue <b>1e</b> and 1-Naphthyl Analogue <b>1h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) benzyl bromide, anhydrous K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (b) 4 M NaOH (aq), MeOH, rt; (c) (5-formylfuran-2-yl)boronic acid (<b>6</b>), cat. Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, toluene:EtOH (7:3), 90 °C; (d) <b>9</b>, 0.1 equiv piperidine, 0.1 equiv AcOH, EtOH, 90 °C; (e) Br<sub>2</sub>, FeBr<sub>3</sub>, CHCl<sub>3</sub>, 2 h, rt; (g) NaNO<sub>2</sub>, H<sub>2</sub>SO<sub>4</sub>, AcOH, then Cu<sub>2</sub>O, reflux; (g) <b>6</b>, cat. Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, toluene:EtOH (7:3), 90 °C. (h) <b>9</b>, 0.1 equiv piperidine, 0.1 equiv AcOH, EtOH, 90 °C.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/medium/jm-2016-010587_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Conformationally Relieved Analogue <b>1q</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01058/20161007/images/large/jm-2016-010587_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01058&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) NaBH<sub>4</sub>, THF, rt; (b) SOCl<sub>2</sub>, pyridine, DCM; (c) NaH, DMF; (d) H<sub>2</sub> (g), Pd/C; (e) NaH, THF, 50 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 21 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Danbolt, N. C.</span><span> </span><span class="NLM_article-title">Glutamate Uptake</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/S0301-0082(00)00067-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1016%2FS0301-0082%2800%2900067-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=11369436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFWns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2001&pages=1-105&author=N.+C.+Danbolt&title=Glutamate+Uptake&doi=10.1016%2FS0301-0082%2800%2900067-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate uptake</span></div><div class="casAuthors">Danbolt, N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-105</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with >1200 refs.  Brain tissue has a remarkable ability to accumulate glutamate.  This ability is due to glutamate transporter proteins present in the plasma membranes of both glial cells and neurons.  The transporter proteins represent the only (significant) mechanism for removal of glutamate from the extracellular fluid and their importance for the long-term maintenance of low and non-toxic concns. of glutamate is now well documented.  In addn. to this simple, but essential glutamate removal role, the glutamate transporters appear to have more sophisticated functions in the modulation of neurotransmission.  They may modify the time course of synaptic events, the extent and pattern of activation and desensitization of receptors outside the synaptic cleft and at neighboring synapses (intersynaptic cross-talk).  Further, the glutamate transporters provide glutamate for synthesis of e.g.  GABA, glutathione, and protein, and for energy prodn.  They also play roles in peripheral organs and tissues (e.g. bone, heart, intestine, kidneys, pancreas, and placenta).  Glutamate uptake appears to be modulated on virtually all possible levels, i.e. DNA transcription, mRNA splicing and degrdn., protein synthesis and targeting, and actual amino acid transport activity and assocd. ion channel activities.  A variety of sol. compds. (e.g. glutamate, cytokines, and growth factors) influence glutamate transporter expression and activities.  Neither the normal functioning of glutamatergic synapses nor the pathogenesis of major neurol. diseases (e.g. cerebral ischemia, hypoglycemia, amyotrophic lateral sclerosis, Alzheimer's disease, traumatic brain injury, epilepsy, and schizophrenia) as well as non-neurol. diseases (e.g. osteoporosis) can be properly understood unless more is learned about these transporter proteins.  Like glutamate itself, glutamate transporters are somehow involved in almost all aspects of normal and abnormal brain activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrbDph2PBuBbVg90H21EOLACvtfcHk0lgNJiUsQ_Zxkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFWns74%253D&md5=a7118c1df858a0994af6207f852f82b6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2800%2900067-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252800%252900067-8%26sid%3Dliteratum%253Aachs%26aulast%3DDanbolt%26aufirst%3DN.%2BC.%26atitle%3DGlutamate%2520Uptake%26jtitle%3DProg.%2520Neurobiol.%26date%3D2001%26volume%3D65%26spage%3D1%26epage%3D105%26doi%3D10.1016%2FS0301-0082%2800%2900067-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Excitatory Amino Acid Transporters as Potential Drug Targets</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span><span class="refDoi"> DOI: 10.1517/14728220902926127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1517%2F14728220902926127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=19456273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFCitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=719-731&author=L.+Bunchauthor=M.+N.+Erichsenauthor=A.+A.+Jensen&title=Excitatory+Amino+Acid+Transporters+as+Potential+Drug+Targets&doi=10.1517%2F14728220902926127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acid transporters as potential drug targets</span></div><div class="casAuthors">Bunch, Lennart; Erichsen, Mette N.; Jensen, Anders A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-731</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Excitatory amino acid transporters (EAATs) are transmembrane proteins responsible for the uptake of (S)-glutamate (Glu) from the synaptic cleft, thereby terminating the glutamatergic neurotransmitter signal.  Today five subtypes have been identified.  Except for EAAT2, their individual roles or functions in the CNS are yet to be fully understood due to the shortage of subtype-selective ligands.  Objective/methods: We examine the latest developments in this field by addressing EAAT expression pattern, localization and pharmacol.  We present highlights of published work on inhibitors as well as enhancers which display subtype preference or selectivity and discuss which pathol. conditions in the CNS such ligands may be beneficial to.  Results/conclusions: Not until subtype-selective enhancers, inhibitors and substrates for all five EAAT subtypes have been discovered can a full and detailed understanding of EAATs be obtained.  Thus we encourage collaboration between org. chemists and mol. pharmacologists, who, together, may pave the way for new EAAT ligands of importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlwp3CUxYad7Vg90H21EOLACvtfcHk0lhSmnJYkHUSEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFCitrw%253D&md5=a7af1f649527b26e6e8052caf6598446</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14728220902926127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220902926127%26sid%3Dliteratum%253Aachs%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DExcitatory%2520Amino%2520Acid%2520Transporters%2520as%2520Potential%2520Drug%2520Targets%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D719%26epage%3D731%26doi%3D10.1517%2F14728220902926127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Vandenberg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, R. M.</span><span> </span><span class="NLM_article-title">Mechanisms of Glutamate Transport</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1621</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span><span class="refDoi"> DOI: 10.1152/physrev.00007.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1152%2Fphysrev.00007.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=24137018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2013&pages=1621-1657&author=R.+J.+Vandenbergauthor=R.+M.+Ryan&title=Mechanisms+of+Glutamate+Transport&doi=10.1152%2Fphysrev.00007.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of glutamate transport</span></div><div class="casAuthors">Vandenberg, Robert J.; Ryan, Renae M.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1621-1657</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  L-Glutamate is the predominant excitatory neurotransmitter in the mammalian central nervous system and plays important roles in a wide variety of brain functions, but it is also a key player in the pathogenesis of many neurol. disorders.  The control of glutamate concns. is crit. to the normal functioning of the central nervous system, and in this review we discuss how glutamate transporters regulate glutamate concns. to maintain dynamic signaling mechanisms between neurons.  In 2004, the crystal structure of a prokaryotic homolog of the mammalian glutamate transporter family of proteins was crystd. and its structure detd.  This has paved the way for a better understanding of the structural basis for glutamate transporter function.  In this review we provide a broad perspective of this field of research, but focus primarily on the more recent studies with a particular emphasis on how our understanding of the structure of glutamate transporters has generated new insights.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzAmcjroPMPLVg90H21EOLACvtfcHk0lhSmnJYkHUSEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShtrrP&md5=b573b96bbaf6f03c835c471cf2aaf7b8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00007.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00007.2013%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberg%26aufirst%3DR.%2BJ.%26aulast%3DRyan%26aufirst%3DR.%2BM.%26atitle%3DMechanisms%2520of%2520Glutamate%2520Transport%26jtitle%3DPhysiol.%2520Rev.%26date%3D2013%26volume%3D93%26spage%3D1621%26epage%3D1657%26doi%3D10.1152%2Fphysrev.00007.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahlke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørn-Yoshimoto, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Excitatory Amino Acid Transporters: Recent Insights into Molecular Mechanisms, Novel Modes of Modulation and New Therapeutic Possibilities</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1016/j.coph.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1016%2Fj.coph.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=25466154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCktbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=116-123&author=A.+A.+Jensenauthor=C.+Fahlkeauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=L.+Bunch&title=Excitatory+Amino+Acid+Transporters%3A+Recent+Insights+into+Molecular+Mechanisms%2C+Novel+Modes+of+Modulation+and+New+Therapeutic+Possibilities&doi=10.1016%2Fj.coph.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities</span></div><div class="casAuthors">Jensen, Anders A.; Fahlke, Christoph; Bjoern-Yoshimoto, Walden E.; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116-123</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The five excitatory amino acid transporters (EAAT1-5) mediating the synaptic uptake of the major excitatory neurotransmitter glutamate are differently expressed throughout the CNS and at the synaptic level.  Although EAATs are crucial for normal excitatory neurotransmission, explorations into the physiol. functions mediated by the different transporter subtypes and their resp. therapeutic potential have so far been sparse, in no small part due to the limited selection of pharmacol. tools available.  In the present update, we outline important new insights into the mol. compns. of EAATs and their intricate transport process, the novel approaches to pharmacol. modulation of the transporters that have emerged, and interesting new perspectives in EAAT as drug targets proposed in recent years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHCPIMplW6KLVg90H21EOLACvtfcHk0ljc2DD4ea8KnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCktbvF&md5=4619d6aebdc64cfd77a44bae4379eb53</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DFahlke%26aufirst%3DC.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DExcitatory%2520Amino%2520Acid%2520Transporters%253A%2520Recent%2520Insights%2520into%2520Molecular%2520Mechanisms%252C%2520Novel%2520Modes%2520of%2520Modulation%2520and%2520New%2520Therapeutic%2520Possibilities%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2015%26volume%3D20%26spage%3D116%26epage%3D123%26doi%3D10.1016%2Fj.coph.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S. G.</span><span> </span><span class="NLM_article-title">New Views of Glutamate Transporter Structure and Function: Advances and Challenges</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1016%2Fj.neuropharm.2010.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=20708631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=172-181&author=J.+Jiangauthor=S.+G.+Amara&title=New+Views+of+Glutamate+Transporter+Structure+and+Function%3A+Advances+and+Challenges&doi=10.1016%2Fj.neuropharm.2010.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New views of glutamate transporter structure and function: Advances and challenges</span></div><div class="casAuthors">Jiang, Jie; Amara, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-181</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neuronal and glial glutamate transporters limit the action of excitatory amino acids after their release during synaptic transmission.  Recent structural and functional investigations have revealed much about the transport and conducting mechanisms of members of the sodium-coupled symporter family responsible for glutamate clearance in the nervous system.  In this review we summarize emerging views on the general structure, binding sites for substrates and coupled ions, and transport mechanisms of mammalian glutamate transporters, integrating results from a large body of work on carrier structure-function relationships with several crystal structures obtained for the archaeal ortholog, GltPh.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAUxmtx--OBLVg90H21EOLACvtfcHk0ljc2DD4ea8KnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FF&md5=4df5a1e8ea9f5be507e3a403aadb2f67</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DAmara%26aufirst%3DS.%2BG.%26atitle%3DNew%2520Views%2520of%2520Glutamate%2520Transporter%2520Structure%2520and%2520Function%253A%2520Advances%2520and%2520Challenges%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D172%26epage%3D181%26doi%3D10.1016%2Fj.neuropharm.2010.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Grewer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gameiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauen, T.</span><span> </span><span class="NLM_article-title">SLC1 Glutamate Transporters</span> <span class="citation_source-journal">Pfluegers Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1007/s00424-013-1397-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1007%2Fs00424-013-1397-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=24240778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyls7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2014&pages=3-24&author=C.+Grewerauthor=A.+Gameiroauthor=T.+Rauen&title=SLC1+Glutamate+Transporters&doi=10.1007%2Fs00424-013-1397-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">SLC1 glutamate transporters</span></div><div class="casAuthors">Grewer, Christof; Gameiro, Armanda; Rauen, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The plasma membrane transporters for the neurotransmitter glutamate belong to the solute carrier 1 family.  They are secondary active transporters, taking up glutamate into the cell against a substantial concn. gradient.  The driving force for concentrative uptake is provided by the cotransport of Na+ ions and the countertransport of one K+ in a step independent of the glutamate translocation step.  Due to eletrogenicity of transport, the transmembrane potential can also act as a driving force.  Glutamate transporters are expressed in many tissues, but are of particular importance in the brain, where they contribute to the termination of excitatory neurotransmission.  Glutamate transporters can also run in reverse, resulting in glutamate release from cells.  Due to these important physiol. functions, glutamate transporter expression and, therefore, the transport rate, are tightly regulated.  This review summarizes recent literature on the functional and biophys. properties, structure-function relationships, regulation, physiol. significance, and pharmacol. of glutamate transporters.  Particular emphasis is on the insight from rapid kinetic and electrophysiol. studies, transcriptional regulation of transporter expression, and reverse transport and its importance for pathophysiol. glutamate release under ischemic conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7CB_CXRaoDrVg90H21EOLACvtfcHk0ljc2DD4ea8KnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyls7%252FK&md5=a15133383ebbc3dbe813b7f34bd02821</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00424-013-1397-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-013-1397-7%26sid%3Dliteratum%253Aachs%26aulast%3DGrewer%26aufirst%3DC.%26aulast%3DGameiro%26aufirst%3DA.%26aulast%3DRauen%26aufirst%3DT.%26atitle%3DSLC1%2520Glutamate%2520Transporters%26jtitle%3DPfluegers%2520Arch.%26date%3D2014%26volume%3D466%26spage%3D3%26epage%3D24%26doi%3D10.1007%2Fs00424-013-1397-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hansen, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haym, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørn-Yoshimoto, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storgaard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">New Insight into the Structure-Activity Relationships of the Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors UCPH-101 and UCPH-102</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1002/cmdc.201500525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1002%2Fcmdc.201500525" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=382-402&author=S.+W.+Hansenauthor=M.+N.+Erichsenauthor=T.+H.+V+Huynhauthor=J.+A.+Ruizauthor=I.+Haymauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=B.+Abrahamsenauthor=J.+Hansenauthor=M.+Storgaardauthor=A.+L.+Eriksenauthor=A.+A.+Jensenauthor=L.+Bunch&title=New+Insight+into+the+Structure-Activity+Relationships+of+the+Selective+Excitatory+Amino+Acid+Transporter+Subtype+1+%28EAAT1%29+Inhibitors+UCPH-101+and+UCPH-102&doi=10.1002%2Fcmdc.201500525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500525%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DS.%2BW.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV%26aulast%3DRuiz%26aufirst%3DJ.%2BA.%26aulast%3DHaym%26aufirst%3DI.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DHansen%26aufirst%3DJ.%26aulast%3DStorgaard%26aufirst%3DM.%26aulast%3DEriksen%26aufirst%3DA.%2BL.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DNew%2520Insight%2520into%2520the%2520Structure-Activity%2520Relationships%2520of%2520the%2520Selective%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520%2528EAAT1%2529%2520Inhibitors%2520UCPH-101%2520and%2520UCPH-102%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D382%26epage%3D402%26doi%3D10.1002%2Fcmdc.201500525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Haym, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, M. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørn-Yoshimoto, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Bioavailability Studies and in Vitro Profiling of the Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitor UCPH-102</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1002/cmdc.201500527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1002%2Fcmdc.201500527" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=403-419&author=I.+Haymauthor=T.+H.+V+Huynhauthor=S.+W.+Hansenauthor=M.+H.+F.+Pedersenauthor=J.+A.+Ruizauthor=M.+N.+Erichsenauthor=M.+Gyntherauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=B.+Abrahamsenauthor=J.+F.+Bastlundauthor=C.+Bundgaardauthor=A.+L.+Eriksenauthor=A.+A.+Jensenauthor=L.+Bunch&title=Bioavailability+Studies+and+in+Vitro+Profiling+of+the+Selective+Excitatory+Amino+Acid+Transporter+Subtype+1+%28EAAT1%29+Inhibitor+UCPH-102&doi=10.1002%2Fcmdc.201500527"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500527%26sid%3Dliteratum%253Aachs%26aulast%3DHaym%26aufirst%3DI.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV%26aulast%3DHansen%26aufirst%3DS.%2BW.%26aulast%3DPedersen%26aufirst%3DM.%2BH.%2BF.%26aulast%3DRuiz%26aufirst%3DJ.%2BA.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DGynther%26aufirst%3DM.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DEriksen%26aufirst%3DA.%2BL.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DBioavailability%2520Studies%2520and%2520in%2520Vitro%2520Profiling%2520of%2520the%2520Selective%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520%2528EAAT1%2529%2520Inhibitor%2520UCPH-102%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D403%26epage%3D419%26doi%3D10.1002%2Fcmdc.201500527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span><span class="refDoi"> DOI: 10.1021/jm8013458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8013458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=912-915&author=A.+A.+Jensenauthor=M.+N.+Erichsenauthor=C.+W.+Nielsenauthor=T.+B.+Stensb%C3%B8lauthor=J.+Kehlerauthor=L.+Bunch&title=Discovery+of+the+First+Selective+Inhibitor+of+Excitatory+Amino+Acid+Transporter+Subtype+1&doi=10.1021%2Fjm8013458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1</span></div><div class="casAuthors">Jensen, Anders A.; Erichsen, Mette N.; Nielsen, Christina W.; Stensboel, Tine B.; Kehler, Jan; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">912-915</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of the first class of subtype-selective inhibitors of the human excitatory amino acid transporter subtype 1 (EAAT1) and its rat orthologue GLAST is reported.  An opening structure-activity relationship of 25 analogs is presented that addresses the influence of substitutions at the 4- and 7-positions of the parental skeleton 2-amino-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile.  The most potent analog 10 displays high nanomolar inhibitory activity at EAAT1 and a >400-fold selectivity over EAAT2 and EAAT3, making it a highly valuable pharmacol. tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVu7PAOshxerVg90H21EOLACvtfcHk0livbwWi_z3d8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs78%253D&md5=7036a6fe617a9908a36fda6a87400e2c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm8013458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8013458%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DNielsen%26aufirst%3DC.%2BW.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520the%2520First%2520Selective%2520Inhibitor%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D912%26epage%3D915%26doi%3D10.1021%2Fjm8013458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monrad, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekker-Jensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationship Study of First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1:2-Amino-4-(4-Methoxyphenyl)-7-(Naphthalen-1-Yl)-5-Oxo-5,6,7,8-Tetrahydro-4 H -Chromene-3-Carbonitrile (UCPH-101)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7180</span><span class="NLM_x">–</span> <span class="NLM_lpage">7191</span><span class="refDoi"> DOI: 10.1021/jm1009154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1009154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7180-7191&author=M.+N.+Erichsenauthor=T.+H.+V.+Huynhauthor=B.+Abrahamsenauthor=J.+F.+Bastlundauthor=C.+Bundgaardauthor=O.+Monradauthor=A.+Bekker-Jensenauthor=C.+W.+Nielsenauthor=K.+Frydenvangauthor=A.+A.+Jensenauthor=L.+Bunch&title=Structure%E2%80%93Activity+Relationship+Study+of+First+Selective+Inhibitor+of+Excitatory+Amino+Acid+Transporter+Subtype+1%3A2-Amino-4-%284-Methoxyphenyl%29-7-%28Naphthalen-1-Yl%29-5-Oxo-5%2C6%2C7%2C8-Tetrahydro-4+H+-Chromene-3-Carbonitrile+%28UCPH-101%29&doi=10.1021%2Fjm1009154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm1009154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009154%26sid%3Dliteratum%253Aachs%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DMonrad%26aufirst%3DO.%26aulast%3DBekker-Jensen%26aufirst%3DA.%26aulast%3DNielsen%26aufirst%3DC.%2BW.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationship%2520Study%2520of%2520First%2520Selective%2520Inhibitor%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%253A2-Amino-4-%25284-Methoxyphenyl%2529-7-%2528Naphthalen-1-Yl%2529-5-Oxo-5%252C6%252C7%252C8-Tetrahydro-4%2520H%2520-Chromene-3-Carbonitrile%2520%2528UCPH-101%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7180%26epage%3D7191%26doi%3D10.1021%2Fjm1009154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Huynh, T. H. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship Study of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitor 2-Amino-4-(4-Methoxyphenyl)-7-(Naphthalen-1-Yl)-5-Oxo-5,6,7,8-Tetrahydro-4H-Chromene-3-Carbonitrile (UCPH-101) and Absolute Configurational as</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5403</span><span class="NLM_x">–</span> <span class="NLM_lpage">5412</span><span class="refDoi"> DOI: 10.1021/jm300345z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300345z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5403-5412&author=T.+H.+V+Huynhauthor=I.+Shimauthor=H.+Bohrauthor=B.+Abrahamsenauthor=B.+Nielsenauthor=A.+A.+Jensenauthor=L.+Bunch&title=Structure-Activity+Relationship+Study+of+Selective+Excitatory+Amino+Acid+Transporter+Subtype+1+%28EAAT1%29+Inhibitor+2-Amino-4-%284-Methoxyphenyl%29-7-%28Naphthalen-1-Yl%29-5-Oxo-5%2C6%2C7%2C8-Tetrahydro-4H-Chromene-3-Carbonitrile+%28UCPH-101%29+and+Absolute+Configurational+as&doi=10.1021%2Fjm300345z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm300345z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300345z%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV%26aulast%3DShim%26aufirst%3DI.%26aulast%3DBohr%26aufirst%3DH.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DStructure-Activity%2520Relationship%2520Study%2520of%2520Selective%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520%2528EAAT1%2529%2520Inhibitor%25202-Amino-4-%25284-Methoxyphenyl%2529-7-%2528Naphthalen-1-Yl%2529-5-Oxo-5%252C6%252C7%252C8-Tetrahydro-4H-Chromene-3-Carbonitrile%2520%2528UCPH-101%2529%2520and%2520Absolute%2520Configurational%2520as%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5403%26epage%3D5412%26doi%3D10.1021%2Fjm300345z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demmer, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Probing for Improved Potency and in Vivo Bioavailability of Excitatory Amino Acid Transporter Subtype 1 Inhibitors UCPH-101 and UCPH-102: Design, Synthesis and Pharmacological Evaluation of Substituted 7-Biphenyl Analogs</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1964</span><span class="NLM_x">–</span> <span class="NLM_lpage">1979</span><span class="refDoi"> DOI: 10.1007/s11064-014-1264-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1007%2Fs11064-014-1264-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=24682739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlWjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=1964-1979&author=M.+N.+Erichsenauthor=J.+Hansenauthor=J.+A.+Ruizauthor=C.+S.+Demmerauthor=B.+Abrahamsenauthor=J.+F.+Bastlundauthor=C.+Bundgaardauthor=A.+A.+Jensenauthor=L.+Bunch&title=Probing+for+Improved+Potency+and+in+Vivo+Bioavailability+of+Excitatory+Amino+Acid+Transporter+Subtype+1+Inhibitors+UCPH-101+and+UCPH-102%3A+Design%2C+Synthesis+and+Pharmacological+Evaluation+of+Substituted+7-Biphenyl+Analogs&doi=10.1007%2Fs11064-014-1264-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Probing for Improved Potency and In Vivo Bioavailability of Excitatory Amino Acid Transporter Subtype 1 Inhibitors UCPH-101 and UCPH-102: Design, Synthesis and Pharmacological Evaluation of Substituted 7-Biphenyl Analogs</span></div><div class="casAuthors">Erichsen, Mette N.; Hansen, Jeanette; Ruiz, Josep A.; Demmer, Charles S.; Abrahamsen, Bjarke; Bastlund, Jesper F.; Bundgaard, Christoffer; Jensen, Anders A.; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1964-1979</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The soly. properties of these EAAT1 inhibitors with the objective to develop analogs more suited as pharmacol. tools for in vivo studies of EAAT1 in terms of their bioavailability was discussed.  A total of 23 novel UCPH-101/102 analogs I [R1 = Me, Ph; R2 = o-Br, o-Ph, o-(m-ClC6H4), etc.] were designed, synthesized and characterized pharmacol. at EAAT1-3 in a [3H]-D-aspartate uptake assay.  Most notably, the potent EAAT1 inhibition displayed of UCPH-101 and UCPH-102 was retained in analog in which the napht-1-yl group in the 7-position of UCPH-102 has been replaced by an o-biphenyl moiety.  In contrast, EAAT1 activity was dramatically compromised in analogs comprising m- and p-biphenyl groups as 7-substituents, resp.  O-biphenyl analog displayed low bioavailability after oral administration in rats, and this problem was addressed by the synthesis of a series of analogs with different chloro, fluoro, methoxy, triflouromethyl and carboxy substitution patterns at the o-biphenyl group and m- and p-pyridine analogs.  Unfortunately, all of the modifications resulted in substantial decreased EAAT1 inhibitory activity, which supported the notion of a very lipophilic binding pocket in EAAT1 for the arom. 7-substituent in these ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDAz_LSWRbT7Vg90H21EOLACvtfcHk0ljB22Dtpy6XKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlWjurw%253D&md5=e31d6f9bcbdd690a2716d1fa31105adf</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs11064-014-1264-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-014-1264-8%26sid%3Dliteratum%253Aachs%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHansen%26aufirst%3DJ.%26aulast%3DRuiz%26aufirst%3DJ.%2BA.%26aulast%3DDemmer%26aufirst%3DC.%2BS.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DProbing%2520for%2520Improved%2520Potency%2520and%2520in%2520Vivo%2520Bioavailability%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520Inhibitors%2520UCPH-101%2520and%2520UCPH-102%253A%2520Design%252C%2520Synthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Substituted%25207-Biphenyl%2520Analogs%26jtitle%3DNeurochem.%2520Res.%26date%3D2014%26volume%3D39%26spage%3D1964%26epage%3D1979%26doi%3D10.1007%2Fs11064-014-1264-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIlvain, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrick, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosanu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J.</span><span> </span><span class="NLM_article-title">Characterization of Novel Aryl-Ether, Biaryl, and Fluorene Aspartic Acid and Diaminopropionic Acid Analogs as Potent Inhibitors of the High-Affinity Glutamate Transporter EAAT2</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">974</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span><span class="refDoi"> DOI: 10.1124/mol.105.012005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1124%2Fmol.105.012005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=16014807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyhu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=974-982&author=J.+Dunlopauthor=H.+B.+McIlvainauthor=T.+A.+Carrickauthor=B.+Jowauthor=Q.+Luauthor=D.+Kowalauthor=S.+Linauthor=A.+Greenfieldauthor=C.+Grosanuauthor=K.+Fanauthor=R.+Petroskiauthor=J.+Williamsauthor=A.+Fosterauthor=J.+Butera&title=Characterization+of+Novel+Aryl-Ether%2C+Biaryl%2C+and+Fluorene+Aspartic+Acid+and+Diaminopropionic+Acid+Analogs+as+Potent+Inhibitors+of+the+High-Affinity+Glutamate+Transporter+EAAT2&doi=10.1124%2Fmol.105.012005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2</span></div><div class="casAuthors">Dunlop, John; McIlvain, H. Beal; Carrick, Tikva A.; Jow, Brian; Lu, Qiang; Kowal, Dianne; Lin, Steven; Greenfield, Alexander; Grosanu, Cristina; Fan, Kristi; Petroski, Robert; Williams, John; Foster, Alan; Butera, John</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">974-982</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In this study, we describe the pharmacol. characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of EAAT2, the predominant glutamate transporter in forebrain regions.  The rank order of potency detd. for the inhibition of human EAAT2 was N4-[4-(2-bromo-4,5-difluorophenoxy)phenyl]-L-asparagine (WAY-213613) (IC50 = 85 ± 5 nM) > N4-(2'-methyl-1,1'-biphenyl-4-yl)-L-asparagine (WAY-213394) (IC50 = 145 ± 22 nM) = N4-[7-(trifluoromethyl)-9H-fluoren-2-yl]-L-asparagine (WAY-212922) (IC50 = 157 ± 11 nM) = 3-{[(4'-chloro-2-methyl-1,1'-biphenyl-4-yl)carbonyl]amino}- L-alanine (WAY-211686) (IC50 = 190 ± 10 nM).  WAY-213613 was the most selective of the compds. examd., with IC50 values for inhibition of EAAT1 and EAAT3 of 5 and 3.8 μM, resp., corresponding to a 59- and 45-fold selectivity toward EAAT2.  An identical rank order to potency [WAY-213613 (35 ± 7 nM) > WAY-213394 (92 ± 13 nM) = WAY-212922 (95 ± 8 nM) = WAY-211686 (101 ± 20 nM)] was obsd. for the inhibition of glutamate uptake in rat cortical synaptosomes, consistent with the predominant contribution of EAAT2 to this activity.  Kinetic studies with each of the compds. in synaptosomes revealed a competitive mechanism of inhibition.  All compds. were detd. to be nonsubstrates by evaluating both the stimulation of currents in EAAT2-injected oocytes and the heteroexchange of D-[3H]aspartate from cortical synaptosomes.  WAY-213613 represents the most potent and selective inhibitor of EAAT2 identified to date.  Taken in combination with its selectivity over ionotropic and metabotropic glutamate receptors, this compd. represents a potential tool for the further elucidation of EAAT2 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVqqndi70Gr7Vg90H21EOLACvtfcHk0ljB22Dtpy6XKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyhu7nK&md5=933a42c1c37af6a8bf8390f8a93e5f82</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.012005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.012005%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DMcIlvain%26aufirst%3DH.%2BB.%26aulast%3DCarrick%26aufirst%3DT.%2BA.%26aulast%3DJow%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DGreenfield%26aufirst%3DA.%26aulast%3DGrosanu%26aufirst%3DC.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DA.%26aulast%3DButera%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520Novel%2520Aryl-Ether%252C%2520Biaryl%252C%2520and%2520Fluorene%2520Aspartic%2520Acid%2520and%2520Diaminopropionic%2520Acid%2520Analogs%2520as%2520Potent%2520Inhibitors%2520of%2520the%2520High-Affinity%2520Glutamate%2520Transporter%2520EAAT2%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D974%26epage%3D982%26doi%3D10.1124%2Fmol.105.012005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hansen, J. C.; Bjørn-Yoshimoto, W. E.; Bisballe, N.; Nielsen, B.; Jensen, A. A.; Bunch, L.</span><span> </span><span class="NLM_article-title">β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01066</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01066" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&author=J.+C.+Hansen&author=W.+E.+Bj%C3%B8rn-Yoshimoto&author=N.+Bisballe&author=B.+Nielsen&author=A.+A.+Jensen&author=L.+Bunch&title=%CE%B2-Sulfonamido+Functionalized+Aspartate+Analogues+as+Excitatory+Amino+Acid+Transporter+Inhibitors%3A+Distinct+Subtype+Selectivity+Profiles+Arising+from+Subtle+Structural+Differences&doi=10.1021%2Facs.jmedchem.6b01066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01066%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DJ.%2BC.%26atitle%3D%25CE%25B2-Sulfonamido%2520Functionalized%2520Aspartate%2520Analogues%2520as%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Inhibitors%253A%2520Distinct%2520Subtype%2520Selectivity%2520Profiles%2520Arising%2520from%2520Subtle%2520Structural%2520Differences%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26doi%3D10.1021%2Facs.jmedchem.6b01066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Esslinger, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerdes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awes, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mavencamp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhoderick, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlin, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, R. J.</span><span> </span><span class="NLM_article-title">The Substituted Aspartate Analogue L-Beta-Threo-Benzyl-Aspartate Preferentially Inhibits the Neuronal Excitatory Amino Acid Transporter EAAT3</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1016%2Fj.neuropharm.2005.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=16183084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFehsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=850-861&author=C.+S.+Esslingerauthor=S.+Agarwalauthor=J.+Gerdesauthor=P.+A.+Wilsonauthor=E.+S.+Davisauthor=A.+N.+Awesauthor=E.+O%E2%80%99Brienauthor=T.+Mavencampauthor=H.+P.+Kochauthor=D.+J.+Poulsenauthor=J.+F.+Rhoderickauthor=A.+R.+Chamberlinauthor=M.+P.+Kavanaughauthor=R.+J.+Bridges&title=The+Substituted+Aspartate+Analogue+L-Beta-Threo-Benzyl-Aspartate+Preferentially+Inhibits+the+Neuronal+Excitatory+Amino+Acid+Transporter+EAAT3&doi=10.1016%2Fj.neuropharm.2005.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The substituted aspartate analogue L-β-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3</span></div><div class="casAuthors">Esslinger, C. Sean; Agarwal, Shailesh; Gerdes, John; Wilson, Paul A.; Davis, Erin S.; Awes, Alicia N.; O'Brien, Erin; Mavencamp, Teri; Koch, Hans P.; Poulsen, David J.; Rhoderick, Joseph F.; Chamberlin, A. Richard; Kavanaugh, Michael P.; Bridges, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">850-861</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The excitatory amino acid transporters (EAATs) play key roles in the regulation of CNS L-glutamate, esp. related to synthesis, signal termination, synaptic spillover, and excitotoxic protection.  Inhibitors available to delineate EAAT pharmacol. and function are essentially limited to those that non-selectively block all EAATs or those that exhibit a substantial preference for EAAT2.  Thus, it is difficult to selectively study the other subtypes, particularly EAAT1 and EAAT3.  Structure activity studies on a series of β-substituted aspartate analogs identify L-β-benzyl-aspartate (L-β-BA) as among the first blockers that potently and preferentially inhibits the neuronal EAAT3 subtype.  Kinetic anal. of D-[3H]aspartate uptake into C17.2 cells expressing the hEAATs demonstrate that L-β-threo-BA is the more potent diastereomer, acts competitively, and exhibits a 10-fold preference for EAAT3 compared to EAAT1 and EAAT2.  Electrophysiol. recordings of EAAT-mediated currents in Xenopus oocytes identify L-β-BA as a non-substrate inhibitor.  Analyzing L-β-threo-BA within the context of a novel EAAT2 pharmacophore model suggests: a highly conserved positioning of the electrostatic carboxyl and amino groups; nearby regions that accommodate select structural modifications (cyclopropyl rings, Me groups, oxygen atoms); and a unique region L-β-threo-BA occupied by the benzyl moieties of L-TBOA, L-β-threo-BA and related analogs.  It is plausible that the preference of L-β-threo-BA and L-TBOA for EAAT3 and EAAT2, resp., could reside in the latter two pharmacophore regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4vqhxyJbFa7Vg90H21EOLACvtfcHk0lg8_EZuRg2etg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFehsL7I&md5=5bf2793da482cf7bbf27e6a3b0d1bce8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DEsslinger%26aufirst%3DC.%2BS.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DGerdes%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DP.%2BA.%26aulast%3DDavis%26aufirst%3DE.%2BS.%26aulast%3DAwes%26aufirst%3DA.%2BN.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%26aulast%3DMavencamp%26aufirst%3DT.%26aulast%3DKoch%26aufirst%3DH.%2BP.%26aulast%3DPoulsen%26aufirst%3DD.%2BJ.%26aulast%3DRhoderick%26aufirst%3DJ.%2BF.%26aulast%3DChamberlin%26aufirst%3DA.%2BR.%26aulast%3DKavanaugh%26aufirst%3DM.%2BP.%26aulast%3DBridges%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520Substituted%2520Aspartate%2520Analogue%2520L-Beta-Threo-Benzyl-Aspartate%2520Preferentially%2520Inhibits%2520the%2520Neuronal%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520EAAT3%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D850%26epage%3D861%26doi%3D10.1016%2Fj.neuropharm.2005.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span> </span><span class="NLM_article-title">Pharmacological Characterization of Human Excitatory Amino Acid Transporters EAAT1, EAAT2 and EAAT3 in a Fluorescence-Based Membrane Potential Assay</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2115</span><span class="NLM_x">–</span> <span class="NLM_lpage">2127</span><span class="refDoi"> DOI: 10.1016/j.bcp.2004.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1016%2Fj.bcp.2004.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=15135308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVCis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=2115-2127&author=A.+A.+Jensenauthor=H.+Br%C3%A4uner-Osborne&title=Pharmacological+Characterization+of+Human+Excitatory+Amino+Acid+Transporters+EAAT1%2C+EAAT2+and+EAAT3+in+a+Fluorescence-Based+Membrane+Potential+Assay&doi=10.1016%2Fj.bcp.2004.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay</span></div><div class="casAuthors">Jensen, Anders A.; Brauner-Osborne, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2115-2127</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We have expressed the human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 stably in HEK293 cells and characterized the transporters pharmacol. in a conventional [3H]-d-aspartate uptake assay and in a fluorescence-based membrane potential assay, the FLIPR Membrane Potential (FMP) assay.  The Km and Ki values obtained for 12 std. EAAT ligands at EAAT1, EAAT2 and EAAT3 in the FMP assay correlated well with the Ki values obtained in the [3H]-d-aspartate assay (r2 values of 0.92, 0.92, and 0.95, resp.).  Furthermore, the pharmacol. characteristics of the cell lines in the FMP assay were in good agreement with previous findings in electrophysiol. studies of the transporters.  The FMP assay was capable of distinguishing between substrates and non-substrate inhibitors and to discriminate between "full" and "partial" substrates at the transporters.  Taking advantage of the prolific nature of the FMP assay, interactions of the EAATs with substrates and inhibitors were studied in some detail.  This is the first report of a high throughput screening assay for EAATs.  We propose that the assay will be of great use in future studies of the transporters.  Although conventional electrophysiol. set-ups might be superior in terms of studying sophisticated kinetic aspects of the uptake process, the FMP assay enables the collection of considerable amts. of highly reproducible data with relatively little labor.  Furthermore, considering that the no. of EAAT ligands presently available is limited, and that almost all of these are characterized by low potency and a low degree of subtype selectivity, future screening of compd. libraries at the EAAT-cell lines in the FMP assay could help identify structurally and pharmacol. novel ligands for the transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS6Um79wVYz7Vg90H21EOLACvtfcHk0lgYsIMisFRelQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVCis78%253D&md5=06e3c536844acca52fdba733175a93c6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26atitle%3DPharmacological%2520Characterization%2520of%2520Human%2520Excitatory%2520Amino%2520Acid%2520Transporters%2520EAAT1%252C%2520EAAT2%2520and%2520EAAT3%2520in%2520a%2520Fluorescence-Based%2520Membrane%2520Potential%2520Assay%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26spage%3D2115%26epage%3D2127%26doi%3D10.1016%2Fj.bcp.2004.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Arriza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadiche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdoch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S.</span><span> </span><span class="NLM_article-title">Functional Comparisons of Three Glutamate Transporter Subtypes Cloned from Human Motor Cortex</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5559</span><span class="NLM_x">–</span> <span class="NLM_lpage">5569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1523%2FJNEUROSCI.14-09-05559.1994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=7521911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=5559-5569&author=J.+Arrizaauthor=W.+Fairmanauthor=J.+Wadicheauthor=G.+Murdochauthor=M.+Kavanaughauthor=S.+Amara&title=Functional+Comparisons+of+Three+Glutamate+Transporter+Subtypes+Cloned+from+Human+Motor+Cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex</span></div><div class="casAuthors">Arriza, Jeffrey L.; Fairman, Wendy A.; Wadiche, Jacques I.; Murdoch, Geoffrey H.; Kavanaugh, Michael P.; Amara, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5559-69</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Reuptake plays an important role in regulating synaptic and extracellular concns. of glutamate.  Three glutamate transporters expressed in human motor cortex, termed EAAT1, EAAT2, and EAAT3 (for excitatory amino acid transporter), have been characterized by their mol. cloning and functional expression.  Each EAAT subtype mRNA was found in all human brain regions analyzed.  The most prominent regional variation in message content was in cerebellum where EAAT1 expression predominated.  EAAT1 and EAAT3 mRNAs were also expressed in various non-nervous tissues, whereas expression of EAAT2 was largely restricted to brain.  The kinetic parameters and pharmacol. characteristics of transport mediated by each EAAT subtype were detd. in transfected mammalian cells by radiolabel uptake and in microinjected oocytes by voltage-clamp measurements.  The affinities of the EAAT subtypes for L-glutamate were similar, with Km detns. varying from 48 to 97 μm in the mammalian cell assay and from 18 to 28 μM in oocytes.  Glutamate uptake inhibitors were used to compare the pharmacologies of the EAAT subtypes.  The EAAT2 subtype was distinguishable from the EAAT1/EAAT3 subtypes by the potency of several inhibitors, but most notably by sensitivity to kainic acid (KA) and dihydrokainic acid (DHK).  KA and DHK potently inhibited EAAT2 transport, but did not significantly affect transport by EAAT1/EAAT3.  Using voltage-clamp measurements, most inhibitors were found to be substrates that elicited transport currents.  In contrast, KA and DHK did not evoke currents and they were found to block EAAT2-mediated transport competitively.  This selective interaction with the EAAT2 subtype could be a significant factor in KA neurotoxicity.  These studies provide a foundation for understanding the role of glutamate transporters in human excitatory neurotransmission and in neuropathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdLh7iGWaRnbVg90H21EOLACvtfcHk0lgYsIMisFRelQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVyrsQ%253D%253D&md5=27b0072f8a4cd584e3b3bcb5582e697f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.14-09-05559.1994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.14-09-05559.1994%26sid%3Dliteratum%253Aachs%26aulast%3DArriza%26aufirst%3DJ.%26aulast%3DFairman%26aufirst%3DW.%26aulast%3DWadiche%26aufirst%3DJ.%26aulast%3DMurdoch%26aufirst%3DG.%26aulast%3DKavanaugh%26aufirst%3DM.%26aulast%3DAmara%26aufirst%3DS.%26atitle%3DFunctional%2520Comparisons%2520of%2520Three%2520Glutamate%2520Transporter%2520Subtypes%2520Cloned%2520from%2520Human%2520Motor%2520Cortex%26jtitle%3DJ.%2520Neurosci.%26date%3D1994%26volume%3D14%26spage%3D5559%26epage%3D5569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Alaux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gefflaut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Chemoenzymatic Synthesis of a Series of 4-Substituted Glutamate Analogues and Pharmacological Characterization at Human Glutamate Transporters Subtypes 1–3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7980</span><span class="NLM_x">–</span> <span class="NLM_lpage">7992</span><span class="refDoi"> DOI: 10.1021/jm050597z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050597z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2htrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7980-7992&author=S.+Alauxauthor=M.+Kuskauthor=E.+Sagotauthor=J.+Bolteauthor=A.+A.+Jensenauthor=H.+Br%C3%A4uner-Osborneauthor=T.+Gefflautauthor=L.+Bunch&title=Chemoenzymatic+Synthesis+of+a+Series+of+4-Substituted+Glutamate+Analogues+and+Pharmacological+Characterization+at+Human+Glutamate+Transporters+Subtypes+1%E2%80%933&doi=10.1021%2Fjm050597z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoenzymatic Synthesis of a Series of 4-Substituted Glutamate Analogues and Pharmacological Characterization at Human Glutamate Transporters Subtypes 1-3</span></div><div class="casAuthors">Alaux, Sebastien; Kusk, Mie; Sagot, Emanuelle; Bolte, Jean; Jensen, Anders A.; Braeuner-Osborne, Hans; Gefflaut, Thierry; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7980-7992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of L-2,4-syn-4-alkylglutamic acid analogs I (R = Me, Et, Pr, Bu, i-Pr, i-Bu, pentyl, iso-pentyl, CH2Ph) were synthesized in high yields and high enantiomeric excess (> 99%) from their corresponding 4-substituted ketoglutaric acids dilithium salts II via enzymic transamination using aspartate aminotransferase (AAT) from pig heart or E. coli.  I were evaluated as potential ligands for the glutamate transporters EAAT1, EAAT2, and EAAT3 (excitatory amino acid transporter, subtypes 1-3) in the FLIPR membrane potential (FMP) assay.  The results showed a distinct change in the pharmacol. profile when the 4-Me group (an EAAT1 substrate and EAAT2,3 inhibitor) was extended to a 4-Et group, as this analog is an inhibitor at all three subtypes, EAAT1-3.  In addn., both large and bulky hydrophobic substituents in the 4-position of L-2,4-syn-glutamic acid are allowed by all three glutamate transporter subtypes EAAT1-3 while maintaining inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSrh51A-3q1rVg90H21EOLACvtfcHk0lj-HHoOkpD0Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2htrfP&md5=5bad1a4908b9df5f7d5e8a6da9b35af7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm050597z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050597z%26sid%3Dliteratum%253Aachs%26aulast%3DAlaux%26aufirst%3DS.%26aulast%3DKusk%26aufirst%3DM.%26aulast%3DSagot%26aufirst%3DE.%26aulast%3DBolte%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DGefflaut%26aufirst%3DT.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DChemoenzymatic%2520Synthesis%2520of%2520a%2520Series%2520of%25204-Substituted%2520Glutamate%2520Analogues%2520and%2520Pharmacological%2520Characterization%2520at%2520Human%2520Glutamate%2520Transporters%2520Subtypes%25201%25E2%2580%25933%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7980%26epage%3D7992%26doi%3D10.1021%2Fjm050597z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kulkarni, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationships Comparing N-(6-Methylpyridin-Yl)-Substituted Aryl Amides to 2-Methyl-6-(Substituted-Arylethynyl)pyridines or 2-Methyl-4-(Substituted-Arylethynyl)thiazoles as Novel Metabotropic Glutamate Receptor Subtype 5 Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3563</span><span class="NLM_x">–</span> <span class="NLM_lpage">3575</span><span class="refDoi"> DOI: 10.1021/jm900172f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900172f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFWns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3563-3575&author=S.+S.+Kulkarniauthor=M.-F.+Zouauthor=J.+Caoauthor=J.+R.+Deschampsauthor=A.+L.+Rodriguezauthor=P.+J.+Connauthor=A.+H.+Newman&title=Structure-Activity+Relationships+Comparing+N-%286-Methylpyridin-Yl%29-Substituted+Aryl+Amides+to+2-Methyl-6-%28Substituted-Arylethynyl%29pyridines+or+2-Methyl-4-%28Substituted-Arylethynyl%29thiazoles+as+Novel+Metabotropic+Glutamate+Receptor+Subtype+5+Antagonists&doi=10.1021%2Fjm900172f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships Comparing N-(6-Methylpyridin-yl)-Substituted Aryl Amides to 2-Methyl-6-(substituted-arylethynyl)pyridines or 2-Methyl-4-(substituted-arylethynyl)thiazoles as Novel Metabotropic Glutamate Receptor Subtype 5 Antagonists</span></div><div class="casAuthors">Kulkarni, Santosh S.; Zou, Mu-Fa; Cao, Jianjing; Deschamps, Jeffrey R.; Rodriguez, Alice L.; Conn, P. Jeffrey; Hauck Newman, Amy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3563-3575</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metabotropic glutamate receptor subtype 5 (mGluR5) has been implicated in anxiety, depression, pain, mental retardation, and addiction.  The potent and selective noncompetitive mGluR5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP, 1) has been a critically important tool used to further elucidate the role of mGluR5 in these CNS disorders.  In an effort to provide novel and structurally diverse selective mGluR5 antagonists, we previously described a set of analogs with moderate activity wherein the alkyne bond was replaced with an amide group.  In the present report, extended series of both amide and alkyne-based ligands were synthesized.  MGluR5 binding and functional data were obtained that identified (1) several novel alkynes with comparable affinities to 1 at mGluR5 (e.g., 10 and 20-23), but (2) most structural variations to the amide template were not well tolerated, although a few potent amides were discovered (e.g., 55 and 56).  Several of these novel analogs show drug-like phys. properties (e.g., cLogP range = 2-5) that support their use for in vivo investigation into the role of mGluR5 in CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvM-VWtFX94LVg90H21EOLACvtfcHk0lj-HHoOkpD0Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFWns7g%253D&md5=4396120f547f4ecd5ef92a02b50ed77f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm900172f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900172f%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BS.%26aulast%3DZou%26aufirst%3DM.-F.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DStructure-Activity%2520Relationships%2520Comparing%2520N-%25286-Methylpyridin-Yl%2529-Substituted%2520Aryl%2520Amides%2520to%25202-Methyl-6-%2528Substituted-Arylethynyl%2529pyridines%2520or%25202-Methyl-4-%2528Substituted-Arylethynyl%2529thiazoles%2520as%2520Novel%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3563%26epage%3D3575%26doi%3D10.1021%2Fjm900172f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pomel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgat-Charvillon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valognes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillieron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Françon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rückle, T.</span><span> </span><span class="NLM_article-title">Furan-2-Ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase Gamma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3857</span><span class="NLM_x">–</span> <span class="NLM_lpage">3871</span><span class="refDoi"> DOI: 10.1021/jm0601598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0601598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3857-3871&author=V.+Pomelauthor=J.+Klicicauthor=D.+Coviniauthor=D.+D.+Churchauthor=J.+P.+Shawauthor=K.+Roulinauthor=F.+Burgat-Charvillonauthor=D.+Valognesauthor=M.+Campsauthor=C.+Chabertauthor=C.+Gillieronauthor=B.+Fran%C3%A7onauthor=D.+Perrinauthor=D.+Leroyauthor=D.+Gretenerauthor=A.+Nicholsauthor=P.+A.+Vitteauthor=S.+Carboniauthor=C.+Rommelauthor=M.+K.+Schwarzauthor=T.+R%C3%BCckle&title=Furan-2-Ylmethylene+Thiazolidinediones+as+Novel%2C+Potent%2C+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+Gamma&doi=10.1021%2Fjm0601598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0601598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601598%26sid%3Dliteratum%253Aachs%26aulast%3DPomel%26aufirst%3DV.%26aulast%3DKlicic%26aufirst%3DJ.%26aulast%3DCovini%26aufirst%3DD.%26aulast%3DChurch%26aufirst%3DD.%2BD.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DRoulin%26aufirst%3DK.%26aulast%3DBurgat-Charvillon%26aufirst%3DF.%26aulast%3DValognes%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DGillieron%26aufirst%3DC.%26aulast%3DFran%25C3%25A7on%26aufirst%3DB.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DGretener%26aufirst%3DD.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DVitte%26aufirst%3DP.%2BA.%26aulast%3DCarboni%26aufirst%3DS.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26atitle%3DFuran-2-Ylmethylene%2520Thiazolidinediones%2520as%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520Gamma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3857%26epage%3D3871%26doi%3D10.1021%2Fjm0601598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahlke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Allosteric Modulation of an Excitatory Amino Acid Transporter: The Subtype-Selective Inhibitor UCPH-101 Exerts Sustained Inhibition of EAAT1 through an Intramonomeric Site in the Trimerization Domain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3396-12.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=10.1523%2FJNEUROSCI.3396-12.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=23325245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVemsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1068-1087&author=B.+Abrahamsenauthor=N.+Schneiderauthor=M.+N.+Erichsenauthor=T.+H.+Huynhauthor=C.+Fahlkeauthor=L.+Bunchauthor=A.+A.+Jensen&title=Allosteric+Modulation+of+an+Excitatory+Amino+Acid+Transporter%3A+The+Subtype-Selective+Inhibitor+UCPH-101+Exerts+Sustained+Inhibition+of+EAAT1+through+an+Intramonomeric+Site+in+the+Trimerization+Domain&doi=10.1523%2FJNEUROSCI.3396-12.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of an excitatory amino acid transporter:the subtype-selective inhibitor UCPH-101 exerts sustained inhibition of EAAT1 through an intramonomeric site in the trimerization domain</span></div><div class="casAuthors">Abrahamsen, Bjarke; Schneider, Nicole; Erichsen, Mette N.; Huynh, Tri H. V.; Fahlke, Christoph; Bunch, Lennart; Jensen, Anders A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1068-1087</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In the present study, the mechanism of action and mol. basis for the activity of the first class of selective inhibitors of the human excitatory amino acid transporter subtype 1 (EAAT1) and its rodent ortholog GLAST are elucidated.  The previously reported specificity of UCPH-101 and UCPH-102 for EAAT1 over EAAT2 and EAAT3 is demonstrated to extend to the EAAT4 and EAAT5 subtypes as well.  Interestingly, brief exposure to UCPH-101 induces a long-lasting inactive state of EAAT1, whereas the inhibition exerted by closely related analogs is substantially more reversible in nature.  In agreement with this, the kinetic properties of UCPH-101 unblocking of the transporter are considerably slower than those of UCPH-102.  UCPH-101 exhibits noncompetitive inhibition of EAAT1, and its binding site in GLAST has been delineated in an elaborate mutagenesis study.  Substitutions of several residues in TM3, TM4c, and TM7a of GLAST have detrimental effects on the inhibitory potency and/or efficacy of UCPH-101 while not affecting the pharmacol. properties of (S)-glutamate or the competitive EAAT inhibitor TBOA significantly.  Hence, UCPH-101 is proposed to target a predominantly hydrophobic crevice in the "trimerization domain" of the GLAST monomer, and the inhibitor is demonstrated to inhibit the uptake through the monomer that it binds to exclusively and not to affect substrate translocation through the other monomers in the GLAST trimer.  The allosteric mode of UCPH-101 inhibition underlines the functional importance of the trimerization domain of the EAAT and demonstrates the feasibility of modulating transporter function through ligand binding to regions distant from its "transport domain.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARUXvJR5bE7Vg90H21EOLACvtfcHk0ljd3HOqtm4KYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVemsLg%253D&md5=5e2b79367256a04008e6180cb9856d6f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3396-12.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3396-12.2013%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DSchneider%26aufirst%3DN.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%26aulast%3DFahlke%26aufirst%3DC.%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DAllosteric%2520Modulation%2520of%2520an%2520Excitatory%2520Amino%2520Acid%2520Transporter%253A%2520The%2520Subtype-Selective%2520Inhibitor%2520UCPH-101%2520Exerts%2520Sustained%2520Inhibition%2520of%2520EAAT1%2520through%2520an%2520Intramonomeric%2520Site%2520in%2520the%2520Trimerization%2520Domain%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D1068%26epage%3D1087%26doi%3D10.1523%2FJNEUROSCI.3396-12.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d46e3952-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i64"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01058">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61336"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01058">10.1021/acs.jmedchem.6b01058</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01058/suppl_file/jm6b01058_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01058/suppl_file/jm6b01058_si_001.csv">jm6b01058_si_001.csv (3.68 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01058%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-19" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01058" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997917af102398","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
